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baCkgROund
Asthma is a common disease during childhood. The prevalence of asthma symptoms ranges from 
20% in preschool children with wheezing, to 5% at school age with a doctor diagnosis of asthma1 2. 
In the Netherlands, around 3.5% of school-aged children visit the doctor for asthma3.
Asthma is a heterogeneous disease, characterized by chronic airway inflammation. Symptoms 
include episodes of wheezing, shortness of breath and cough, which can be triggered by factors 
such as allergens or infections4. Diagnosis is based on history of respiratory symptoms, combined 
with variable expiratory airflow limitation. The most commonly used lung function test for the 
diagnosis of asthma is spirometry. Most typically, spirometry in asthmatic children would demon-
strate airway obstruction, reflected by a lower Forced Expiratory Volume in the first second (FEV1), 
or a lower FEV1/Forced Vital Capacity (FVC). Additionally, the Forced Expiratory Flow after exhaling 
75% of the FVC (FEF75) could be decreased, which reflects airflow limitation of the smaller airways5. 
However, lung function as measured by spirometry is not necessarily abnormal in children with 
asthma, which is reflected by a high positive predicting value, but a low negative predicting value6.
It has been proposed that asthma has its origins in early life7 8. Early-life exposures and in-
fectious diseases could have an effect on the developing immune and respiratory systems. This 
might lead to developmental adaptations, resulting in a lower lung function and an increased risk 
of asthma in later childhood. Additionally, lower lung function and asthma in childhood might 
predispose to respiratory disease in adulthood, such as chronic obstructive pulmonary disease9 10.
Various environmental exposures during fetal life and infancy could be related to childhood 
lung function and asthma, possibly through a mediating effect of lower respiratory tract infec-
tions. Both infections during fetal life or childhood, as well as carriage of bacteria, either specific 
or combined in the microbiome, might be associated with childhood lung function and asthma. 
Lastly, respiratory tract infections and airway bacteria might influence each other, further compli-
cating the possible relation with lung function and asthma. The identification of these early-life 
exposures and infectious diseases contributing to adverse respiratory health helps to understand 
the development of disease, and is the first step for developing future prevention strategies.
fetal and infant exposures
Previously, maternal psychological distress during pregnancy has been associated with an up to 
2-fold increased risk of wheezing and asthma in the offspring at preschool age11-13. An underly-
ing mechanism could be disturbances in the development of the fetal hypothalamic-pituitary-
adrenal axis14 15. Unmeasured confounding of socio-economic and lifestyle factors might play a 
role as well. Maternal psychological distress reflects intra-uterine mechanisms, while paternal 
psychological distress reflects unmeasured confounding od socio-economic and lifestyle factors. 
Therefore, studying both maternal and paternal psychological distress during pregnancy might 
help in understanding the associations of exposure to psychological distress during pregnancy 
with childhood asthma16. Their long-term effects need to be elucidated. Additionally, psycho-
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logical distress during pregnancy might be associated with lower respiratory tract infections, and 
these infections might mediate the association of psychological distress during pregnancy with 
childhood lung function and asthma17.
During infancy, breastfeeding, and specifically exclusive or prolonged breastfeeding is protec-
tive against early-life respiratory tract infections, wheezing and asthma18-20. Whether there is 
an effect of breastfeeding on lung function or asthma at school-age remains inconclusive21 22. 
Possibly, associations of breastfeeding with later-life respiratory health might be mediated by 
early-life respiratory tract infections.
Fetal and childhood infections
The immune system plays a key role in the pathogenesis of asthma23. Early-life infections might 
lead to a disturbance of the still developing immune system, thereby affecting the risk of asthma. 
Upper respiratory tract infections, such as the non-specific common cold, are very frequent in the 
first years of life24 25. The prevalence of specific upper respiratory tract infections, such as otitis 
media, is 0.3-1.6 episodes per child year24 25. The prevalence of lower respiratory tract infections, 
such as pneumonia and bronchitis, has been estimated at 0.02-0.37 episodes per child year24 26. 
Early-life respiratory tract infections have been associated with an increased risk of asthma in 
early childhood, and chronic obstructive respiratory disease in adulthood27-30. One of the pro-
posed mechanisms for these associations is allergic sensitization, leading to airway inflammation, 
obstruction and hyperreactivity31-33. Thus far, the associations of respiratory tract infections with 
respiratory health at school age, specifically lung function, are not well known.
Specifically, maternal Chlamydia trachomatis infection during pregnancy may predispose 
individuals to an increased risk of childhood asthma. Maternal Chlamydia trachomatis infection 
during pregnancy has been associated with chorioamnionitis, which might lead to fetal immune 
changes, such as increased production of Interleukins or IgE34-37. Mice studies have demonstrated 
that the murine biovar of Chlamydia trachomatis, is associated with specific IgE in broncho-
alveolar lavage fluid and an increased production of interleukins when mice are infected in the 
neonatal period38. Additionally, infection in these mice in the neonatal period is associated with 
an increase in alveolar diameter, suggesting that the infection also has an effect on the respiratory 
system39. Lastly, Chlamydia trachomatis has been associated with an increased risk of prematu-
rity, which could be a mediator in the association with asthma40-42. In humans, it is unknown if 
maternal Chlamydia trachomatis infection during pregnancy affects the risk of childhood asthma.
Viral infections during childhood might also affect the immune system and thereby the risk of 
asthma . Specifically, Epstein-Barr virus and Cytomegalovirus have been proposed to be associated 
with atopy43-46. Infection with either of these herpesviridae is common in childhood47 48. The immune 
response to these infections is however different, with predominantly a T-helper-2 type response 
for Epstein-Barr virus, and a T-helper-1 type response for Cytomegalovirus49 50. Therefore, infection, 
and specifically possible combinations of these infections, might lead to a T-helper cell mediated re-
sponse including memory T-cell expansions, and subsequently an increased risk of asthma or atopy.
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Childhood bacterial carriage and the microbiome
Next to infections, bacterial carriage or the microbiome may be important for development of 
childhood asthma.51. Both bacterial carriage and the microbiome reflect the community of micro-
organisms in or on the human body. The most interesting locations of the microbiome related to 
respiratory health are the airway and the gut52-55.
Airway bacterial carriage, specifically carriage of Haemophilus influenzae, Moraxella catarrhalis 
and Streptococcus pneumonia in infancy, has been associated with an increased risk of lower 
respiratory tract infections, wheezing and asthma56 57. Respiratory tract infections might also 
influence airway bacterial carriage58-61. The specific direction of the associations between airway 
bacterial carriage and respiratory tract infections, as well as the associations of airway bacterial 
carriage with respiratory health outcomes at school age has not been established yet.
Rather than a focus on specific bacteria, recent developments enable analysis of the complete 
microbiome in large observational studies, 55. Shifts in microbiome composition are suggested to 
have localized but also systemic effects on maturation of the immune system, and may promote 
a more inflammatory state by evoking T-helper mediating response that suppresses T-helper 
2 activity62 . In children, the gut microbiome has been associated with the risk of respiratory 
morbidity53 63 64. Specifically, the gut microbiome seems to be important for the development 
of respiratory health in preschool children. The role of the gut microbiome in later childhood in 
relation to atopic disease and respiratory health remains unclear.
hyPOThESIS
The main hypothesis for this thesis is that factors in early-life, especially infections and bacteria, 
induce developmental adaptations in the pulmonary and immune system, which subsequently 
lead to an increased risk of lower lung function and asthma in childhood (Figure 1.1).
ObjECTIvES
The major aims of this thesis are:
1. To assess whether fetal and infant exposures, such as maternal psychological distress during 
pregnancy and breastfeeding, are associated with school-age lung function and asthma, and 
whether these associations are mediated by lower respiratory tract infections.
2. To assess whether fetal and childhood respiratory and other infections are associated with 
childhood respiratory health.
3. To assess whether childhood airway bacterial carriage and the gut microbiome are associated 
with childhood respiratory health.
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gEnERal dESIgn
The studies presented in this thesis were embedded in a populati on-based prospecti ve cohort 
study, the Generati on R Study, and an internati onal collaborati on of diff erent cohort studies.
The Generati on R Study
The Generati on R Study is a populati on-based prospecti ve cohort study from fetal life onwards65. The 
study is designed to identi fy early environmental and geneti cs causes and causal pathways leading to 
normal and abnormal growth, development and health from fetal life, into childhood and adulthood. 
Enrolment was aimed in the fi rst trimester, but was allowed unti l birth of the child. In total, 9,778 
mothers with a delivery date from April 2002 unti l January 2006 were enrolled in the study. A total 
of 1,232 pregnant women and their children form the focus cohort, a subgroup of Dutch children 
for additi onal detailed studies66. At enrolment during pregnancy, urine samples were collected and 
tested for Chlamydia trachomati s in a subgroup of 4,055 women. During the 2nd trimester, maternal 
and paternal psychological distress was assessed by questi onnaires. Informati on on birth charac-
teristi cs such as gestati onal age at birth and birth weight was obtained from midwife and hospital 
registries. During the preschool period, unti l age 4 years, informati on was mostly obtained from 
postal questi onnaires, and included questi ons on wheezing and respiratory tract infecti ons. In the 
focus cohort, detailed measurements were performed in the preschool period, including repeated 
assessment of airway bacterial carriage. At age 6 years, IgG anti bodies against Cytomegalovirus and 
Epstein-Barr virus were measured. At age 10 years, lung functi on was measured by spirometry ac-
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Figure 1.1. Overview of exposures infl uencing childhood asthma development studied in this thesis.
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cording to the American Thoracic Society/European Respiratory Society (ATS/ERS) guidelines at our 
research center67. Informati on on wheezing and ever diagnosis of asthma was obtained by parental 
questi onnaires based on the Internati onal Study on Asthma and Allergy in Childhood (ISAAC)68. Cur-
rent asthma, defi ned as ever diagnosis of asthma with either wheezing or asthma medicati on use in 
the past 12 months. Informati on on inhalant allergic sensiti zati on was obtained by skin-prick tests. 
Stool samples were collected for assessment of the gut microbiome (Figure 1.2).
 ENROLMENT 
Enrolment was aimed at early pregnancy, but was 
allowed until birth 
FETAL PERIOD 
Questionnaires on parental socio-demographic and 
lifestyle related factors, including psychological distress 
Hands-on measurements including urine sample 
BIRTH 
Information on birth characteristics obtained from midwife 
and hospital registries 
PRESCHOOL AGE (0-4 YEARS) 
Questionnaires on lifestyle and health, including parental 
psychological distress, and child’s breastfeeding, 
respiratory tract infections and wheezing 
Hands-on measurements, including nasal and 
nasopharyngeal swabs for airway bacterial carriage 
 
SCHOOL AGE (6 YEARS) 
Questionnaires on lifestyle and health, including 
respiratory tract infections and wheezing 
Hands-on measurement including blood samples for IgG 
antibodies for Cytomegalovirus and Epstein-Barr virus 
SCHOOL AGE (10 YEARS) 
Questionnaires on lifestyle and health, including asthma 
and wheezing 
Hands-on measurement including spirometry for lung 
function, skin prick test for allergic sensitization, and 
stool sample for gut microbiome 
Figure 1.2 Overview of data collecti on of the Generati on R Study used in this thesis
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Eu Child Cohort network
A meta-analysis was conducted within the framework of the LifeCycle Project. European preg-
nancy and birth cohorts were identified from existing collaborations and literature and together 
form the EU Child Cohort Network. Inclusion criteria were cohorts that had included children 
born between 1989 and 2013, had available data on respiratory tract infections in early life and 
childhood lung function and/or asthma, and were willing and able to exchange original data. We 
selected European cohorts from both the LifeCycle project and other existing collaborations.
OuTlInE Of ThIS ThESIS
Chapter 2 focuses on the association of fetal and infant exposures with childhood respira-
tory health. In Chapter 2,1, the influence of parental psychological distress during pregnancy on 
school-age lung function and asthma is examined and discussed. The association of breastfeeding 
with school-age lung function and asthma is the focus of Chapter 2.2 In Chapter 3, associations 
of early-life respiratory and other infections with later-life childhood respiratory health are 
analysed. The association of respiratory tract infections with lung function and asthma in the 
Generation R Study, and in an international collaboration, are presented in Chapters 3.1 and 3.2, 
respectively. Chapter 3.3 focuses on the association of maternal Chlamydia trachomatis infection 
during pregnancy with childhood lower respiratory tract infections and wheezing, and school-age 
lung function and asthma. The associations of childhood Epstein-Barr virus and Cytomegalovirus 
infection with school age-lung function and asthma are described in Chapter 3.4. Chapter 4 
examines the effects of airway bacterial carriage and the gut microbiome on respiratory health. 
Chapter 4.1 focuses on the bidirectional associations of airway bacterial carriage with childhood 
lower respiratory tract infections, and the associations with childhood wheezing, and school-age 
lung function and asthma. The cross-sectional association of the gut microbiome with atopic and 
respiratory disease is reported in Chapter 4.2. In Chapter 4.3, an overview is given on the role of 
respiratory tract infections and the microbiome in the development of asthma. The main findings 
of this thesis and their possible implications are discussed in the general discussion in Chapter 5, 
followed by the summaries in both English and Dutch in Chapter 6.
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Parental psychological distress during 
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Although maternal psychological distress during pregnancy is associated with increased risks of 
respiratory morbidity in preschool children, it is unknown whether this association persists into 
later childhood.
Objective
To examine the association of parental psychological distress during pregnancy with lung function 
and asthma at school-age.
Methods
This study of 4,231 children was embedded in a population-based prospective cohort. Parental 
psychological distress were assessed by the Brief Symptom Inventory during and 3 years after 
pregnancy, and in mothers also at 2 and 6 months after pregnancy. At age 10 years, lung function 
was obtained by spirometry, and asthma by questionnaire.
Results
Prevalence of asthma was 5.9%. Maternal overall psychological distress during pregnancy was 
associated with a lower forced vital capacity (FVC) (z-score difference (95% CI): -0.10 (-0.20, 
-0.01) per 1-unit increase), maternal depressive symptoms during pregnancy with a lower forced 
expiratory volume in the first second (FEV1) and FVC (-0.13 (-0.24, -0.01) and -0.13 (-0.24, -0.02) 
when using clinical cut-offs) in their children. All maternal psychological distress measures during 
pregnancy were associated with an increased risk of asthma (range OR (95% CI): 1.46 (1.12, 1.90) 
to 1.91 (1.26, 2.91)). Additional adjustment for paternal psychological distress during pregnancy, 
and parental psychological distress after pregnancy did not materially change the associations. 
Paternal psychological distress during pregnancy was not associated with childhood respiratory 
morbidity.
Conclusion
Maternal, not paternal, psychological distress during pregnancy is associated with an increased 
risk of asthma, and partly lower lung function in children. This suggests intrauterine programming 
for the risk of later-life respiratory disease.
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InTROduCTIOn
Early life is a sensitive period for the development of respiratory health1. We, and others, previ-
ously showed that maternal psychological distress during pregnancy is associated with increased 
risks of wheezing and asthma in their preschool-aged children2-7. This suggests a potential role 
of intrauterine mechanisms, such as altered programming of the fetal hypothalamic–pitu-
itary–adrenal (HPA) axis, leading to adaptive airway and lung development and asthma8-10. The 
association of maternal psychological distress during pregnancy with childhood asthma might 
also be explained by residual confounding factors, such as unmeasured genetic, social, behavioral 
or environmental factors. Since these residual confounding factors are shared by mother and 
father, while only maternal psychological distress might have intra-uterine effects, examining 
paternal psychological distress during pregnancy in relation to childhood asthma is of importance 
to account for these residual confounders3 11. Only few studies measured paternal psychological 
distress, and observed that this is not associated with an increased risk of respiratory symptoms 
in early childhood, suggesting an intra-uterine effect2 3 7. To date, the associations of maternal 
and paternal psychological distress during pregnancy with asthma in later childhood, and the 
association with lung function are not fully clear12 13. We hypothesize that maternal psychological 
distress during pregnancy, but not paternal psychological distress, is associated with school-age 
lower lung function and asthma, suggesting intrauterine programming for the risk of respiratory 
disease.
Therefore, we examined the association of maternal psychological distress during pregnancy 
with lung function and asthma in children aged 10 years in a population-based prospective study. 
Further, we assessed whether these associations were independent of paternal psychological 
distress during pregnancy, and parental psychological distress after pregnancy.
METhOdS
Design
This study was embedded in the Generation R Study, a population-based prospective cohort study 
from early fetal life onwards in Rotterdam, the Netherlands14. The study has been approved by the 
Medical Ethical Committee of the Erasmus MC, University Medical Centre in Rotterdam. Written 
informed consent was obtained from all parents or legal guardians of the participants. Children 
from twin pregnancies (n=185), with missing information on maternal psychological distress dur-
ing pregnancy (n=2,595) or missing information on both lung function and asthma (n=382) were 
excluded, which left a total of 4,231 subjects at age 10 years for the current analyses.
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Maternal and paternal psychological distress
Maternal and paternal psychological distress were assessed by questionnaires completed in the 
2nd trimester of pregnancy and 3 years after pregnancy. Both parents were asked to complete 
their own questionnaires. At 2 and 6 months after pregnancy, only maternal psychological distress 
was assessed. We used the Brief Symptom Inventory, a validated 53-item self-report question-
naire covering a broad spectrum of psychological distress experienced in the last 7 days15 16. A 
global scale (Global Severity Index (GSI)) and nine symptom scales were defined17 18. The GSI 
is a measure of the current level or the depth of symptoms and denotes overall psychological 
distress. Of the symptom scales, we used the depressive and anxiety symptom scale only since 
in general, depression and anxiety are considered the most common psychological distress dur-
ing and after pregnancy. Other subscales encompass less prevalent disorders as somatization, 
obsessive-compulsion, interpersonal sensitivity, hostility, phobia, paranoia and psychoticism. All 
scales were repeated at 2 months after pregnancy, and 6 months and 3 years after pregnancy, 
only depressive and anxiety symptoms were used. All items (53 for the GSI and 6 for both depres-
sive and anxiety symptoms) were rated on a 5-point unidimensional scale ranging from 0 (‘not 
at all’) to 4 (‘extremely’). Total scores for each scale were calculated by summing the item scores 
and dividing this by the number of endorsed items. Based on Dutch cut-off values, mothers and 
fathers were categorized as having clinically relevant psychological distress (no; yes) when having 
a score of ≥ 0.71 or ≥ 0.66 on the global scale, ≥ 0.80 or ≥ 0.71 on the depressive symptom scale 
and ≥ 0.71 or ≥ 0.65 on the anxiety symptom scale, respectively19. The Cronbach’s alpha, reflect-
ing internal consistency of the different scales ranged from 0.72 to 0.93, which is considered 
acceptable to excellent. Spearman correlations between parental psychological distress during 
and after pregnancy varied between 0.29 and 0.45 (weak to moderate), and between maternal 
and paternal psychological distress between 0.12 and 0.23 (very weak to weak).
School-age lung function and asthma
Lung function was measured by spirometry at the age of 10 years (median 9.7 (5-95% range 9.5-
10.3)), as reported earlier20. In short, forced expiratory volume in 1 second (FEV1), forced vital ca-
pacity (FVC), FEV1/FVC, and forced expiratory flow after exhaling 75% of FVC (FEF75) were measured 
in accordance with the American Thoracic Society (ATS) and European Respiratory Society (ERS) 
recommendations, and converted into sex-, height-, age-, and ethnicity adjusted z-scores accord-
ing to the Global Lung Initiative reference data21 22. Additionally, we included 281 children whose 
spirometry did not meet formal reproducibility criteria, but who had at least one adequate curve 
with respect to reach and duration of plateau according to ATS/ERS criteria. Observed sizes and di-
rection of effect estimates were similar as to when these children were excluded23. Current asthma 
was defined as ever diagnosis of asthma, with either wheezing or any asthma medication use in the 
past 12 months at the age of 10 years. Information on asthma diagnosis and wheezing was obtained 
by a parental questionnaire, based on the International Study on Asthma and Allergy in Childhood 
(ISAAC) Questionnaire (“Has your child ever had asthma diagnosed by a doctor?” and “Has your 
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child suffered from attacks of wheezing in the chest in the past 12 months?”).24Information on 
asthma medication use was obtained during the visit to our research center.
Covariates
Information on maternal characteristics included age, parity, ethnicity, educational level, smoking 
during pregnancy, body mass index at enrollment, history of asthma and atopy, and pet keep-
ing, and were obtained from multiple questionnaires during pregnancy. Information on paternal 
characteristics included age, ethnicity, educational level, smoking before pregnancy, body mass 
index at enrolment, and history of asthma and atopy, and were obtained by a questionnaire dur-
ing pregnancy. Information on child’s sex, gestational age at birth, and birthweight were obtained 
from midwife and hospital records. Information on child’s ethnicity was based on questionnaires 
during pregnancy, and information on breastfeeding and daycare attendance were obtained by 
questionnaires in the first year of life. Information on childhood lower respiratory tract infec-
tions (<3 years and >3-6 years) was assessed by yearly questionnaires, and included pneumonia, 
bronchitis and bronchiolitis.
Statistical analysis
First, we compared the characteristics of children included in and excluded from our study due 
to loss to follow-up by using Man-Whitney U tests, T-tests and Chi square tests. Second, we used 
linear and logistic regression models to study the associations of maternal psychological distress 
during pregnancy with lung function and current asthma, respectively. Overall psychological 
distress, depressive and anxiety symptoms were studied separately, and both continuous mea-
sures and clinical cut-offs were used. Analyses were adjusted for confounders, which were first 
selected from the literature, and subsequently included in the model if they were associated with 
maternal psychological distress and lung function or asthma, or if the effect sizes of unadjusted 
analyses changed 10% or more after adding a confounder (main model). All confounders selected 
from literature met these criteria, and we therefore included all confounders in the model. Ad-
ditionally, we added paternal psychological distress during pregnancy to the model, to minimize 
the potential correlated effect of maternal and paternal psychological distress during pregnancy 
on childhood lung function and asthma, and assess the individual effect of maternal psychological 
distress during pregnancy. Next, we added maternal psychological distress after pregnancy to the 
main model as a mediator to disentangle the individual effect of maternal psychological distress 
during pregnancy on respiratory morbidity of the child. We assessed the change in effect esti-
mates for the associations of maternal psychological distress during pregnancy with lung function 
and asthma, after additional adjustment for maternal psychological distress after pregnancy, by 
using the following formulas for percentage change: and 100 * (Effect estimatefull model – Effect 
estimateoriginal model)/(Effect estimateoriginal model) for continuous lung function measures, and 100 * 
(Effect estimatefull model – Effect estimateoriginal model)/(Effect estimateoriginal model – 1) for categorical 
asthma. All other confounders were kept similar to the model with only maternal distress during 
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pregnancy, to ascertain that the change in effect estimate is only due to the additional adjustment 
for parental psychological distress after pregnancy.
To assess residual confounding effects of unmeasured genetic, social, behavioral or environmen-
tal factors, we studied the associations of paternal psychological distress during pregnancy with lung 
function and asthma. Additionally, we adjusted the associations for paternal psychological distress 
after pregnancy including change in effect estimates similar as for maternal psychological distress. 
Last, we assessed whether associations of maternal psychological distress during pregnancy with 
lung function and asthma were mediated by childhood lower respiratory tract infections.
Since parental psychological distress after pregnancy is likely to be correlated to parental dis-
tress during pregnancy, adding psychological distress after pregnancy to the model could lead to 
multicollinearity. Correlations between parental psychological distress during and after pregnancy 
were however below 0.5. Additionally, we assessed the Variance Inflation Factor and tolerance 
statistics, which are measures for multicollinearity, of the models were parental psychological 
distress after pregnancy was added to parental psychological distress during pregnancy. Both 
these measured showed no indication for multicollinearity and inflation of the model. Lastly, we 
performed a sensitivity analysis focusing on patterns of depressive and anxiety symptoms. In 
this analysis, depressive and anxiety symptoms during and after pregnancy were combined into 
the following groups: never, symptoms during pregnancy only, symptoms after pregnancy only, 
and both symptoms during and after pregnancy. Symptoms after pregnancy reflect psychological 
distress at either 2, 6 or 36 months after pregnancy.
Missing data in covariates (range between 0 and 33%), maternal psychological distress after 
pregnancy and paternal psychological distress during and after pregnancy (range between 26 and 
41%) were imputed by multiple imputation using the Markov Chain Monte Carlo method25. We only 
present the pooled results based on the imputed datasets, since we observed no major differences 
in the magnitude or direction of the effect when compared to complete case analysis. All measures 
of association are presented with their 95% Confidence Intervals (95% CI). Statistical analyses were 
performed using SPSS version 24.0 for Windows software (SPSS Inc.) and R version 3.4.1.
RESulTS
Subject’s characteristics
Parental and child characteristics are presented in Table 2.1.1 and 2.1.2, respectively. Of the 
participating mothers, 8.6% (n = 362) had clinically relevant overall psychological distress, and of 
the participating fathers, 3.9% (n = 167). The mean (SD) values for FEV1, FVC, FEV1 /FVC and FEF75 
were 2.02 L (0.30), 2.33 L (0.36), 86.72% (5.66) and 1.15 L/s (0.35), respectively. The prevalence 
of current asthma in children aged 10 years was 5.9% (n = 213). Most prominently, children lost 
to follow up had more often lower educated, non-European parents, and a lower gestational age 
at birth and birthweight (Supplementary Table S2.1.1).
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Table 2.1.1. Characteristics of mothers and fathers
n= 4,231
Mothers fathers
Age, years 30.9 (4.8) 33.4 (5.6)
Parity, nulliparous 59.5 (2,516) --
Ethnicity, non-European 31.4 (1,329) 35.6 (1,507)
Education, lower 48.1 (2,034) 48.9 (2,068)
Smoking during pregnancy, yes 26.5 (1,122) --
Smoking before pregnancy, yes -- 41.6 (1,761)
Body mass index at enrolment, kg/m2 24.5 (4.2) 25.3 (3.4)
History of asthma or atopy, yes 37.7 (1,594) 33.7 (1,425)
Pet keeping, yes 35.9 (1,520) --
Psychological distress during pregnancy
Overall psychological distress, continuously1 0.15 (0.00, 0.91) 0.08 (0.00, 0.55)
Overall psychological distress, yes 8.6 (362) 3.9 (167)
Depressive symptoms, continuously1 0.00 (0.00, 1.00) 0.00 (0.00, 0.67)
Depressive symptoms, yes 8.2 (348) 4.3 (182)
Anxiety symptoms, continuously1 0.17 (0.00, 1.00) 0.00 (0.00, 0.75)
Anxiety symptoms, yes 9.3 (395) 8.0 (337)
Psychological distress at 2 months after pregnancy
Overall psychological distress, continuously1 0.13 (0.00, 0.93) --
Overall psychological distress, yes 7.9 (333) --
Depressive symptoms, continuously1 0.00 (0.00, 1.08) --
Depressive symptoms, yes 8.2 (349) --
Anxiety symptoms, continuously1 0.00 (0.00, 1.00) --
Anxiety symptoms, yes 8.3 (350) --
Psychological distress at 6 months after pregnancy
Depressive symptoms, continuously1 0.17 (0.00, 1.17) --
Depressive symptoms, yes 8.5 (358) --
Anxiety symptoms, continuously1 0.00 (0.00, 1.17) --
Anxiety symptoms, yes 9.9 (417) --
Psychological distress at 36 months after pregnancy
Depressive symptoms, continuously1 0.00 (0.00, 0.78) 0.00 (0.00, 0.68)
Depressive symptoms, yes 5.1 (217) 4.4 (187)
Anxiety symptoms, continuously1 0.00 (0.00, 0.80) 0.00 (0.00, 0.68)
Anxiety symptoms, yes 5.1 (214) 7.7 (324)
Values are means (SD), 1medians (5-95% range) or valid percentages (absolute numbers). Data on maternal 
depressive (n=5) and anxiety (n=6) symptoms during pregnancy was missing and not imputed. Not all infor-
mation was available for both mothers and fathers, as denoted by --.
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Maternal psychological distress, lung function and asthma
Unadjusted associations of maternal psychological distress during pregnancy with school-age 
lung function and asthma can be found in Supplementary Table S2.1.2, After adjustment for 
confounders, and when studied continuously, only maternal overall psychological distress dur-
ing pregnancy was associated with a lower FVC (z-score difference (95% CI): -0.10 (-0.20, -0.01)) 
(Table 2.1.3) in their children. When using clinical cut-offs, only maternal depressive symptoms 
during pregnancy were associated with a lower FEV1 and FVC (-0.13 (-0.24, -0.01) and -0.13 (-0.24, 
-0.02), respectively). Additional adjustment for paternal psychological distress during pregnancy 
did not change the direction or magnitude of the effect (Table 2.1.4). When we additionally 
adjusted for maternal psychological distress at 2, 6 and 36 months after pregnancy, and paternal 
psychological distress 36 months after pregnancy, the size and direction of the associations of 
depressive symptoms with a lower FEV1 and FVC remained unchanged, except when adjusting 
for maternal psychological distress at 2 months (Table 2.1.5). The percentages change in effect 
estimates were, however, non-significant (data not shown).
Maternal overall psychological distress, and depressive and anxiety symptoms during preg-
nancy were all associated with an increased risk of current asthma in their children, both continu-
ously and when using clinical cut-offs (range odds ratios (95% CI): 1.46 (1.12, 1.90) to 1.91 (1.26, 
2.91)) (Table 2.1.3). When we additionally adjusted for paternal psychological distress during 
pregnancy, the associations of maternal psychological distress with asthma remained essentially 
Table 2.1.2. Characteristics of the children
n = 4,231
Sex, female 51.2 (2,166)
Gestational age at birth, weeks1 40.1 (37.1, 42.1)
Birthweight (grams) 3,450 (545)
Ethnicity, non-European 29.1 (1,233)
Ever breastfeeding, yes 90.9 (3,847)
Day care attendance 1st year, yes 57.4 (2,428)
FEV1, L 2.02 (0.30)
FVC, L 2.33 (0.36)
FEV1/FVC, % 86.72 (5.66)
FEF75, L/s 1.15 (0.35)
FEV1, z-score 0.17 (0.97)
FVC, z-score 0.21 (0.93)
FEV1/FVC, z-score -0.10 (0.94)
FEF75, z-score 0.04 (0.91)
Current asthma, yes 5.9 (213)
Values are means (SD), 1medians (5-95% range) or valid percentages (absolute numbers). Lung function mea-
sures (n=474) and current asthma (n=591) were missing and not imputed. Forced Expiratory Flow in 1 second 
(FEV1), Forced Vital Capacity (FVC), Forced Expiratory Flow after exhaling 95% of FVC (FEF75).


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































unchanged (Table 2.1.4). Additional adjustment for maternal psychological distress at 2, 6 and 
36 months after pregnancy did not change the direction or magnitude of the effect estimates for 
the association with asthma, including a non-significant percentage change in effect estimates 
(Table 2.1.5). Analysis of patterns of psychological distress demonstrated that mostly depressive 
or anxiety symptoms both during and after pregnancy are associated with an increased risk of 
asthma (Supplementary Table S2.1.3). Separating the confounders into three different groups, 
including lifestyle and health-related factors, socio-economic factors and birth and early child-
hood factors, showed no differences in size or direction of effect estimates of the associations of 
maternal psychological distress with asthma (Supplementary Table S2.1.4). However, lifestyle and 
health-related factors seemed to account for attenuation of the effect of maternal psychological 
distress with FEF75 only. Additional adjustment for childhood lower respiratory tract infections did 
not change the direction or magnitude of the effect estimates for the association with asthma, 
including a non-significant percentage change in effect estimates (data not shown).
Paternal psychological distress, lung function and asthma
Paternal psychological distress during pregnancy was not associated with lung function or asthma 
in their children (Table 2.1.6). The associations of paternal psychological distress during pregnancy 
with lung function and asthma remained essentially unchanged after additional adjustment for 
paternal psychological distress at 36 months after pregnancy (Supplementary Table S2.1.5). Only 
the associations of clinical cut-offs of anxiety with FEV1 and FVC became significant, as opposed 
to before adjustment for paternal psychological distress after birth (-0.15 (-0.29, -0.00) and -0.14 
(-0.29, -0.00), respectively). However, the percentages change for these, and other associations, 
when adding paternal psychological distress after pregnancy to the model, were non-significant 
(Supplementary Table S2.1.6).
dISCuSSIOn
The results of this prospective population-based cohort study showed that children of mothers 
with overall psychological distress, and depressive or anxiety symptoms during pregnancy had 
an increased risk of asthma at the age of 10 years. Children of mothers with overall psycho-
logical distress, when measured continuously, had a lower FVC, and children of mothers with 
depressive symptoms, when using clinical cut-offs, had a lower FEV1 and FVC. These findings 
were mostly independent of paternal psychological distress during pregnancy, and maternal and 
paternal psychological distress after pregnancy. The strongest effects were found for mothers that 
experienced psychological distress both during and after pregnancy. Although effects of distress 
during pregnancy only were not significant, this is most likely due to power, given that the effects 
estimates are in the same range as for the main analysis. Paternal psychological distress during 
pregnancy was not associated with an increased risk of lower lung function or asthma. Our results 
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may indicate an intrauterine effect of maternal psychological distress during pregnancy on fetal 
lung development and respiratory morbidity rather than an effect of unmeasured genetic, social, 
behavioral or environmental factors.
Comparison with previous studies
Studies examining the association of maternal psychological distress with childhood lung function 
are scarce. One study found that high prenatal, but also postnatal maternal psychological distress, 
measured as negative life events, was associated with a lower FEV1, FVC and mid-expiratory flow 
(FEF25-75), but not FEV1/FVC at age 7 years 26. This is in line with our study, were we demonstrate 
that the association of maternal psychological distress with a lower FEV1 and FVC remains present 
in later childhood. These significant findings, compared to the more robust findings for the asthma 
outcome, are few and effect sizes are small from a clinical perspective but of importance from an 
etiological perspective. Studies examining the association of maternal psychological stress during 
pregnancy on wheezing and asthma have been summarized in two recent meta-analyses5 6. Both 
meta-analyses focused mostly on wheezing and asthma until preschool age, with only few studies 
included that measured respiratory outcomes after the age of 6 years. One meta-analysis including 
10 studies, found that maternal psychological stress during pregnancy was associated a 1.56-fold 
increased risk of any respiratory morbidity5. When the associations with asthma and wheezing 
were studied separately, the effect sizes were approximately in the same range, although the 
latter showed high heterogeneity. The other, more recent, meta-analysis including 24 studies 
demonstrated that any maternal psychological stress during pregnancy was associated with a 
1.13-fold increased risk of asthma6. This was most likely driven by anxiety during pregnancy, since 
only this association was significant when different types of psychological distress were studied 
separately. Anxiety, depression and negative life events during pregnancy were all associated 
with an increased risk of wheezing (OR or RR 1.19, 1.74 and 1.23, respectively). Our study dem-
onstrates that maternal stress during pregnancy is associated with an increased risk of asthma 
even at a later age, with effect sizes within the same range. Additionally, we demonstrated that 
these results are independent of paternal psychological distress during pregnancy and parental 
psychological distress after pregnancy, which was not studied in these meta-analyses.
Possible mechanisms
Our results suggest that intrauterine mechanisms may underlie the associations of maternal 
psychological distress with childhood lung function and asthma in their children, rather than 
unmeasured genetic, social, behavioral or environmental factors. One potential intrauterine 
mechanism is excess of glucocorticoid production due to maternal psychological distress, which 
could lead impaired development of the fetal HPA axis8. Additionally, maternal psychological 
distress could influence the stimulation of corticotrophin releasing hormone (CRH) secretion, 
which results in increased CRH levels in the foetal circulation and could overstimulate the foetal 
HPA axis. Moreover, glucocorticoid-regulated genes are key to fetal lung development, especially 
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during the first and second trimesters of pregnancy9. Any disruption in this process could lead to 
developmental adaptations of the lungs and hence, altered lung function.
Further, epigenetics has been proposed as a possible mechanism. It has been demonstrated 
that maternal depression and anxiety are associated with methylation of the glucocorticoid 
receptor gene NR3C1 in cord blood27. Additionally, one study demonstrated an association of 
prenatal maternal stress with differently methylated regions (DMRs) related to the HPA axis, 
immune responses, and lung organogenesis28. Lastly, oxidative stress and the microbiome have 
been speculated as possible underlying mechanisms for the association of maternal psychological 
distress during pregnancy with offspring lung function and asthma29-31. However, these mecha-
nisms should be studied in more detail.
Strengths and limitations
The major strength of this study is the use of a large population-based prospective cohort with 
follow-up until school age. In our study, we used a well-known measure of psychological distress, 
frequently used in epidemiological studies to assess psychological distress at multiple time points, 
both continuously and with clinical cut-offs. Additionally, we adjusted for multiple possible con-
founding factors, and considered paternal psychological distress to assess unmeasured confound-
ing factors. Some methodological limitations should be discussed. As in any prospective cohort 
study, our population was subject to loss to follow-up. Of those with singleton live-born children 
with consent at age 10 years, 73% responded to the questionnaire measuring psychological dis-
tress. This loss to follow-up could lead to bias if the associations of maternal psychological distress 
during pregnancy with lung function and asthma were different between those included and 
not included in the study. This could lead to both an under- or overestimation of the association 
and, although this is unlikely it cannot be excluded32. Additionally, self-reporting of exposure and 
outcomes could potentially lead to information bias which could lead to misclassification. The use 
of validated questionnaires could have minimized the information bias. The prevalence of asthma 
seems relatively low, but lies within national and worldwide prevalence rates33 34. We consider 
the self-reported asthma as truly asthma because questions were based on the validated ISAAC 
Questionnaire, and wheezing or asthma medication use in the past 12 months were used to bet-
ter define current asthma. Additionally, results were similar when we used persistent asthma as 
an outcome (data not shown). Moreover, psychological distress was measured only once during 
pregnancy. Hence, we do not know whether maternal psychological distress varied in intensity or 
persistence throughout pregnancy. However, one study that measured maternal anxiety at 2 time 
points during pregnancy demonstrated associations with asthma that were comparable for both 
time points, suggesting that timing in pregnancy seems to have a less prominent role in prenatal 
programming2. Still, future studies need to confirm these results. Lastly, although we adjusted for 
numerous confounders, we might not have had information on all possible confounding factors, 
such as maternal or child genetic predisposition for psychological stress disorders, or childhood 
exposures such as air pollution. Although some of their effects might be minimal and are highly 
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correlated with presently used confounders, they could potentially have a substantial effect given 
the relatively small prevalence of asthma.
In conclusion, our results suggest a possible intrauterine effect of maternal psychological 
distress during pregnancy on the risk of asthma and partly lower lung function in children at the 
age of 10 years. Results were independent of maternal psychological distress after pregnancy and 
paternal psychological distress during pregnancy and after pregnancy. Further studies are needed 
to explore underlying mechanisms.
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Age (years) 30.9 (4.8) 30.1 (7.8) <0.001
Parity, nulliparous (%) 59.5 (2,516) 47.1 (1,488) <0.001
Ethnicity, non-European (%) 30.9 (1,289) 45.1 (1,325) <0.001
Education, lower (%) 47.2 (1,937) 60.8 (1,587) <0.001
Smoking during pregnancy, yes (%) 24.2 (941) 22.2 (366) 0.112
History of asthma or atopy, yes (%) 37.6 (1,434) 36.2 (591) 0.329
Pet keeping, yes (%) 34.9 (1,310) 29.6 (348) 0.001
Body mass index at enrolment (kg/m2) 24.5 (4.17) 25.2 (4.7) <0.001
Maternal overall psychological distress during pregnancy1 0.15 (0.00, 0.91) 0.15 (0.00, 1.21) 0.268
Paternal Characteristics
Age (years) 33.4 (5.4) 33.3 (5.5) 0.790
Ethnicity, non-European (%) 25.1 (865) 34.5 (496) <0.001
Education, lower (%) 54.7 (1,743) 49.6 (598) 0.003
Smoking before pregnancy, yes (%) 42.2 (1,639) 42.5 (517) 0.307
History of asthma or atopy, yes (%) 32.2 (1,005) 32.6 (360) 0.803
Body mass index at enrollment (kg/m2) 25.2 (3.3) 25.4 (3.6) 0.070
Paternal overall psychological distress during pregnancy1 0.06 (0.00, 0.51) 0.08 (0.00, 0.54) 0.568
Child characteristics
Sex, female (%) 51.2 (2,166) 48.1 (1,520) 0.008
Gestational age at birth (weeks)1 40.1 (37.1, 42.1) 39.9 (36.0, 42.0) <0.001
Birth weight (grams) 3,450 (544) 3,354 (605) <0.001
Ethnicity, non-European (%) 28.7 (1,207) 41.5 (1,220) <0.001
Ever breastfeeding, yes (%) 92.6 (3,290) 91.7 (1,390) 0.252
Day care attendance 1st year, yes (%) 63.3 (1,791) 58.1 (548) 0.005
Values are means (SD), 1medians (5-95% range) or valid percentages (absolute numbers) based on observed 
data. P values for difference are calculated by independent sample T-test for continuous variables with a nor-
mal distribution, the Mann-Whitney U-test for continuous variables with a skewed distribution, and Pearson’s 
Chi-square test for categorical variables.






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Durati on and exclusiveness of 
breastf eeding and school-age lung functi on 
and asthma
van Meel ER, de Jong M, Elbert NJ, den Dekker HT, Reiss IK, de Jongste JC, 
Jaddoe VWV, Duijts L.




Breastfeeding reduces the risk of asthma in early childhood, but it is not clear whether its effect 
on respiratory morbidity is still present in later childhood.
Objective
We examined the associations of any breastfeeding, breastfeeding duration and exclusiveness 
with lung function and asthma in school-aged children, and whether associations were influenced 
by respiratory tract infections and maternal or child’s atopic status.
Methods
This study among 4,464 children was embedded in a population-based prospective cohort study. 
Information on breastfeeding was obtained by multiple questionnaires from birth until age 1 year. 
At age 10 years, lung function was measured by spirometry, and information on asthma was 
obtained by questionnaire. Adjusted linear and logistic regression models were used to examine 
the associations.
Results
Shorter duration of breastfeeding was associated with a lower Forced Expiratory Volume in 1 
second (FEV1) only (Z-score change (95% CI): -0.01 (-0.02, -0.00) per month shorter breastfeed-
ing), but not asthma. When categorized, breastfeeding for 2-4 months was associated with a 
lower Forced Vital Capacity (FVC) (Z-score change (95% CI): -0.11 (-0.20, -0.03), compared with 
breastfeeding for ≥6 months. Non-exclusive breastfeeding for 4 months was associated with a 
lower FVC (Z-score change (95% CI) -0.08 (-0.16, -0.01), compared with exclusive breastfeeding 
for 4 months. Results did not materially change after additional adjustment for lower respiratory 
tract infections, and were not modified by maternal history of asthma or atopy, child’s eczema or 
inhalant allergic sensitization.
Conclusion
Shorter duration and non-exclusivity of breastfeeding were associated with a lower FEV1 and FVC, 
but not asthma, at school-age.
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InTROduCTIOn
Early life exposures may affect the development and maturation of the respiratory system in 
early childhood and influence later respiratory health 1. Our 2 3 and other previous studies 4-10, 
suggest that prolonged and exclusive breastfeeding reduces the risk of wheezing and asthma in 
infancy and early childhood, whereas the beneficial effect of breastfeeding on lung function 11-18 
and asthma in later childhood remains unclear 19. In a recent meta-analysis 8 of 42 observational 
studies, ever and prolonged breastfeeding were associated with an up to 12% and 10% reduced 
risk of asthma at age 5-18 years, respectively, while exclusive breastfeeding for longer than 3-4 
months was not. A systematic review of 5 birth cohorts and 3 cross-sectional studies 20 suggested 
that prolonged and exclusive breastfeeding improved lung function in children until age 18 years. 
However, categorization of breastfeeding duration and exclusiveness differed between studies, 
effects could not be examined in detail, and heterogeneity was large. More recent studies 16 17 21 
were performed mostly in high risk populations 16 21 with relatively small sample sizes. Not only 
are population-based studies on the effect of breastfeeding on lung function and asthma in later 
childhood scarce, most studies lack prospectively collected, detailed information on breastfeed-
ing. Additionally, it has been shown that breastfeeding is associated with a reduced prevalence 
of lower respiratory tract infections22 23. Subsequently, it is suggested that a reduced prevalence 
of respiratory tract infections may result in less lung damage and a better lung function and less 
respiratory morbidity later in life24. This proposes a possible mediating role for lower respiratory 
tract infections in the association of breastfeeding with lung function and asthma. Previously, we 
showed that shorter and less exclusive breastfeeding was associated with an increased risk of 
early wheezing or asthma at age 6 years, which was partly explained by respiratory tract infections 
in early and to a lesser extent in later life2. The effect of respiratory tract infections on associations 
of breastfeeding with lung function and asthma at older ages are less known. Lastly, the role of 
maternal and child’s atopic status on the association of breastfeeding with lung function and 
asthma is not fully clear10 11 20.
Therefore, we examined in a population-based prospective cohort study, with detailed infor-
mation on breastfeeding and frequently measured over time, the associations of any breastfeed-
ing, breastfeeding duration and exclusiveness of breastfeeding with lung function and asthma in 
school-age children. Additionally, we examined if associations were mediated by lower respiratory 
tract infections or modified by maternal or child’s atopic status.
METhOdS
Design and cohort
This study was embedded in the Generation R Study, a population-based prospective cohort study 
from early fetal life until young adulthood in Rotterdam, the Netherlands. A detailed description 
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of the study design has been published previously 25. The study has been approved by the Medical 
Ethical Committee of the Erasmus MC, University Medical Centre in Rotterdam (MEC-2012-165). 
Written informed consent was obtained from parents or legal representatives of all participants. 
Children were excluded for the current analyses if the parents or legal representatives did not 
give consent for participation in this phase, if they are twins, if information on breastfeeding was 
missing and if information on both lung function and asthma were missing. As a result, a total of 
4,464 mothers and their children were included for the current analyses.
Breastfeeding duration and exclusiveness
Data on breastfeeding was collected using questionnaires administered at 2, 6, and 12 months 
after birth. Response rates varied between 71-82%. The duration of breastfeeding was assessed 
by asking whether mothers ever breastfed their child and at what age they stopped breastfeed-
ing. Children were classified as ‘never breastfed’ and ‘ever breastfed’. Among those who were 
breastfed, duration of breastfeeding was categorized into four groups: ‘<2 months’, ‘2-4 months’, 
‘4-6 months’, and ‘≥6 months’. Breastfeeding duration was also measured continuously by using 
the number of months a child was breastfed as a continuous variable. Exclusivity of breastfeeding 
was defined by the age of introduction of infant formula, other drinks, or food, and categorized 
into ‘non-exclusive breastfeeding for 4 months’ and ‘exclusive breastfeeding for 4 months’. Analy-
ses that focused on breastfeeding duration and exclusiveness were performed among children 
that were ever breastfed.
School-age lung function and asthma
At age 10 years (mean 9.8, SD 0.3), children visited our research center. Spirometry was performed 
according to the American Thoracic Society and European Respiratory Society recommenda-
tions 26. Lung function measures included Forced Expiratory Volume in 1 second (FEV1), Forced 
Vital Capacity (FVC), FEV1/FVC and Forced Expiratory Flow after exhaling 75% of FVC (FEF75), and 
were converted into sex-, height-, age-, and ethnicity-adjusted z-scores according to the Global 
Lung Initiative reference data 27. Children were asked to stop the use of short- and/or long acting 
bronchodilators 8 to 48 hours before spirometry, respectively, if they did not suffer from asthma 
symptoms. A current acute asthma attack or respiratory tract infection were contra-indications 
for spirometry. Questionnaires based on the International Study on Asthma and Allergy in Child-
hood (ISAAC) Questionnaire 28 at age 10 years provided information on ever asthma (no; yes) and 
current wheezing (no; yes), and information on asthma medication use (no; yes) was obtained 
during the visit at the research center. Current asthma (no; yes) was defined as ever diagnosis of 
asthma with either wheezing or medication use in the past 12 months at age 10 years.
Covariates
Information on maternal characteristics included educational level, history of asthma or atopy, 
pet keeping, damp patches or mold in the house, parity, psychiatric symptoms defined using the 
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Global Severity Index (GSI)29 30, body mass index (BMI) at intake, and smoking during pregnancy, 
and were obtained from multiple questionnaires completed by the mother during pregnancy. 
Midwife and hospital registries at birth provided information on child’s sex, gestational age at 
birth, and birth weight. We collected information about child’s ethnicity and daycare attendance 
by questionnaires during the first year of life. Information on physician-attended lower respira-
tory tract infections was obtained by multiple questionnaires at age 6 months to 6 years. Lower 
respiratory tract infections included bronchitis, bronchiolitis and pneumonia and were catego-
rized into early (≤3 years) and late (3-6 years) lower respiratory tract infections. At age 10 years, 
information on ever diagnosis of eczema was obtained by questionnaire. Allergic sensitization for 
the five most common inhalant allergens (house dust mite, grass, birch, cat and dog; ALK-Abelló 
B.V., Almere, The Netherlands) was determined by a skin prick test at the age of 10 years, using 
the ‘scanned area method’ 31.
Statistical analysis
First, for the loss to follow-up analysis, we compared characteristics of children included and not 
included in the study using T-tests for normal distributed continuous variables, Mann-Whitney 
tests for non-normal distributed continuous variables, and Chi-square tests for categorical vari-
ables. Second, we used linear and logistic regression models to examine the associations of ever 
breastfeeding and duration and exclusiveness of breastfeeding with lung function and asthma, 
respectively. Analyses were adjusted for potential confounders, which were 1) selected from 
literature, or 2) if they were related to breastfeeding and asthma or lung function, or 3) if the 
effect estimate of the unadjusted analyses changed ≥10% when we additionally adjusted for a 
confounder. Third, we examined if the associations of breastfeeding with lung function or asthma 
were explained by lower respiratory tract infections by additionally adjusting for these variables 
in a mediation analysis. We examined effect modification by maternal history of asthma or atopy, 
and child’s eczema or inhalant allergic sensitization by testing their interactive effect. We did 
not apply multiple testing due to strong correlations between different breastfeeding and lung 
function measures, which could potentially lead to overadjustment and, as an effect, possible 
false negative findings. Missing data for covariates were <20% except for day care attendance 
(25.6%). Missing data in covariates were imputed using the multiple imputation method using 
chained equations to select the most likely value for a missing response. Ten new datasets were 
created by imputation. All analyses were performed with both the original data (complete case 
analysis) and with imputed missing data. No major differences in the magnitude or direction of 
the effect estimates were observed between analyses with imputed missing data and complete 
cases only. We only present the results based on imputed datasets. All measures of association 
are presented with their 95% Confidence Intervals (95% CI). Statistical analyses were performed 




Maternal and child characteristics are presented in Table 2.2.1. Of the 4,464 included children, 
7.4% (n=331) were never breastfed. Of the children who were ever breastfed, 26.6% (n=865) were 
breastfed for <2 months, 23.6% (n=767) for 2-4 months, 13.7% (n=446) for 4-6 months and 36.1% 
(n=1,175) for ≥6 months. 71.0% (n=2,370) of the children were non-exclusively breastfed for 4 
months. Mean FEV1 (SD) was 2.02 L (0.30), FVC 2.34 L (0.36), FEV1/FVC 86.64% (5.66) and FEF75 
1.14 L/s (0.35) at the age of 10 years. The prevalence of current asthma at age 10 years was 5.6% 
(n=221). Supplementary Table S2.2.1 shows the same characteristics for children that were ever 
breastfed versus never breastfed separately. Children not included in the analysis had mothers 
who had a lower education, a higher prevalence of multiparity and smoking during pregnancy, a 
higher psychiatric symptom score and a higher BMI at intake. Children were born younger, had a 
lower birth weight, were less often from European ethnicity, and had a lower prevalence of day 
care attendance (Supplementary Table S2.2.2).
Breastfeeding and lung function or asthma
Ever breastfeeding was not associated with lung function or asthma, when compared with never 
breastfeeding (Table 2.2.2). When measured continuously, shorter duration of breastfeeding was 
associated with a lower FEV1 (Z-score change (95% CI): -0.01 (-0.02, -0.00) per month shorter 
breastfeeding). When breastfeeding was categorized, results showed that only children who were 
breastfed for 2-4 months had a lower FVC (-0.11 (-0.20, -0.03)), compared with children that were 
breastfed for ≥6 months. Children who were not exclusively breastfed for 4 months had a lower 
FVC (-0.08 (-0.16, -0.01)), compared with children who were exclusively breastfed for 4 months. 
Breastfeeding duration and exclusiveness were not associated with FEV1/FVC, FEF75, or current 
asthma at age 10 years. We observed small changes in effect estimates between the crude and 
adjusted model (range change: Z-score change 0.00 to 0.06; OR 0.00 to 0.32).
Additional adjustment for early and late lower respiratory tract infections did not materially 
change the effect estimates of the associations of any breastfeeding, breastfeeding duration and 
exclusiveness with lung function and current asthma at age 10 years (Table 2.2.3). This suggests 
that there is no mediating effect of lower respiratory tract infections in the association of breast-
feeding with lung function and asthma. Associations were not modified by maternal atopic status 
reflected by maternal history of asthma or atopy (p-values ranging from 0.118 to 0.986 when 
added to the model with confounders). Additionally, associations were not consistently modified 
by child’s atopic status reflected by child’s eczema or inhalant allergic sensitization (p-values for 
interaction 0.014, 0.019 and 0.034, and other 57 ranging from 0.064 to 0.986, when added to 
model with confounders).
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Table 2.2.1. Characteristics of children and their mothers
n = 4,464
Maternal characteristics
Education, lower (%) 44.8 (1,999)
History of asthma or atopy, yes (%) 37.5 (1,673)
Pet keeping, yes (%) 36.4 (1,627)
Damp patches or mold in house, yes (%) 11.3 (504)
Parity, nullipara (%) 57.4 (2,562)
Psychiatric symptoms during pregnancy (GSI)1 0.15 (0.00-0.87)
Body mass index at intake (kg/m2) 24.44 (4.19)
Smoking during pregnancy, yes (%) 22.8 (1,019)
Children’s characteristics
Female sex (%) 50.8 (2,268)
Gestational age at birth (weeks)1 40.1 (37.1-42.1)
Birth weight (grams) 3,459 (541)
Ethnicity, European (%) 71.9 (3,211)
Day care attendance 1st year, yes (%) 59.6 (2,660)
Early lower respiratory tract infections, yes (%) 25.6 (1,143)
Late lower respiratory tract infections, yes (%) 10.2 (457)
Ever eczema at age 10 years, yes (%) 23.4 (1,043)
Inhalant allergic sensitization at age 10 years, yes (%) 34.3 (1,531)
Never breastfeeding (%) 7.4 (331)
Breastfeeding duration (%)
<2 months 26.6 (865)
2-4 months 23.6 (767)
4-6 months 13.7 (446)
≥6 months 36.1 (1,175)
Non-exclusive breastfeeding for 4 months (%) 71.0 (2,370)
FEV1 (L) 2.02 (0.30)
FVC (L) 2.34 (0.36)
FEV1/FVC (%) 86.64 (5.66)
FEF75 (L/s) 1.14 (0.35)
Current asthma at age 10 years, yes (%) 5.6 (221)
Values are means (SD), valid percentages (absolute numbers) or 1medians (95% range), based on imputed 
data. Data on breastfeeding duration (n=1,211), breastfeeding exclusiveness (n=1,126), Forced Expiratory 
Flow in 1 second (FEV1) (n=470), Forced Vital Capacity (FVC) (n=466), FEV1/FVC ratio (n=470), Forced Expirato-



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































We observed in a large population-based prospective cohort study that a shorter duration of 
breastfeeding was associated with a lower FEV1 and FVC, and non-exclusive breastfeeding with a 
lower FVC in school-aged children. The z-score changes relate to a mean decrease in lung function 
of circa 3 to 40 mL or a 0.1 to 1.7% change. Associations were not explained by lower respiratory 
tract infections, or modified by maternal history of asthma or atopy, child’s eczema or inhalant 
allergic sensitization. Breastfeeding duration and exclusiveness were not associated with other 
lung function outcomes or asthma.
Comparison with previous studies
A meta-analysis of 117 observational studies showed that prolonged and exclusive breastfeeding 
was associated with a decreased risk of asthma in early childhood but not consistently in later 
childhood 19. Results of our previous 2 3 and current studies comprising detailed breastfeeding 
categorization suggest that the protective effect of breastfeeding on asthma in early childhood 
does not prolong into school-age. A possible explanation is a diminishing effect of breastfeeding 
over time due to other factors such as environmental stimuli that exceed the protective effect of 
breastfeeding on respiratory morbidity in later childhood 32. Additionally, asthma at a later age 
could more likely be atopic asthma 5. Since we found no interactive effect of atopy, this might 
explain the difference between the effects on asthma and lung function. Some studies even ob-
served an increased asthma risk at school-age in prolonged and exclusive breastfed children 33 34. 
However, we found that shorter duration of breastfeeding and less exclusive breastfeeding were 
associated with lower FEV1 or FVC 12-14 18 at school-age. Results of our population based cohort 
study are consistent with the conclusions of a recent systematic review 20, where the strongest 
association was found for duration of breastfeeding for more than 4 months with an up to 40 
ml increase in FEV1 and an up to 100 ml increase in FVC. Exclusive breastfeeding for more than 
4 months was not associated with FEV1, but showed beneficial effects on Peak Expiratory Flow 
rates (PEF). However, later studies performed in high risk populations failed to find an association 
between prolonged and exclusive breastfeeding with FEV1, FVC and other lung function mea-
surements such as Forced Expiratory Flow after exhaling 50% (FEF50) and between 25 and 75% 
(FEF25-75) of the FVC, probably due to the relatively small sample sizes 16 21. One study found an 
association of exclusive breastfeeding for 6 months with FEV1/FVC, in asthmatic children only 21. 
Studies among adults up to 79 years of age showed that shorter duration of breastfeeding was 
associated with a lower FEV1 35, while any breastfeeding was not associated with FEV1 and FVC 36. 
These results suggest that use of detailed breastfeeding measures is important, and that the 
effect of prolonged and exclusive breastfeeding on lung growth and airway obstruction might 
even persist into adulthood. More population-based cohort studies with detailed measurements 
of breastfeeding and respiratory morbidity at older ages are needed to fully disentangle the effect 
of breastfeeding on lung function and asthma across the life course.
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Our mediation analysis showed that the observed associations were not explained by early or 
late lower respiratory tract infections, while previous studies suggested a potential mediating 
effect of lower respiratory tract infections 2 3 22 in early childhood. Possible explanations could be a 
misclassification of asthma at an early age (due to symptoms of lower respiratory tract infections 
or transient wheezing) or a diminishing effect over time of lower respiratory tract infections on 
lung function or asthma. We found no modifying effect of maternal and child’s atopic status, 
which suggest no deleterious effect of breastfeeding by mothers with asthma or atopy. This is 
in line with most cohort studies 5 10 13 15 17 37, although some studies suggest that breastfeeding by 
asthmatic mothers is associated with an increased risk of asthma 6 14 and with a reduction in FEV1/
FVC and FEF25-75/FVC in their children 14. However, these deleterious associations were found in 
atopic children only 6 and in relatively small sample sizes 14, which limits the generalizability of 
the results. No previous study explored child’s atopy as an effect modifier in the associations of 
breastfeeding with lung function, and our results are therefore difficult to compare.
Possible mechanisms
Various underlying mechanisms of the effect of breastfeeding on lung function outcomes or 
asthma have been proposed. Breast milk is immunologically complex, as it can be protective 
but could also possibly induce allergies 4. Breastfeeding and its components, such as secretory 
IgA, cytokines, long chain fatty acids and oligosaccharides, might affect the developing immune 
system of the child. This could subsequently have a beneficial effect on development of asthma 
and allergy 4 22 38. Breastfeeding might also alter the gut microbiota and promote gut maturation, 
which could mediate the development of asthma 22. Also, breastfeeding might have a beneficial 
effect on lung development 38-40 by stimulating lung growth through cytokines and growth factors 
such as TGF-β1 and IGF-I in breast milk 38 39. Although lower respiratory tract infections have 
been suggested as a mediating factor in the association of breastfeeding with lung function and 
asthma, we found no evidence for this hypothesis. Therefore other mechanisms might be more 
relevant. Additionally, new hypotheses suggest that breastfeeding has an impact on DNA meth-
ylation and thereby leads to differences in gene expression profiles 41 42. An understanding of (epi)
genetic factors may further clarify the underlying mechanisms of the effect of breastfeeding on 
respiratory morbidity.
Strengths and limitations
This study was embedded in a population-based prospective cohort study with a large number 
of participants and detailed information on breastfeeding, lung function and asthma. However, 
some limitations do apply to this study. First, selection bias towards a more affluent and healthy 
population might have occurred due to differences in characteristics between those lost to 
follow-up and included in the study 43. Second, misclassification of breastfeeding categorization 
might have occurred, but since we expect this misclassification to be random, meaning irrespec-
tive of lung function or asthma, this would have only led to an underestimation of our results. 
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Third, information on current asthma and eczema was obtained by questionnaires. Validated 
questions were adapted from the ISAAC Core Questionnaires, which is considered a reliable 
instrument and sufficient for studying these outcomes in epidemiological studies44. However, 
misclassification due to self-report might be present. Also, with these questionnaires it is not 
possible to distinguish different phenotypes of asthma. However, no strong relationship between 
phenotypes and clinical patterns or response to treatment has been found previously, potentially 
limiting the usefulness of phenotype distinction45. Fourth, information on lower respiratory tract 
infections was also obtained by questionnaire. The possibility of misclassification and recall bias 
were reduced by using only physician-attended lower respiratory tract infections and by annual 
collection, respectively. Fifth, it was not possible to study any changes in the association of breast-
feeding with lung function between the age of 6 and 10 years because different lung function 
tests, Rint and fractional exhaled nitric oxid (FeNO) versus spirometry, were applied. At the age of 
6 years, children that were not breastfed had lower FeNO levels, most likely due to an increased 
prevalence of lower respiratory tract infections2. Last, although we adjusted for many essential 
confounders, residual confounding due to unmeasured or insufficient measured confounders 
might have influenced our results.
In conclusion, we demonstrated that shorter duration of breastfeeding was associated with a 
lower FEV1 and FVC, and non-exclusive breastfeeding for 4 months with a lower FVC among school-
age children. Results were not mediated by lower respiratory tract infections and not modified by 
maternal asthma or atopy, child’s eczema or inhalant allergic sensitization. Breastfeeding duration 
and exclusiveness were not associated with asthma at school-age. Further studies are needed to 
examine the underlying mechanisms of breastfeeding that lead to respiratory changes and the 
effect of breastfeeding on lung function and asthma at older ages.
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Education, lower (%) 43.0 (1,779) 66.5 (220)
History of asthma or atopy, yes (%) 37.4 (1,544) 39.0 (129)
Pet keeping, yes (%) 35.7 (1,475) 46.2 (153)
Damp patches or mold in house, yes (%) 11.9 (490) 4.2 (14)
Parity, nullipara (%) 58.0 (2,397) 49.5 (164)
Psychiatric symptoms during pregnancy (GSI)1 0.15 (0.00-0.87) 0.19 (0.00-1.01)
Body mass index at intake (kg/m2) 24.34 (4.08) 25.3 (5.25)
Smoking during pregnancy, yes (%) 21.9 (905) 34.4 (114)
Children’s characteristics
Female sex (%) 50.9 (2,105) 49.2 (163)
Gestational age at birth (weeks)1 40.1 (37.1-42.1) 40.0 (37.1-42.0)
Birth weight (grams) 3,462 (539.7) 3,421 (557.0)
Ethnicity, European (%) 69.0 (2,851) 78.9 (261)
Day care attendance 1st year, yes (%) 60.5 (2,501) 48.0 (159)
Early lower respiratory tract infections, yes (%) 25.3 (1,044) 29.9 (99)
Late lower respiratory tract infections, yes (%) 9.8 (405) 15.7 (52)
Ever eczema at age 10 years, yes (%) 23.2 (957) 26.3 (87)
Inhalant allergic sensitization at age 10 years, yes (%) 34.5 (1,427) 31.4 (104)
FEV1 (L) 2.02 (0.30) 1.97 (0.28)
FVC (L) 2.34 (0.36) 2.28 (0.33)
FEV1/FVC (%) 86.62 (5.66) 86.80 (5.62)
FEF75 (L/s) 1.14 (0.35) 1.12 (0.34)
Current asthma at age 10 years, yes (%) 5.6 (204) 5.7 (17)
Values are means (SD), valid percentages (absolute numbers) or 1medians (95% range), based on imputed 
data. Data on breastfeeding duration (n=1,211), breastfeeding exclusiveness (n=1,126), Forced Expiratory 
Flow in 1 second (FEV1) (n=470), Forced Vital Capacity (FVC) (n=466), FEV1/FVC ratio (n=470), Forced Expirato-
ry Flow after exhaling 75% of FVC (FEF75) (n=467) and current asthma (n=543) was missing, and not imputed.
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Test for difference 
p-value
Maternal characteristics
Education, primary or secondary (%) 43.4 (1,835) 70.2 (3,113) < 0.001
History of asthma or atopy, yes (%) 37.5 (1,471) 36.4 (554) N.S.
Pet keeping, yes (%) 34.1 (1,211) 32.4 (447) N.S.
Damp patches or mould in house, yes (%) 10.0 (363) 11.5 (358) 0.043
Parity, nullipara (%) 58.1 (2,542) 52.4 (2,697) < 0.001
Psychiatric symptoms during pregnancy (GSI)1 0.13 (0.00-0.85) 0.19 (0.00-1.17) < 0.001
Body mass index at intake (kg/m2) 24.42 (4.17) 25.31 (4.83) < 0.001
Smoking during pregnancy, yes (%) 22.2 (887) 27.2 (420) < 0.001
Children’s characteristics
Female sex (%) 50.8 (2,268) 48.1 (2,541) 0.008
Gestational age at birth (weeks)1 40.1 (37.1-42.1) 39.9 (35.9-42.0) < 0.001
Birth weight (grams) 3,459 (541) 3,322 (616) < 0.001
Ethnicity, European (%) 72.8 (3,209) 51.5 (2,476) < 0.001
Day care attendance 1st year, yes (%) 63.2 (2,096) 53.4 (243) < 0.001
Early lower respiratory tract infections, yes (%) 31.0 (793) 40.8 (137) < 0.001
Late lower respiratory tract infections, yes (%) 8.6 (284) 18.8 (101) < 0.001
Ever eczema at 10 years, yes (%) 22.6 (882) 23.5 (217) N.S.
Inhalant allergic sensitization at 10 years, yes (%) 31.8 (1,044) 33.6 (297) N.S.
Values are means (SD), valid percentages (absolute numbers) or 1medians (5-95% range). Test for difference is 
chi-squared test for categorical values, t-test for continuous variables, and Mann Whitney test for non-normal 








Fetal and childhood infections 

 Chapter 3.1
A populati on-based prospecti ve cohort 
study examining the infl uence of early-life 
respiratory tract infecti ons on school-age 
lung functi on and asthma.
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Early-life respiratory tract infections could affect airway obstruction and increase asthma risk in 
later life. However, results from previous studies are inconsistent.
Objective
We examined the associations of early life respiratory tract infections with lung function and 
asthma in school-aged children.
Methods
This study among 5,197 children born between April 2002 and January 2006 was embedded in a 
population-based prospective cohort study. Information on physician-attended upper and lower 
respiratory tract infections until age 6 years (categorized into ≤3 and >3-6 years) was obtained by 
annual questionnaires. Spirometry measures and physician-diagnosed asthma were assessed at 
age 10 years.
Results
Upper respiratory tract infections were not associated with adverse respiratory outcomes. 
Compared with children without lower respiratory tract infections ≤3 years, children with lower 
respiratory tract infections ≤3 years had a lower forced expiratory volume in 1 second (FEV1), 
forced vital capacity (FVC), FEV1/FVC and forced expiratory flow at 75% of FVC (FEF75) (Z-score 
(95% CI): ranging from -0.22 (-0.31, -0.12) to -0.12 (-0.21, -0.03)), and an increased risk of asthma 
(odds ratio (95% CI): 1.79 (1.19, 2.59)). Children with lower respiratory tract infections >3-6 years 
had an increased risk of asthma (3.53 (2.37, 5.17)) only. Results were not mediated by antibiotic 
or paracetamol use, and not modified by inhalant allergic sensitization. Cross-lagged modeling 
showed that results were not bidirectional and independent of preschool wheezing patterns.
Conclusion
Early-life lower respiratory tract infections ≤3 years are most consistently associated with lower 
lung function and increased risk of asthma in school-aged children.
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InTROduCTIOn
It has been hypothesized that respiratory tract infections in early life influence the risk of lower 
lung function1-4 and asthma5-10 in later childhood and adulthood. Respiratory tract infections could 
lead to higher airway sensitization leading to airway obstruction and hyperreactivity11, and subse-
quently asthma. Respiratory tract infections might lead to persistent respiratory morbidity since 
both the immune and respiratory system are under development in early life. In observational 
studies, findings on the association of respiratory tract infections with lung function or asthma 
have been inconclusive1-10. Differences in results might be explained by power issues, ascertain-
ment of respiratory tract infections, use of different lung function measurements, definitions of 
asthma, age of the outcome, and use of covariates. Most studies that examined associations of 
respiratory tract infections with asthma focused on children at high risk for atopy5-7 9 10, which 
leads to limited external validity. Additionally, child’s antibiotic12-17 and paracetamol17-19 use are 
suggested to be associated with increased risks of childhood asthma, and their effect on the 
associations of respiratory tract infections with lung function and asthma is unclear. Antibiotic or 
paracetamol use might have an effect on the risk of lower lung function and asthma, by influenc-
ing the microbiome or glutathione levels, respectively. However, any found association could also 
be the result of confounding by indication or reverse causality. Additionally, parents might change 
smoking behavior as a result of respiratory infections, which could subsequently influence the risk 
of asthma. Therefore, second-hand smoke exposure might act as a mediator in this association. 
Associations of respiratory tract infections with asthma seem different between subgroups of 
children with or without allergic sensitization, which suggests a modifying effect of allergy6 7. Last, 
it is unclear whether early respiratory tract infections lead to lower lung function and asthma or 
that lower lung function and asthma, represented by wheezing at preschool age, lead to vulner-
ability for respiratory tract infections.
Therefore, we examined in a population-based prospective cohort study the association of 
early-life respiratory tract infections with lung function and asthma in school-aged children, tak-
ing bidirectional associations and preschool wheezing into account. Next, we examined if these 
associations are explained by children’s paracetamol and antibiotic use or modified by current 
inhalant allergic sensitization status, and if findings were specific for respiratory tract infections. 
This study adds to the current literature by examining the association of respiratory tract infec-
tions with lung function and asthma on a population-based level, using detailed and longitudi-
nally measured information on both upper and lower respiratory tract infections, and respiratory 
outcomes measures, applying a unique approach to identify bidirectional associations, and taking 
the effect of infections in general into account. With this, we aim to provide new evidence for a 




This study was embedded in the Generation R Study, a population-based prospective cohort 
study from early fetal life onwards in Rotterdam, The Netherlands. Women with a delivery data 
between April 2002 and January 2006 living in Rotterdam were eligible for participation in the 
study, as described previously20. The study has been approved by the Medical Ethical Committee 
of the Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands (MEC-
2012-165). Written informed consent was obtained from parents or legal representatives of all 
participants. A total of 5,197 children were included for the current analyses.
Early life respiratory tract infections
Information on parental reported physician-attended upper and lower respiratory tract infections 
was obtained by questionnaires at the ages of 6 months and 1, 2, 3, 4 and 6 years. Response rates 
ranged from 71 to 80%. Questions about physician-attended upper respiratory tract infections 
included ear and throat infections, false croup and whooping cough, and about lower respiratory 
tract infections bronchitis, bronchiolitis and pneumonia in the past 6 or 12 months (no or yes, not 
physician-attended; yes, physician-attended). We combined each individual respiratory tract in-
fection into groups of upper and lower respiratory tract infections. For the cross-lagged analyses, 
respiratory tract infections were first analyzed per year, and to improve readability subsequently 
combined into early (≤3 years: at least 1 infection in this period vs. no infections or late infections 
only) and late (3-6 years: at least 1 infection in this period vs. no infections or early infections only) 
upper and lower respiratory tract infections. The cut-off point of 3 years was chosen to obtain 
sufficient power, based on end of highest velocity of maturation of lungs and the immune system 
until this age21-23, and for consistency with categorization of wheezing patterns.
School-age lung function and asthma
At age 10 years, Forced Expiratory Volume in 1 second (FEV1), Forced Vital Capacity (FVC), FEV1/
FVC and Forced Expiratory Flow after expiring 75% of FVC (FEF75) were measured by spirom-
etry (MasterScreen-Pneumo, Jaeger Toennies (Viasys) CareFusion Netherlands). All curves were 
scored by two trained researchers according to the ERS/ATS guidelines24 and when necessary 
discussed with a senior researcher. Reproducible curves were converted into sex-, age-, height- 
and ethnicity-adjusted z-scores25. Current asthma was defined as 1) ever diagnosis of physician-
diagnosed asthma with 2) either wheezing or any asthma medication use in the past 12 months. 
Questions on asthma and wheezing were adapted from the International Study on Asthma and 
Allergy in Childhood (ISAAC), and information on medication use was obtained at the research 
center. Wheezing was reported by annual parental questionnaires from birth to age 4 years, and 
at age 6 years. We combined preschool wheezing patterns into early (≤3 years) and late (>3-6 
years) wheezing, similar to groups of respiratory tract infections.
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Covariates
Information on maternal characteristics included educational level, body mass index at intake, 
parity, smoking during pregnancy, psychiatric symptoms, pet keeping, and history of asthma and 
atopy, and were obtained from multiple questionnaires during pregnancy. Mode of delivery and 
child’s sex, gestational age at birth, and birth weight were obtained from midwife and hospital 
records at birth. Information on country of birth, breastfeeding, day care attendance, environ-
mental tobacco smoke exposure, antibiotic and paracetamol use were obtained by multiple ques-
tionnaires at age 6 months to 2 years. Ethnicity was based on country of birth of both parents. 
Inhalant allergic sensitization at the age of 10 years was measured by skin prick test using the 
‘scanned area method’26.
Other infections
Information on infections other than respiratory tract infections were collected by similar ques-
tionnaires as respiratory tract infections and included physician-diagnosed gastro-enteritis and 
urinary tract infection (no or yes, not physician-attended; yes physician-attended). Similarly to 
respiratory tract infections, other infections were combined into early (≤3 years) and late (3-6 
years) infections.
Statistical
analysis First, we examined associations of respiratory tract infections with lung function measures 
and asthma using linear and logistic regression models, respectively. Analyses were adjusted for 
potential confounders, which were selected from literature8 9 27-29, if they were related to respira-
tory tract infections and the outcomes of interest, or if the effect estimate of the unadjusted 
analyses changed ≥10% when we additionally adjusted for a confounder. Missing data of covari-
ates were imputed by the multiple imputation method using chained equations to select the most 
likely value for a missing response. Ten new datasets were created by imputation. Additionally, to 
take correlations between respiratory tract infections into account, both any and individual upper 
respiratory tract infections were adjusted for any preceding upper respiratory tract infections, 
and any and individual lower respiratory tract infections for any preceding lower respiratory tract 
infections. We did not apply multiple testing due to strong correlations between the different 
infections and lung function measures, since that could potentially lead to false negative findings. 
Second, we examined if associations were mediated by children’s antibiotic or paracetamol use 
or environmental tobacco smoke exposure by additionally adjusting for these variables, or were 
modified by inhalant allergic sensitization by testing their interactive effects. Statistical analyses 
were performed with the Statistical Package of Social Sciences version 21.0 for Windows (SPSS 
Inc). Third, we applied a cross-lagged model using Mplus version 7.11 for Windows (Muthén & 
Muthén). With a cross-lagged model, bidirectional associations between the exposure, respira-
tory tract infections until age 5 years, and the outcome, wheezing until age 5 years, and lung 
function or asthma at age 10 years, can be studied within the same model. In this model, logistic 
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or linear regression models are used to study the associations of early respiratory tract infections 
with early and late wheezing and lung function or asthma, of late respiratory tract infections with 
late wheezing and lung function or asthma, and of early wheezing with late respiratory tract infec-
tions, while taking associations over time between respiratory tract infections, and wheezing and 
lung function or asthma into account30 31. These models enable us to disentangle the direction of 
the observed associations, such as whether respiratory tract infections influence the risk of lower 
lung function and asthma, or vice versa. Last, sensitivity analyses were performed to examine the 
associations of gastro-enteritis and urinary tract infection with lung function and asthma. These 
sensitivity analyses could prove insight to whether any associations of respiratory tract infections 
with lung function and asthma are due to a specific respiratory tract infection effect, or due to 




Maternal and child characteristics are shown in Table 3.1.1. The highest prevalence of upper and 
lower respiratory tract infections was at the age of 2 years (24.0% and 8.5%, Figure 3.1.1A and B, 
respectively). At age 10 years, mean FEV1 (SD) was 2.02 L (0.30), FVC 2.33 L (0.36), FEV1/FCV 86.6% 
(5.7) and FEF75 1.14 L/s (0.35) (Table 3.1.1). Current asthma was present in 5.5% of the children. 
Current asthma was defined as ever asthma (9.4%), combined with wheezing (4.4%) or medica-
tion use (17.4%) in the past 12 months. Those not included in the analysis had, among others, 
mothers who were lower educated and had a higher prevalence of smoking during pregnancy. 
These children were more often born younger, had a lower birth weight, and a lower prevalence 
of breastfeeding (Supplementary Table S3.1.1).
Respiratory tract infections and lung function or asthma
Results from models on crude associations of upper and lower respiratory tract infections with 
lung function and asthma are shown in Supplementary Table S3.1.2 Results of per year analyses 
showed that upper respiratory tract infections were not consistently associated with lung func-
tion measures or asthma (Table 3.1.2 and Supplementary Table S3.1.2). Lower respiratory tract 
infections at ages 6 months, 1, 2, 3 and 6 years were associated with lower FEV1, FVC, FEV1/
FVC or FEF75, with Z-score differences (95% CI) ranging from -0.19 (-0.32, -0.05) to -0.34 (-0.50, 
-0.18) (Table 3.1.2). Lower respiratory tract infections at ages 2 to 6 years were associated with 
an increased risk of current asthma at 10 years, with odds ratios (95% CI) ranging from 4.19 (2.65, 
6.64) to 13.45 (7.22, 25.05). Associations of individual upper and lower respiratory tract infections 
with lung function and current asthma are given in Supplementary Table S3.1.3 and S3.1.4. After 
adjustment for antibiotic and paracetamol use, and environmental tobacco smoke exposure, 
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the strength and direction of the effect estimates did not materially change (data not shown). 
We observed no consistent interactive effect of upper and lower respiratory tract infections and 
inhalant allergic sensitization for the associations with lung function and asthma, (p-values>0.05).
Table 3.1.1. Characteristics of children and their mothers
n = 5,197
Maternal characteristics
Education, higher (%) 51.6 (2,685)
Body mass index at intake (kg/m2) 24.6 (4.25)
Parity, nullipara (%) 56.6 (2,942)
Smoking during pregnancy, yes (%) 14.0 (729)
Psychiatric symptoms during pregnancy (GSI)1 0.17 (0.06,0.38)
Pet keeping, yes (%) 38.1 (1,982)
History of asthma or atopy, yes (%) 37.2 (1,936)
Mode of delivery, caesarian section (%) 13.6 (709)
Children’s characteristics
Female sex (%) 50.5 (2,626)
Gestational age at birth (weeks)1 40.0 (39.1, 41.0)
Preterm birth <37 weeks (%) 4.3 (223)
Birth weight (grams) 3,444 (550)
Breastfeeding never (%) 8.1 (419)
Day care attendance 1st year, yes (%) 58.2 (3,025)
Environmental tobacco smoke exposure first 2 years, yes (%) 19.3 (1,005)
Use of antibiotics 1st year, yes (%) 63.0 (3,278)
Use of paracetamol 1st year, yes (%) 87.8 (4,569)
Inhalant allergic sensitization at age 10 years, yes (%) 31.8 (1.172)
FEV1 (L) 2.02 (0.30)
FEV1 (Z-score) 0.17 (0.97)
FVC (L) 2.33 (0.36)
FVC (Z-score) 0.21 (0.93)
FEV/FEV (%) 86.6 (5.7)
FEV1/FVC (Z-score) -0.11 (0.95)
FEF75 (L/s) 1.14 (0.35)
FEF75 (Z-score) 0.00 (0.91)
Current asthma, yes (%) 5.5 (252)
Early wheezing, yes (%) 59.5 (1,828)
Late wheezing, yes (%) 20.0 (690)
Values are means (SD), valid percentages (absolute numbers) or 1medians (25-75% range) based on imputed 
data. Global Severity Index (GSI). Data on Forced Vital Capacity (FVC) (available n=4,672), Forced Expiratory 
Flow in 1 second (FEV1) (n=4,672), FEV1/FVC ratio (n=4,672), Forced Expiratory Flow when 75% of the FVC 




Cross-lagged modelling showed no associati on of upper respiratory tract infecti ons ≤3 years with 
lung functi on measures (Figure 3.1.2A, B and C) or asthma (Figure 3.1.2D). Compared with no 
upper respiratory tract infecti ons >3-6 years, upper respiratory tract infecti ons >3-6 years were 
associated with a higher FEV1/FVC and FEF75 (0.08 (0.02, 0.15) and 0.10 (0.04, 0.17), respecti vely, 
but not FEV1. Upper respiratory tract infecti ons >3-6 years were associated with a decreased risk 





Figure 3.1.1. Prevalence of upper (A) and lower (B) respiratory tract infecti ons.
Values represent % of specifi c upper and lower respiratory tract infecti ons per age, and were not imputed. 
Not available – no data on this specifi c infecti on at this ti mepoint (n.a.)
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Figure 3.1.2. Directi on of associati ons of upper respiratory tract infecti ons (URTI) with wheezing and FEV1 (A), 
FEV1/FVC (B) FEF75 (C) and current asthma (D) at age 10 years. Values are odds rati os (OR) or change in Z-scores 
with their corresponding 95% confi dence interval (95% CI) derived from binomial logisti c or linear regres-
sion models, respecti vely, using cross-lagged modeling which takes bidirecti onal associati ons into account. 
Models are adjusted for maternal educati on, body mass index, parity, smoking during pregnancy, psychiatric 
symptoms during pregnancy, pet keeping, history of asthma or atopy, mode of delivery, and child’s sex, gesta-
ti onal age at birth, birth weight corrected for gestati onal age at birth, breastf eeding and day care att endance. 
Arrows indicate the directi on of the associati ons and if they are signifi cant (bold) or non-signifi cant (dashed). 
Forced Expiratory Flow in 1 second (FEV1), Forced Vital Capacity (FVC), Forced Expiratory Flow when 75% of 
the FVC is exhaled. For Figure 3.1.2B, C and D only the right lower quadrant of the fi gure is presented. All 
other directi ons and eff ect esti mates of the associati ons were approximately the same as presented in Figure 
3.1.2A.
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Figure 3.1.3. Directi on of associati ons of lower respiratory tract infecti ons (LRTI) with wheezing patt erns and 
FEV1 (A), FVC (B), FEV1/FVC (C), FEF75 (D) and current asthma (E) at age 10 years. Values are odds rati os (OR) 
or Z-scores with their corresponding 95% confi dence interval (95% CI) derived from binomial logisti c or linear 
regression models, respecti vely, using cross-lagged modeling which takes bidirecti onal associati ons into ac-
count. Models are also adjusted for maternal educati on, body mass index, parity, smoking during pregnancy, 
psychiatric symptoms during pregnancy, pet keeping, history of asthma or atopy, mode of delivery, and child’s 
sex, gestati onal age at birth, birth weight corrected for gestati onal age at birth, breastf eeding and day care 
att endance. Arrows indicate the directi on of the associati ons and if they are signifi cant (bold) or non-signifi -
cant (dashed). Forced Expiratory Flow in 1 second (FEV1), Forced Vital Capacity (FVC), Forced Expiratory Flow 
when 75% of the FVC is exhaled. For Figure 3.1.3B, C, D and E, only the right lower quadrant of the fi gure 
is presented. All other directi ons and eff ect esti mates of the associati ons were approximately the same as 
presented in Figure 3.1.3A.
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were associated with lower FEV1, FVC, FEV1/FVC and FEF75 (range -0.12 (-0.21, -0.03) to -0.22 
(-0.31, -0.12) (Figure 3.1.3A, B, C and D). Lower respiratory tract infections ≤3 and >3-6 years were 
also associated with an increased risk of current asthma (1.79 (1.19, 2.59) and 3.53 (2.37, 5.17), 
respectively) (Figure 3.1.3E). Lower respiratory tract infections >3-6 years were not associated 
with any lung function measurements. The directions from preschool wheezing patterns to later 
upper and lower respiratory tract infections were not significant.
Other infections
Cross-lagged modelling showed that gastro-enteritis was not associated with lung function 
measures (data not shown). Gastro-enteritis ≤3 years, but not >3-6 years, was associated with 
an increased risk of current asthma (1.68 (1.13, 2.47)) (Supplementary Figure 3.1.1SA). Urinary 
tract infections ≤3 year were associated with a higher FEV1 (0.18 (0.00, 0.35), but not with current 
asthma (Supplementary Figure S3.1.1B).
dISCuSSIOn
We observed in large population-based prospective cohort study that lower respiratory tract 
infections ≤3 years were most strongly and consistently associated with lower lung function and 
an increased risk of current asthma at school-age. These associations were not mediated by use 
of antibiotics or paracetamol and environmental tobacco smoke exposure, and not modified by 
inhalant allergic sensitization. Additionally, we observed that these associations were not bidirec-
tional, independent of preschool wheezing patterns, and not due to a general infection status. 
Upper respiratory tract infections at any age were not associated with lower lung function, and 
only upper respiratory tract infections at the age of 2 years were associated with an increased 
risk of asthma.
Comparison with previous studies
Previous prospective cohort studies observed inconclusive associations of respiratory tract infec-
tions with lung function or asthma, both in children and in adulthood1-10. Some studies that used 
viral sampling found that specific viral triggers, such as respiratory syncytial virus6-9 or rhinovirus6 9 
were associated with an 2.1 to 3.9-fold increased risk of wheeze or 2.6 to 9.8-fold increased risk 
of asthma in children aged 5 to 10 years. However, other studies showed that not a specific viral 
trigger, but the number of infections was associated with an increased risk of asthma, current 
wheeze or bronchial hyperreactivity at age 7 years5 10. Two previous studies among children age 56 
and 10 years7 showed that associations of specific lower respiratory tract infections with asthma 
and wheeze were only present in children who were sensitized before the age of 2 years. Others 
showed no modifying effect of sensitization for the associations of respiratory syncytial virus, 
rhinovirus infections or both with the risk of asthma at age 6 years9. Some differences could be 
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explained by differences in the size of study groups4-7 9. Also, most studies examined children at 
high risk for atopy, which reduces generalizability4-7 9 10. Most studies were focused on respiratory 
tract infections in either the first year or the first 3 years of life4-7 9 10 32. Our findings are consistent 
with previous findings, and now show that results are applicable to a general population, are not 
mediated by use of antibiotics or paracetamol and environmental tobacco smoke exposure, and 
not modified by inhalant allergic sensitization. Our sensitivity analysis for non-respiratory tract 
infections showed an association of gastro-enteritis ≤3 years with asthma only. Since urinary tract 
infections at any age were not associated with any adverse respiratory outcome, the effect of 
gastro-enteritis might be specific, and we speculate that this could be mediated by the intestinal 
microbiome 33. Another possibility however is that infections in general could have an effect on 
the immune system, and thereby influence the risk of asthma.
When we took possible bidirectional associations into account, cross-lagged modeling showed 
that lower respiratory tract infections ≤3 years were associated with lower lung function and 
current asthma, and lower respiratory tract infections at 3-6 years only with current asthma. 
By using cross-lagged models, we confirmed the direction of the association of respiratory tract 
infections with lung function and asthma, and not vice versa. These findings are supported by a 
randomized clinical trial, which observed that vaccination for respiratory syncytial virus infections 
led to a reduction of the number of wheezing days in the first year of life, suggesting causality 
from viral infection to wheeze34.
We observed that lower respiratory tract infections, specifically bronchitis, bronchiolitis and 
pneumonia, were associated with lower lung function and an increased risk of asthma. Previous 
studies suggested that childhood respiratory tract infections influence lung function at school age 
and in adulthood1-3 35 36. In adults up to 70 years of age, early life bronchitis3 36 and pneumonia1-3 36 
were associated with a lower FEV1, FVC and, in lesser extent, a lower FEV1/FVC. Together with the 
present finding, these findings suggest that exposure to respiratory tract infections in early life 
might affect respiratory health during the life course.
Potential mechanisms
Lung development starts in utero, and continues during childhood21 37, similar to the development 
of the immune system22 37 38. In early life, the developing respiratory and immune system could be 
affected by lower respiratory tract infections leading to persistent adverse adaptations and sub-
sequently lower lung function and an increased risk of asthma. Non-specific immune responses 
mediated by epithelial cells and phagocytes, and adaptive immune responses mediated by T cells, 
could contribute to airway inflammation in response to viral triggers38. Early airway infections 
could lead to changes in endothelial cell physiology, such as increased vascular permeability 
and hence, bronchial wall edema39 40. Because of the immaturity of the respiratory and immune 
systems at a young age, these processes with potential persistent consequences are more likely 
to occur when lower respiratory tract infections occur early in life. Our findings are in line with 
this hypothesis because we observed that mainly lower respiratory tract infections ≤3 years were 
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associated with lower lung function and increased risk of asthma. The effect of upper respiratory 
tract infections on the lungs seems to be less distinct, most probably because upper respiratory 
tract infections do not affect the lungs directly.
The immune system is also important for the resolution of airway inflammation after infec-
tions and a less developed immune system could potentially lead to persistent changes of airway 
physiology and function after infections39. To date, the immunological pathways responsible for 
the persistence of structural and functional abnormalities after respiratory tract infections have 
not yet been identified. The immune response to infections and the risk of developing lower lung 
function and asthma could both be dependent on common factors, such as the microbiome41 or 
(epi)genetic factors39, and need to be examined in future studies.
Strengths and limitations
This study was embedded in a population-based, prospective cohort study with a large number of 
participants, and detailed and longitudinally measured information on both upper and lower re-
spiratory tract infections, and respiratory outcomes measures. Furthermore, we applied a unique 
method to identify bidirectional associations using cross-lagged modeling. Since the study was 
not limited to a high-risk population, the findings are applicable to the general population. How-
ever, some limitations apply to our study. First, selection bias towards a more affluent and healthy 
population might have been present. Also, we used multiple imputation to reduce potential bias 
due to missing data in covariates. By using this method we assumed that data in covariates was 
missing at random. However, it might be possible that some data was missing not at random, 
which may have led to bias 42. Second, information on respiratory tract infections was parental 
based information, collected with questionnaires, which might have led to recall or misclassifica-
tion bias. If so, we expect this possible misclassification to be random because information on 
infections was collected before the outcome was known, and would most probably have led to an 
underestimation of our observed effect estimates. Our study lacked viral or bacteriological sam-
pling at the time of symptoms of respiratory tract infections, although it is suggested that not the 
specific microbial trigger but respiratory tract infections in general are important for the risk of 
asthma5. Third, information on asthma and wheezing was obtained by questionnaires. Although 
these questionnaires were adapted from ISAAC43, which was validated in various age groups and 
is considered as a reliable measure in epidemiological studies, misclassification due to self-report 
might still have been present. Prevalences of early and late wheezing in our study slightly differ 
from previous birth cohort studies44 due to the definition used for optimal cross-lagged model-
ing. Fourth, we did not have lung function measurements before the occurrence of respiratory 
tract infections. Therefore, we cannot distinguish whether the lower lung function is a result 
of the respiratory tract infections only, or whether it was already present before the infections 
occurred45. It has been suggested however, that lower respiratory tract infections impair lung 
function independent of lung function at younger age46. We partly addressed this issue by our 
statistical effort using cross-lagged modeling. Fifth, inhalant allergic sensitization was measured 
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at the age of 10 years. Early measurements or longitudinal patterns of allergic sensitization might 
be needed to better examine the intermediating role of allergy. Last, even though we corrected 
for numerous confounders, residual confounding due to unmeasured confounders, for example 
genetic susceptibility47 or maternal infections during pregnancy48, could have affected our results.
In conclusion, our results suggest that lower respiratory tract infections ≤3 years are most 
strongly and consistently associated with lower lung function and increased risk of asthma at 
school-age, while lower respiratory tract infections at 3-6 years were associated with asthma only. 
Upper respiratory tract infections were not associated with lower lung function or an increased 
risk of asthma, except at the age of 2 years with asthma. Cross-lagged modeling showed that ob-
served associations were not bidirectional, independent of wheezing in early life and most likely 
not due to infections in general. Therefore, our findings support the hypothesis that early-life 
respiratory tract infections might have a direct effect on lung development and the risk of asthma. 
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Supplementary Figure S3.1.1. Directi on of associati ons of gastro-enteriti s (A) and urinary tract infecti ons 
(B) with wheezing patt erns and current asthma, at age 10 years. Values are odds rati os (OR) with their cor-
responding 95% confi dence interval (95% CI) derived from binomial logisti c regression models, using cross-
lagged modeling which takes bidirecti onal associati ons into account. Models are also adjusted for maternal 
educati on, body mass index, parity, smoking during pregnancy, psychiatric symptoms during pregnancy, pet 
keeping, history of asthma or atopy, mode of delivery, and child’s sex, gestati onal age at birth, birth weight 
corrected for gestati onal age at birth, breastf eeding and day care att endance. Arrows indicate the directi on of 
the associati ons and if they are signifi cant (bold) or non-signifi cant (dashed). Gastro-enteriti s (GE-iti s), urinary 
tract infecti on (UTI).
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Supplementary Table S3.1.1. Characteristics of those included and not included in the study.
Included subjects not included subjects
Test for 
difference
n = 5,197 n = 4,704 p-value
Maternal characteristics
Education, higher (%) 53.2 (2,603) 39.4 (368) 0.000
Body mass index at intake (kg/m2) 24.5 (4.2) 25.3 (4.9) 0.000
Parity, nullipara 56.4 (2,935) 48.4 (554) 0.000
Smoking during pregnancy, yes (%) 13.7 (637) 20.5 (184) 0.000
Psychiatric symptoms during pregnancy (GSI)1 0.15 (0.00, 0.88) 0.19 (0.00, 1.30) 0.000
Pet keeping, yes (%) 34.4 (1,425) 29.4 (233) 0.006
History of asthma or atopy, yes (%) 37.1 (1,694) 37.4 (331) N.S.
Mode of delivery, caesarian section (%) 12.9 (602) 13.0 (494) N.S.
Children’s characteristics
Female sex (%) 50.5 (2,626) 48.0 (2,183) 0.015
Gestational age at birth (weeks)1 40.1 (37.0, 42.0) 39.9 (35.9, 42.0) 0.000
Birth weight (grams) 3,445 (549) 3,316 (620) 0.000
Breastfeeding ever, no (%) 7.3 (319) 9.9 (69) 0.015
Day care attendance 1st year, yes (%) 62.9 (2,123) 53.9 (216) 0.000
Values are means (SD), valid percentages (absolute numbers) or 1medians (5-95% range). Differences be-
tween groups were evaluated using t-tests for continuous variables, chi-square tests for categorical variables 
or Mann-Whitney U tests for non-normal distributed variables. Non-significant (N.S.)
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Chlamydia trachomati s infecti on during 
pregnancy and childhood asthma-related 
morbidity: a populati on-based prospecti ve 
cohort study.
van Meel ER, Att anasi M, Jaddoe VWV, Reiss IKM, Moll HA, de Jongste JC, Duijts L.




Chlamydia trachomatis is the most commonly reported sexually transmitted disease, and although 
infection during pregnancy is associated with neonatal complications, long-term respiratory 
consequences are unknown. We aimed to determine whether Chlamydia trachomatis infection 
during pregnancy is associated with asthma related symptoms across childhood
Methods
This study among 2,475 children and their mothers was embedded in a population-based pro-
spective cohort study. Maternal urine samples were tested for Chlamydia trachomatis infection 
during pregnancy. Questionnaires provided information on childhood physician-attended lower 
respiratory tract infections and wheezing, and current asthma at age 10 years. Lung function was 
measured by spirometry at age 10 years.
Results
The prevalence of Chlamydia trachomatis infection during pregnancy was 3.2% (78/2,475). Chla-
mydia trachomatis infection during pregnancy was not associated with lower respiratory tract 
infections until age 6 years, but was associated with a higher odds of wheezing in children until 
age 10 years (odds ratio (OR) (95% confidence interval (CI)) 1.50 (1.10, 2.03)). Chlamydia tracho-
matis infection during pregnancy was associated with an increased odds of asthma (OR (95% CI): 
2.29 (1.02, 5.13)), and with a lower FEV1/FVC and FEF75 (Z-score difference (95% CI): -0.28 (-0.52, 
-0.04) and -0.24 (-0.46, -0.01), respectively) in children at age 10 years. The observed associations 
were only partly explained by mode of delivery, gestational age at birth or birth weight.
Conclusion
Chlamydia trachomatis infection during pregnancy is associated with increased odds of wheezing, 
asthma, and impaired lung function. The causality of the observed associations and potential 
underlying mechanisms need to be explored.
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InTROduCTIOn
Chlamydia trachomatis is the most commonly reported sexually transmitted disease in Western 
countries1-3. It is hypothesized that Chlamydia trachomatis during pregnancy could affect childhood 
respiratory health through direct or indirect effects. Chlamydia trachomatis during pregnancy 
could directly lead to placental inflammation, potentially leading to altered immune and atopic 
development, and persistent risks of respiratory morbidity of the child 4 5. Chlamydia trachomatis 
infection during pregnancy is known to be associated with a 1.3 to 4-fold increased risk of neonatal 
complications such as perinatal mortality, preterm birth, low birth weight and pneumonia 4 6-10. 
Preterm birth, low birth weight and neonatal respiratory disease are known to predispose to 
respiratory morbidity at later ages 11-13. Therefore, Chlamydia trachomatis during pregnancy might 
also be associated with respiratory health in later life indirectly through these altered birth char-
acteristics. Previous small sample-sized observational studies focused mostly on the association of 
Chlamydia trachomatis infection in children with their respiratory health, and suggested that an 
infection in infancy is associated with adverse respiratory health 14 15. Only one prospective cohort 
study was performed, studying the association between Chlamydia trachomatis and asthma in a 
sub-analysis only, and reported that treatment for Chlamydia trachomatis during pregnancy was 
associated with a 3-fold increased risk of asthma in the offspring at age 7 years 16. However, no 
studies have examined the association of Chlamydia trachomatis during pregnancy with respira-
tory health or with objective lung function measurements later in childhood.
We hypothesize that Chlamydia trachomatis during pregnancy leads to fetal respiratory and 
immunological developmental adaptations, predisposing children to long-term asthma related 
morbidity. We examined in a population-based prospective cohort study the associations of 
Chlamydia trachomatis infection during pregnancy with the odds of lower respiratory tract infec-
tions, wheezing, asthma and impaired lung function in children. We also examined whether any 
associations were explained by mode of delivery, gestational age at birth or birth weight.
METhOdS
Design
This study was embedded in the Generation R Study, a population-based prospective cohort 
from early fetal life onwards in Rotterdam, the Netherlands comprising 9,901 children and their 
mothers 17. The study has been approved by the Medical Ethical Committee of the Erasmus MC, 
University Medical Center Rotterdam, Rotterdam, The Netherlands (MEC-2012-165). Written 
informed consent was obtained from mothers, parents or legal representatives of all children. The 
Chlamydia trachomatis substudy was performed between February 2003 and January 2005, and 
comprised 4,055 mothers and children 6. Non-singleton or non-live born children and children 
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without information on at least one of the respiratory outcomes were excluded, which left a total 
of 2,475 children and their mothers for the current analysis.
Chlamydia trachomatis infection during pregnancy
Women provided a first-void urine specimen to test for Chlamydia trachomatis at enrolment, 
as described previously 6. In summary, urine samples were stored at 4°C, transported the same 
or following working day, and processed within 24 hours of receipt by the laboratory. DNA was 
isolated from five pooled urine specimens using the MagNA Pure LC Bacterial DNA isolation Kit 
III (Roche Molecular Systems, Alameda, USA) and amplified by polymerase chain reaction (PCR) 
(Cobas Amplicor, Roche Molecular Diagnostics, Branchburg, USA). Urines from positive pools 
were individually re-tested, and reported as negative or positive. Due to the observational nature 
of this study and the fact that screening for Chlamydia trachomatis during pregnancy was not part 
of standard care, results were not reported back to the women.
Asthma and asthma related morbidity in childhood
We obtained information on lower respiratory tract infections (physician-attended pneumonia, 
bronchitis or bronchiolitis) by annual questionnaires from birth to the age of 4 years, and at 
the age of 6 years. Information on wheezing was obtained at similar ages, and at age 10 years. 
Information on asthma medication use in the past 12 months was obtained during the visit at 
the research center (median age 9.8 years, 5-95% range 9.5-10.4 years). Asthma was defined as 
ever diagnosis of asthma, obtained by questionnaire at the age 10 years, with either wheezing or 
medication use in the past 12 months. All questions on wheezing and asthma were based on the 
International Study on Asthma and Allergy in Childhood (ISAAC) Questionnaire 18.
We performed spirometry according to the American Thoracic Society (ATS) and European Respi-
ratory Society (ERS) recommendations during the visit at the research center at the age of 10 years. 
Children (n=154) with a >5% deviation in Forced Expiratory Volume in 1 second (FEV1) or Forced Vital 
Capacity (FVC), but with at least one blow with adequate reach and duration of plateau according to 
ATS/ERS criteria were additionally included 19 20. Lung function measures included FEV1, FVC, FEV1/
FVC and Forced Expiratory Flow after exhaling 75% of FVC (FEF75), and were converted into sex-, 
height-, age-, and ethnicity-adjusted z-scores according to the Global Lung Initiative reference data 21.
Covariates
Information on maternal age, educational level, risk behavior including ever treatment for sexu-
ally transmitted diseases and multiple sexual partners in the year before pregnancy, psychiatric 
symptoms, smoking during pregnancy, and alcohol use during pregnancy, was obtained by mul-
tiple questionnaires during pregnancy 17. Midwife and hospital registries provided information 
on mode of delivery, child’s sex, gestational age at birth, and birth weight 17. Child’s ethnicity 
was based on questionnaires during pregnancy. Questionnaires after birth provided information 
about child’s breastfeeding and day care attendance.
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Statistical analysis
First, we performed a loss-to-follow-up analysis by comparing characteristics of children included 
in our study and those lost to follow-up by using independent samples T-tests, Mann-Whitney 
U tests, and Pearson’s Chi-square tests. Second, we used generalized estimating equation (GEE) 
models with an unstructured correlation matrix to examine the associations of Chlamydia 
trachomatis infection during pregnancy with the odds of lower respiratory tract infections and 
wheezing of the child until age 6 and 10 years, respectively. These models take the correlations 
between repeated measurements of either lower respiratory tract infections or wheezing within 
the same subject into account. Both an unstructured and first order autoregressive correlation 
structure was tested, and the difference between these matrices was assessed by means of the 
Quasilikelihood under the Independence model Criterion (QIC) statistic 22 23. Given that both 
correlation structures yielded similar results, but with a lower QIC for the first order autoregres-
sive correlation structure, this structure was used in the final model. Third, we used logistic and 
linear regression models to examine the associations of Chlamydia trachomatis infection during 
pregnancy with the odds of asthma and lung function measures, respectively. All multivariable 
analyses were adjusted for maternal age, educational level, psychiatric symptoms, and smoking 
and alcohol use during pregnancy, and child’s ethnicity, breastfeeding and day care attendance 
in the first year of life (confounder model). Confounders were selected from literature first, and 
were subsequently tested for their association with both the determinant and the outcome, , 
or a change of the unadjusted effect estimates with 10% or more when added to the univari-
ate model 24-28. A directed acyclic graph (DAG) was created to visualize the relationship between 
exposure, outcome and possible covariates . Confounders were included in the final model if they 
were either associated with determinant and outcome, and not in the causal pathway, or if the 
effect estimate changed with more than 10% when they were included. To address potential re-
sidual confounding related to Chlamydia trachomatis infection during pregnancy, we additionally 
examined whether risk behavior including ever treatment for a sexually transmitted disease (yes/
no) and multiple sexual partners in the year before pregnancy (yes/no) differed among women 
with and without Chlamydia trachomatis during pregnancy by means of a Fisher’s exact test.
We examined if the associations of Chlamydia trachomatis during pregnancy with respiratory 
morbidity were explained by mode of delivery, gestational age or birth weight by additionally 
adjusting for these variables (full model). We assessed the change in effect estimates after addi-
tional adjustment for these variables, by using the following formulas for percentage change: 100 
* (Effect estimatefull model – Effect estimateoriginal model)/(Effect estimateoriginal model – 1) for categorical 
lower respiratory tract infections, wheezing and asthma, and 100 * (Effect estimatefull model – Effect 
estimateoriginal model)/(Effect estimateoriginal model) for continuous lung function measures 11. Addition-
ally, we tested possible effect-modification by gestational age at urine sampling for Chlamydia 
diagnosis by adding an interaction term to the model. Missing data in covariates, and in repeated 
measures of lower respiratory tract infections and wheezing, was imputed by the multiple impu-
tation method using chained equations to select the most likely value for a missing response 29, 
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creating ten new datasets. Since we observed no major differences in the magnitude or direction 
of the effect estimates between analyses with imputed missing data and complete cases only, we 
only present the results based on imputed datasets. All measures of association are presented as 
odds ratios (OR) or Z-score differences and their corresponding 95% Confidence Intervals (95% 
CI). Statistical analyses were performed using SPSS version 24.0 for Windows software (IBM Corp), 
SAS version 9.4 for Windows (SAS Institute Inc., Cary, NC, USA) and R version 3.4.1.
RESulTS
Subject characteristics
Maternal and child characteristics are presented in Table 3.3.1. The prevalence of Chlamydia 
trachomatis infection during pregnancy was 3.1% (78/2,475). The prevalence of childhood lower 
respiratory tract infections decreased after age 2 years, while the prevalence of childhood wheez-
ing decreased gradually until age 10 years. Among the children born to mothers without versus 
with a Chlamydia trachomatis during pregnancy, the prevalence of asthma at age 10 years was 
5.3% (101/1,893), versus 14.5% (8/55) (p-value for difference 0.004). Main results of the loss-to-
follow-up analysis showed that children not included in the study had mother who more often 
had Chlamydia trachomatis during pregnancy, and had a lower gestational age at birth and birth 
weight (Supplementary Table S3.3.1).
Chlamydia trachomatis, asthma and asthma related morbidity
None of the children with a lower respiratory tract infection at age 6 months, was born to a mother 
with Chlamydia trachomatis infection during pregnancy, and therefore only lower respiratory 
tract infections from age 1 year onwards were included in the model. Chlamydia trachomatis in-
fection during pregnancy was not associated with annual or overall odds of lower respiratory tract 
infections in childhood (Figure 3.3.1). Compared to children born to mothers without Chlamydia 
trachomatis infection during pregnancy, those born to mothers with a Chlamydia trachomatis 
infection during pregnancy had an increased odds of wheezing until age 10 years (odds ratio (OR) 
(95% confidence interval (CI)) 1.50 (1.10 to 2.03)) (Figure 3.3.1), and an increased odds of asthma 
(OR (95% CI): 2.29 (1.02 to 5.13)) (Table 3.2.2). Additionally, these children had a lower FEV1/
FVC (Z-score difference (95% CI): -0.28 (-0.52 to -0.04)) and FEF75 (Z-score difference (95% CI): 
-0.24 (-0.46 to -0.01)) at age 10 years, but not a lower FEV1 or FVC (Table 3.3.2). The proportion 
of women ever treated for a sexually transmitted disease did not differ between the groups with 
and without Chlamydia trachomatis infection during pregnancy (12.1% vs 11.6%, p-value 0.84). 
The proportion of women having multiple sexual partners in the year before pregnancy in the 
group with Chlamydia trachomatis during pregnancy was lower than in the group without (0% vs 
7.6%, p-value 0.02).
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Age, mean (SD), y 30.76 (4.8) 30.86 (4.7) 27.58 (6.2)
Caesarian section, No. (%) 361 (14.6) 309 (12.9) 12 (15.4)
Low/middle education level, No. (%) 1,218 (49.2) 1,161 (48.4) 56 (71.8)
Maternal psychiatric symptoms, median (IQR) 0.16 (0.07, 0.37) 0.15 (0.03, 0.31) 0.27 (0.12, 0.45)
Smoking during pregnancy, No. (%) 611 (24.7) 589 (24.6) 23 (29.5)
Alcohol use during pregnancy, No. (%) 1,417 (57.3) 1,373 (57.3) 44 (56.4)
Chlamydia trachomatis infection during pregnancy, No. (%) 78 (3.1) N/A N/A
Child’s characteristics
Female sex, No. (%) 1,230 (49.7) 1,193 (49.8) 37 (47.4)
Gestational age at birth, median (IQR), weeks 40.1 (39.3, 41.0) 40.1 (39.3, 41.0) 40.0 (39.1, 41.0)
Birth weight, mean (SD), grams 3,446 (546) 3,450 (545) 3,327 (627)
European ethnicity, No. (%) 1,556 (62.9) 1,591 (67.3) 30 (41.0)
Ever breastfeeding, No. (%) 2,301 (93.0) 2,229 (93.0) 71 (91.0)
Day care attendance 1st year, No. (%) 1,350 (54.5) 1,325 (55.3) 25 (32.1)
Lower respiratory tract infections, No. (%)
 Age 1 year 210 (8.5) 202 (8.4) 8 (10.2)
 Age 2 years 317 (12.8) 310 (12.9) 7 (9.0)
 Age 3 years 203 (8.2) 193 (8.1) 10 (12.8)
 Age 4 years 159 (6.4) 149 (6.2) 10 (12.8)
 Age 6 years 145 (5.8) 139 (5.8) 6 (7.6)
Wheezing, No. (%)
 Age 1 year 773 (31.2) 741 (30.9) 32 (41.0)
 Age 2 years 541 (21.9) 519 (21.7) 22 (28.2)
 Age 3 years 377 (15.2) 354 (14.8) 23 (29.5)
 Age 4 years 381 (15.4) 363 (15.1) 18 (23.1)
 Age 6 years 294 (11.9) 281 (11.7) 13 (16.7)
 Age 10 years 162 (6.5) 152 (6.3) 11 (14.1)
Asthma, No. (%) 109 (5.6) 101 (5.3) 8 (14.5)
Lung function measures
 FEV1 (L) 2.02 (0.30) 2.03 (0.30) 1.97 (0.32)
 FVC (L) 2.34 (0.37) 2.34 (0.37) 2.27 (0.39)
 FEV1/FVC (%) 86.94 (5.68) 86.9 (5.7) 85.9 (5.1)
 FEF75 (L/s) 1.16 (0.35) 1.16 (0.35) 1.04 (0.32)
Abbreviations: IQR, interquartile range; N/A, not applicable; FEV1, Forced Expiratory Volume in the first sec-
ond; FVC, Forced Vital Capacity; FEF75, Forced Expiratory Flow after exhaling 75% of FVC. Data was missing and 
not imputed for asthma (n=527) and lung function measures (n=433).
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Additional adjustment for mode of delivery, gestational age at birth or birth weight did not ma-
terially change the effect estimates of the association of Chlamydia trachomatis infection during 
pregnancy with childhood respiratory health (Table 3.3.1 for asthma and lung function, Supple-
mentary Table S3.3.2 and S3.3.3 for lower respiratory tract infections and wheezing, respectively). 
The percentual changes in the association of Chlamydia trachomatis during pregnancy with lung 
function and asthma after additional adjustment for birth characteristics ranged from -6.2 to 1.1 
(Table 3.3.1), and were non-significant. The percentual changes for the overall odds of lower 
respiratory tract infection and wheezing were –2.7% (95% CI: -156 to 175%) and -5.0% (-24.7 to 
-0.2%), respectively. There was no effect modification by gestational age at diagnosis for associa-
tions of Chlamydia trachomatis with respiratory health (p-values for interaction between 0.434 
and 0.887).
dISCuSSIOn
We observed that children of mothers with a Chlamydia trachomatis infection during pregnancy 
had increased odds of wheezing, asthma and impaired lung function in childhood. These observed 
associations with asthma and lung function were not explained by mode of delivery, gestational 
age at birth or birth weight, while the associations with overall wheezing were partly explained by 
these birth characteristics. Chlamydia trachomatis infection during pregnancy was not associated 
with lower respiratory tract infections across childhood.
Strengths and limitations
The major strength of this study is that it is embedded in a large prospective population-based 
cohort with longitudinal measurement of multiple respiratory outcomes, and adjustment for rel-
evant confounders. Additionally, we used a highly sensitive microbiological method to diagnose 
 
Figure 3.3.1. Associations of Chlamydia trachomatis infection during pregnancy with lower respiratory tract 
infections from age 1 to 6 years, and wheezing from age 1 to 10 years. Odds ratios with 95% confidence in-
terval from generalized estimating equation models. †p-value 0.028, ‡p-value 0.013. Models are adjusted for 
maternal age, educational level, psychiatric symptoms, and smoking and alcohol use during pregnancy, and 
child’s ethnicity, breastfeeding and day care attendance in the first year of life.

































































































































































































































































































































































































































































































































































































































































































































































































































Chlamydia trachomatis 30. The study was performed in a low-risk population, which increases 
generalizability to the general population. Some limitations need to be discussed. As in most pro-
spective cohorts, loss to follow-up might have led towards selection of a more healthy population. 
The prevalence of Chlamydia trachomatis infection during pregnancy was higher in those lost to 
follow-up, which most likely might have led to an underestimation of the observed associations. 
The low absolute numbers of Chlamydia trachomatis infection during pregnancy and of specific 
diagnoses of lower respiratory tract infections might have led to lack of power to show asso-
ciations. A previous study did observe a prevalence of 7% of Chlamydia trachomatis in children 
until age 6 months with respiratory tract infections 31. However, the study population comprised 
children presenting with respiratory complaints to a specialised university medical center, which 
is not comparable to our general more healthy study population. Our results might suggest that 
the risk of overall wheezing is driven by the significant association of Chlamydia trachomatis with 
wheezing at the age of 3 years. However, the effects estimates for wheezing at all other ages are 
also taken into account and were moderate to strong (1.22 to 2.06). Their lack of significance 
was most probably due to a low prevalence of Chlamydia trachomatis. The confidence intervals 
of the percentage change due to mediators were large, which could be due to the large confi-
dence intervals of the original effect estimates. Information on lower respiratory tract infections, 
wheezing and asthma was obtained by questionnaire, which might have led to reporting bias. For 
wheezing and asthma however, validated and frequently used ISAAC questionnaires were used. 
Last, we did not observe increased risk behavior, such as multiple sexual partners or treatment for 
previous STDs of women with Chlamydia trachomatis infection during pregnancy. Although we 
took various potential confounders and mediators into account, residual confounding might be 
an issue, as in any observational study. As our study was largely focused on subclinical chlamydia 
trachomatis infection, we assume the large majority of women was not treated with antibiotics.
Comparison with previous studies
Chlamydia trachomatis infection during pregnancy is associated with neonatal complications 
such as preterm birth and neonatal respiratory morbidity 5 7 8. Only one prospective birth cohort 
study among 8,088 mothers and children demonstrated that treatment for Chlamydia during 
pregnancy, as reported by the mother as treatment for a gynaecological infection, was associated 
with a 3-fold increased risk of asthma in the offspring at age 7 years 16. These women were most 
likely symptomatic, while due to non-selective urine screening women in our study were most 
likely asymptomatic. Additionally, in this study treatment for Chlamydia was self-reported, and 
studied in a sub-analysis only, which could have led to bias. Our findings suggest that Chlamydia 
trachomatis infection during pregnancy is also associated with asthma in later childhood and 
impaired lung function measurements reflecting airflow limitation and obstruction in the small 
airways. To our knowledge, the current study is the first study that examined the associations of 
Chlamydia trachomatis infection during pregnancy with various types of respiratory morbidity 
and objective lung function measurements in childhood.
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Other studies focused on the associations of Chlamydial infections in infancy with childhood 
outcomes. An observational study compared 18 children hospitalized for Chlamydial pneumonia 
with 19 controls and reported that infants with Chlamydial pneumonia were more likely to have 
asthma at age 7 years, and more often had an impaired lung function and bronchial hyperreactiv-
ity 14. Findings from another study comparing 40 children hospitalized for pneumonia or bronchitis 
in infancy with 71 healthy controls suggest that the association of Chlamydia infection in infancy 
with respiratory diseases is not solely explained by respiratory tract infections 15. Children with 
Chlamydial lower respiratory tract infections in infancy had an increased risk of cough and were 
more likely to have an abnormal functional residual capacity until age 5 years than children with 
non-Chlamydial lower respiratory tract infections. Overall, we did not observe associations of 
Chlamydia trachomatis infection during pregnancy with lower respiratory tract infections. This 
might be due to the low prevalence of lower respiratory tract infections in this general, non-
hospital based population. These findings suggest that Chlamydia trachomatis infection during 
pregnancy specifically predisposes children for asthma related symptoms, but not to general 
respiratory tract infections.
Explanation and implications of the findings
Because of the observational design of the study, we cannot draw conclusions on the under-
lying causality and mechanisms. In vitro studies have elucidated possible direct mechanisms 
underlying the association between Chlamydia trachomatis and respiratory health. An in vitro 
study among neonatal and adult mice showed that mice infected as neonates with Chlamydia 
muridarim, the murine biovar of Chlamydia trachomatis, were not able to clear the infection, 
had Chlamydia muridarum specific IgE in BAL fluid and serum, and had an increased production 
of IL-4 and IL-10, while this was not observed for mice infected in adulthood 32. Both IgE and IL-4 
are of importance in asthma pathogenesis, which might explain our observed association with 
asthma. Additionally, a related in vitro study demonstrated that alveolar diameter was increased 
in mice that were infected in the neonatal period, but not in mice infected in infancy or adult-
hood, which might imply that Chlamydia trachomatis directly affects the lungs 33. These findings 
suggest that Chlamydial infection during early life specifically might lead to developmental lung 
and immune system adaptations and consequently an increased risk of wheezing, asthma and 
lower lung function in later life, but not lower respiratory tract infections. We did not observe any 
modifying effect of gestational age at diagnosis of Chlamydia trachomatis on respiratory health. 
However, Chlamydia trachomatis could have been asymptomatically present for a longer duration 
of time 34 35. Chlamydia trachomatis infection during pregnancy may lead to chorioamnionitis 5 6. 
Chorioamnionitis itself is associated with an increased risk of asthma or impaired lung function 
especially in children born preterm 36-39, possibly through immune changes in the child as a result 
of the chorioamnionitis 40. In our study, the associations of Chlamydia trachomatis infection dur-
ing pregnancy with school-age lung function and asthma were not explained by preterm birth, 
while the association with childhood wheezing was. This might imply that this mediation has only 
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short-term effects. Further studies are needed to assess whether chorioamnionitis explains the 
observed associations. Lastly, co-infections during pregnancy might play a role in the association 
of Chlamydia trachomatis with respiratory health. Previous studies demonstrated that Chlamydia 
trachomatis can co-occur with for example Neisseria gonorrhoeae and Trichomonas vaginalis, 
mostly in high-risk populations, but their association with respiratory health is unclear 41-44.
Our findings are important from both an etiological and population-health perspective. They 
suggest that a Chlamydia trachomatis infection during pregnancy leads to fetal developmental 
adaptations, which predispose children to asthma related morbidity, rather through lower lung 
function than susceptibility for lower respiratory tract infections. Population attributable frac-
tions (calculated as prevalence of exposure among cases*(1-1/RR)) of Chlamydia trachomatis for 
asthma and overall wheezing in this study were 4.2 and 1.2%, respectively 45. We only observed 
associations of Chlamydia trachomatis on FEV1/FVC and FEF75, and not the other lung function 
measures. Although the effect sizes are important from an etiological perspective, they should 
be carefully considered from a clinical perspective. Chlamydia trachomatis infections are com-
mon, and infections are mostly asymptomatic. Screening of pregnancy women for Chlamydia 
trachomatis is recommended within the United States for all women under the age of 25, or 
women with risk factors for a sexually transmitted disease 46 47. According to local practice, screen-
ing for Chlamydia trachomatis is not routine practice, although it has been suggested to be 
cost-effective 48. Chlamydia trachomatis can be treated easily and effectively with a single-dose 
therapy of azithromycin, even during pregnancy 46 49. Implementation of screening and treatment 
of pregnant women in the United States has led to a decrease of Chlamydia trachomatis infection 
of the newborn, and morbidity such as preterm rupture of the membranes and preterm birth 47 50. 
Additionally, prevention due to vaccination could be considered in the future 51-53. Replication of 
these findings would be of interest, and future studies should focus on the effects of treatment 
during pregnancy on intra-uterine transmission, chorioanmionitis and long term offspring health.
Conclusion and future research
Our results suggest that Chlamydia trachomatis infection during pregnancy is associated with in-
creased odds of wheezing, asthma, and impaired lung function across childhood. The causality of 
the observed associations and potential underlying biological mechanisms need to be explored.
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Age, mean (SD), y 30.76 (4.82) 27.96 (5.49) <0.001
Caesarian section, No. (%) 275 (12.3) 170 (13.1) 0.523
Low/middle education level, No. (%) 1,117 (47.7) 947 (72.2) <0.001
Maternal psychiatric symptoms, median (IQR)    0.15 (0.06, 0.33) 0.25 (0.10, 0.52) 0.006
Smoking during pregnancy, No. (%) 520 (24.0) 24 (32.4) 0.098
Alcohol use during pregnancy, No. (%) 1,239 (58.2) 492 (39.0) <0.001
Chlamydia trachomatis infection, No. (%) 78 (3.2) 79 (5.0) 0.003
Child’s characteristics
Female sex, No. (%) 1,230 (49.7) 713 47.4) 0.155
Gestational age at birth, median (IQR), weeks 40.1 (39.3, 41.0) 39.9 (38.9, 40.9) <0.001
Birth weight, mean (SD), grams 3,447 (543) 3,344 (612) <0.001
European ethnicity, No. (%) 1,621 (66.5) 636 (45.3) <0.001
Ever breastfeeding, No. (%) 1,977 (93.5) 41 (91.1) 0.527
Day care attendance 1st year, No. (%) 1,021 (61.8) 11 (52.4) 0.377
Abbreviation: IQR, interquartile range. Differences between groups were evaluated using t-tests for continu-
ous variables, chi-square tests for categorical variables or Mann-Whitney U tests for non-normal distributed 
variables. Values are based on observed data. 






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The infl uence of Epstein-Barr virus and 
Cytomegalovirus on childhood respiratory 
health: a populati on-based prospecti ve 
cohort study.
van Meel ER, Jaddoe VWV, Reiss IKM, van Zelm MC, de Jongste JC, Moll HA, Duijts L.




Epstein-Barr virus (EBV) and Cytomegalovirus (CMV) infection are common in early childhood. 
CMV infection favors a T-helper-1 and EBV infection a T-helper-2 cell response, possibly leading to 
disbalanced T-helper cell response, and subsequent risk of asthma or atopy.
Objective
To study the associations of EBV and CMV with lung function, asthma and inhalant allergic sensi-
tization at school age.
Methods
This study among 3,546 children was embedded in a population-based prospective cohort. At age 
6 years, serum IgG levels against EBV and CMV were measured by ELISA. At age 10 years, lung 
function was measured by spirometry, asthma by questionnaire and inhalant allergic sensitization 
by skin prick test.
Results
Unadjusted models showed that seropositivity for EBV was associated with a higher FEV1 and 
FEF75 (Z-score difference (95% CI): 0.09 (0.02, 0.16) and 0.09 (0.02, 0.15)), while seropositivity 
for CMV was not. Specific combinations of viruses showed that seropositivity for EBV was only 
associated with FEV1 and FEF75 in the presence of seropositivity for CMV (0.12 (0.04, 0.20)) and 
0.08 (0.01, 0.15)). Seropositivity for CMV in the absence of seropositivity for EBV was associated 
with an increased risk of inhalant allergic sensitization (OR (95% CI): 1.31 (1.02, 1.68)). All effect 
estimates attenuated into non-significant mainly after adjustment for child’s ethnicity. Seroposi-
tivity for EBV or CMV was not associated with asthma.
Conclusion
Associations of EBV and CMV infections in early childhood with school-age lung function and 
inhalant allergic sensitization are explained by ethnicity, or sociodemographic and lifestyle related 
factors.
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InTROduCTIOn
Infectious diseases in early life are suggested to influence the risk of lower lung function and 
asthma in later childhood and adulthood1-4. Epstein-Barr virus (EBV) and Cytomegalovirus (CMV) 
are herpesviridae that are commonly present. Between 60 and 90% of the adults are seroposi-
tive with the peak of infections occurring in childhood, and result in life-long viral persistence5-7. 
Successful viral suppression is dependent on expanded T-cell memory population. Both viruses 
primarily affect immune cells, but do not have the same effects. EBV favors a T-helper-2 cell medi-
ated response and mostly seems to affect B-cells8 9. CMV has a T-helper-1 cell mediated response, 
and impacts on T-cell and natural killer (NK) cell differentation10 11. Moreover, both viruses drive 
memory T-cell expansions in young children12 13. Therefore, infections with these viruses could 
lead to a disbalance in immune responses, specifically T-helper cell mediated responses, and 
subsequently an increased risk of asthma2-4. A prospective cohort study demonstrated that EBV 
coinfection enhances immune maturation driven by CVM14. Two other studies found that children 
with EBV had a reduced antibody response to measles or rubella vaccination, while children 
co-infected with CMV had not15 16. This further suggests that these herpesviridae might have 
interacting effects on the immune system. Results from previous studies on the associations of 
seropositivity for EBV or CMV with asthma and atopy are inconsistent2 4 17. This might be explained 
by the examination of EBV or CMV solely, while co-infections of these viruses might be more 
important given their difference in immune response3 4. This is supported by a cohort study that 
demonstrated that CMV in the absence of EBV at the age of 4 years was associated with an in-
creased risk of specific IgE of inhalant allergens, or inhalant and food allergens combined, but not 
asthma3. Studies on associations of EBV or CMV with atopic outcomes at older ages in childhood, 
including more objective respiratory measures such as lung function, are lacking.
Therefore, we examined the associations of childhood EBV or CMV, solely and in combination, 
with school-age lung function, asthma and inhalant allergic sensitization in a population-based 




This study was embedded in the Generation R Study, a population-based prospective cohort from 
early fetal life onwards in Rotterdam, the Netherlands 18. The study is designed to identify early 
environmental and genetic causes and causal pathways leading to normal and abnormal growth, 
development and health from fetal life to childhood and young adulthood. In total, 9,778 mothers 
with a delivery date from April 2002 until January 2006 were enrolled in the study. Response at 
baseline was 61%, and general follow-up rates until the age of 10 years were around 80%. The 
study has been approved by the Medical Ethical Committee of the Erasmus MC, University Medi-
cal Center Rotterdam, Rotterdam, The Netherlands (MEC-2012-165). Written informed consent 
was obtained from parents or legal representatives of all children. Of the 7,393 children with 
participation at age 10 years, we excluded twins (n=185), children without information on EBV or 
CMV (n=3,709), and without information on respiratory health (n=484), which left 3,546 children 
for the current analysis .
Ebv and CMv
Venous blood samples were obtained by antecubital venipuncture during a visit at the research 
center (median age 6.0 years, 5-95% range 5.7-7.2 years). The response rate for serum samples 
was 69%. Samples were stored for a maximum of 4 hours at 4 ⁰C, and transported twice daily 
for further processing and storage. Serum samples were analyzed using ELISA for IgG antibodies 
against EBV capsid antigen (native mixture of several viral capsid antigens) and CMV (purified 
native antigens strain ‘AD169’) (EUROIMMUN, Lübeck, Germany). As described earlier, seroposi-
tivity was defined as a sample-treshold ratio above 0.8 for EBV and 0.6 for CMV12. The presence 
of seropositivity for the viruses were further combined into neither, EBV only, CMV only, and both 
EBV and CMV.
Respiratory health
We performed spirometry according to the American Thoracic Society (ATS) and European Re-
spiratory Society (ERS) recommendations during a visit at the research centre (median age 9.7 
years, 5-95% range 9.5-10.3 years). Lung function measures included Forced Expiratory Volume in 
1 second (FEV1), Forced Vital Capacity (FVC), FEV1/FVC and Forced Expiratory Flow after exhaling 
75% of FVC (FEF75), and were converted into sex-, height-, age-, and ethnicity-adjusted z-scores 
according to the Global Lung Initiative reference data19. Children (n=239) with a >5%, instead 
of ≤5%, deviation in FEV1 and FVC, and at least one blow with adequate reach and duration of 
plateau according to ATS/ERS criteria were also included. The effect estimates for the associations 
did not differ when we in- or excluded those children 20 21.. Information on asthma medication 
use in the past 12 months was obtained during the research centre visit. Asthma was defined as 
ever diagnosis of asthma, obtained by questionnaire at the age 10 years, with either wheezing or 
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asthma medication use in the past 12 months. Questions on wheezing and asthma were based on 
the International Study on Asthma and Allergy in Childhood (ISAAC) Questionnaire obtained by 
post (“Has your child suffered from attacks of wheezing in the chest in the past 12 months?” (no/
yes, <4 attacks/yes ≥4 attacks) and “Has your child ever had asthma diagnosed by a doctor?” (no/
yes <3 years/yes 3-6 years/yes >6 years of age))22. Information on medication use was obtained 
by a short questionnaire during the visit at the research center (“Did your child receive any pre-
scribed medication in the past 12 months for complaints of the airways, lungs, allergy or skin? If 
yes, which medication was this?” (no/yes: <name prescribed drug>)). Median time between the 
questionnaire and visit to the research center was 1.4 (5-95% range -6-12) weeks. As described 
earlier, inhalant allergic sensitization at the age of 10 years was measured by skin prick test (SPT), 
using the scanned are method23. Inhalant allergens included house dust mite, 5-grass mixture, 
birch, cat and dog (ALK-Albelló B.V., Almere, the Netherlands). Children were considered to have 
inhalant allergic sensitization when they were sensitized to at least one inhalant allergen.
Covariates
At enrollment, information on maternal age, ever history of asthma and atopy (no/yes), educa-
tional level (low or middle/high), body mass index, parity, and current pet keeping (no/yes) was 
obtained by questionnaires during pregnancy. Information on maternal smoking during pregnancy 
was obtained in early, mid and late pregnancy by questionnaires, and combined into no smoking 
or quitting in early pregnancy/continued smoking. Psychological distress during mid pregnancy 
was measured by the Brief Symptom inventory24. Child’s gestational age at birth and birth weight 
were obtained from midwife and hospital records at birth. Child’s ethnicity was based on country 
of birth of the parents from parental questionnaires at enrolment, and combined (European/
non-European). Questionnaires in the first year of life provided information on ever breastfeeding 
(no/yes) and daycare attendance in the first year of life (no/yes).
Statistical analysis
First, we compared characteristics of mothers and children included in the study to those lost to 
follow-up. Next, we studied the associations of both EBV and CMV solely and combined (neither, 
EBV only, CMV only or both EBV and CMV) with lung function, and asthma and inhalant allergic 
sensitization by using linear and logistic regression models, respectively. All models were adjusted 
for confounders, which were selected from literature, and were associated with the exposure 
and the outcome, or changed the effect estimates of univariate analyses with 10% or more when 
added to the crude model. Confounders were grouped into sociodemographic and health-related 
factors (maternal age, history of asthma and atopy, educational level, parity, and psychological 
distress during pregnancy), lifestyle related factors (maternal body mass index, smoking during 
pregnancy and pet keeping, and child’s birth weight adjusted for gestational age, breastfeeding 
and daycare attendance) and child’s ethnicity. Models were adjusted for each group of con-
founders separately, and finally for all groups of confounders. The percentage of missing data in 
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confounders was between 1.7 and 24.8%, except for daycare attendance (37.9%). Missing data 
was imputed by multiple imputation using chained equations to select the most likely value for 
a missing response, creating ten new datasets. Since we observed no major differences in the 
magnitude or direction of the effect estimates between analyses with imputed missing data and 
complete cases only, we only present the results based on imputed datasets. All measures of 
association are presented as odds ratios (OR) or Z-score differences and their corresponding 95% 
Confidence Intervals (95% CI). Statistical analyses were performed using SPSS version 25.0 for 
Windows software (IBM Corp).
RESulTS
Subject characteristics
Characteristics of children and their mothers are presented in Table 3.4.1. At the age of 6 years, 
50.4% (n=1,787) of the children were seropositive for EBV, and 41.5% (n=1,470) for CMV. When 
we combined the viruses, 32.6% (n=1,155) of the children was seropositive for none of the vi-
ruses, 26.0% (n=921) for EBV only, 17.0% (n=604) for CMV only, and 24.4% (n=866) for both. The 
prevalence of current asthma at the age of 10 years was 5.8% (n=172), and of inhalant allergic 
sensitization 31.7% (n=818). Children not included in the analysis had mothers who were younger 
and lower educated, had a higher body mass index and had more psychological distress during 
pregnancy. Children were more often of non-European ethnicity, had a lower gestational age and 
birth weight, and were more likely to be seropositive for EBV, but not CMV (Supplementary Table 
S3.4.1).
EBV, CMV and respiratory health
In the unadjusted analyses, EBV, but not CMV, was associated with a higher FEV1 and FEF75 (Z-
score difference (95% Confidence Interval): 0.09 (0.02, 0.16) and 0.09 (0.02, 0.15), respectively) 
(Table 3.4.2). Combinations of seropositivity for the viruses showed that only seropositivity for 
EBV in the presence of seropositivity for CMV was associated with higher FEV1, FVC and FEF75 (Z-
score difference (95% CI): 0.12 (0.04, 0.20), 0.10 (0.02, 0.17) and 0.08 (0.01, 0.15), respectively)). 
Seropositivity for EBV or CMV, or combinations of seropositivity for the viruses were not associ-
ated with asthma. Seropositivity for EBV or CMV solely were not associated with inhalant allergic 
sensitization. Combinations of seropositivity for the viruses demonstrated that only seropositivity 
for CMV in the absence of seropositivity for EBV was associated with an increased risk of inhal-
ant allergic sensitization (OR (95% CI): 1.29 (1.01, 1.65). After adjustment for confounders, all 
effect estimates attenuated into non-significant (Table 3.4.3 and Supplementary Table S3.4.2). 
The associations of the viruses with lung function were mainly explained by ethnicity of the child, 
while the association with inhalant allergic sensitization was explained by sociodemographic and 
health-related factors, lifestyle related factors, and ethnicity.
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Table 3.4.1. Characteristics of children and their mothers
n = 3,546
Maternal characteristics
Age (years) 31.2 (4.9)
History of asthma or atopy, yes (%) 36.2 (1,285)
Educational level, low/middle (%) 50.3 (1,751)
Body mass index at intake (kg/m2) 24.6 (4.2)
Parity, nulliparous (%) 55.5 (1,967)
Psychological distress during pregnancy1 0.17 (0.00, 0.93)
Smoking during pregnancy, yes (%) 14.4 (512)
Pet keeping, yes (%) 36.4 (1,290)
Child’s characteristics
Female sex (%) 48.8 (1,729)
Gestational age at birth (weeks)1 40.1 (37.0, 42.0)
Birth weight (grams) 3,447 (546)
Ethnicity, European (%) 67.7 (2,399)
Ever breastfeeding, yes (%) 91.7 (3,252)
Day care attendance 1st year, yes (%) 55.4 (1,966)
EBV IgG at 6 years, positive (%) 50.4 (1,787)
CMV IgG at 6 years, positive (%) 41.5 (1,470)
Combination of infections (%)
Neither 32.6 (1,155)
EBV only 26.0 (921)
CMV only 17.0 (604)
Both 24.4 (866)
Lung function measures
FEV1 (L) 2.02 (0.30)
FVC (L) 2.34 (0.36)
FEV1/FVC (%) 87.0 (5.6)
FEF75 (L/s) 1.15 (0.35)
Asthma, yes (%) 5.8 (172)
Inhalant allergic sensitization, yes (%) 31.7 (818)
Values are means (SD), valid percentages (absolute numbers) or 1medians (5-95th percentiles). Values are 
based on imputed data. Data was missing and not imputed for lung function measures (n=382), asthma 
(n=561), and inhalant allergic sensitization (n=965). Epstein-Barr virus (EBV). Cytomegalovirus (CMV). Forced 
Expiratory Volume in the first second (FEV1). Forced Vital Capacity (FVC). Forced Expiratory Flow after exhaling 



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In this population-based prospective cohort study we observed that seropositivity for EBV in early 
childhood was associated with higher lung function at school age. This association was driven by 
seropositivity for EBV in in the presence of seropositivity for CMV. Seropositivity for EBV or CMV 
were not associated with asthma. Only seropositivity for CMV in the absence of seropositivity 
for EBV was associated with an increased risk of inhalant allergic sensitization. The associations 
of the viruses with respiratory health were fully explained by ethnicity, or sociodemographic and 
health-related factors, and lifestyle related factors.
Comparison with previous studies
We observed that EBV and CMV in early childhood were not independently associated with 
respiratory health in later childhood life. To our knowledge, this is the first study to associate EBV 
or CMV with lung function measures, and respiratory health later in childhood. A cross-sectional 
analysis within a prospective cohort study demonstrated that seropositivity for EBV was not as-
sociated with asthma or allergic sensitization at age 4 years2. Additionally, they demonstrated 
that CMV solely was not associated with asthma, allergy or allergic sensitization3. Two studies 
have shown that CMV in the absence of EBV was associated with an increased risk of allergic 
sensitization measured by IgE, at either 2 or 4 years of age3 4. Our result that CMV in the absence 
of EBV is associated with an increased risk of inhalant allergic sensitization is in line with these 
findings. However, we additionally found that these associations were explained by confounding 
factors. The composition of the study population, difference in confounders or measurement 
of allergic sensitization by skin prick test as opposed to specific serum IgE might explain this 
difference in results. We could not replicate the finding that EBV was associated with a decreased 
risk of allergic sensitization4. Similar to previous findings, we showed that EBV and CMV, solely 
or combined, were not associated with asthma2 3. A case-control study comparing CMV DNA be-
tween adults with and without asthma, demonstrated that those with asthma were more likely to 
be positive for CMV DNA25. Additionally, the number of CMV copies was higher in elderly, defined 
as age above 65 years, with asthma as compared to elderly without asthma. The number of CMV 
copies was not different in non-elderly with and without asthma. The number of CMV copies was 
also higher in elderly with asthma as compared to non-elderly with asthma. This suggests that 
age might be of importance, although due to the cross-sectional nature of the study it was not 
possible to disentangle the direction of the effect. Further studies are needed to examine the role 
of age of the child at virus infection, and the role of ethnicity and other confounding factors in the 
association of EBV and CMV with respiratory health across the life course.
The influence of Epstein-Barr virus and Cytomegalovirus on childhood respiratory health 161
Strengths and limitations
This study was embedded in a population-based cohort study, and detailed measurements of 
respiratory health, and information on numerous confounders are important strengths. Some 
limitations should be discussed. First, prospective cohort studies have suggested that early infec-
tion with herpesviridae might lead to a decreased risk of atopy, measured by SPT or IgE, and 
late infections to an increased risk17 26. However, we measured seropositivity for IgG only and 
were not able to determine age of seroconversion. Additionally, children in our study with an 
infection occurring between 6 and 10 years of age would be classified as seronegative, leading 
to dilution of the effect. Second, it has been suggested that immune responses might differ be-
tween asymptomatic and mononucleosis-like infections. Unfortunately, we did not have detailed 
information on the clinical course of the herpesviridae infections. However, given that we study 
a childhood cohort with infections before 6 years of age, these infections are most likely mild or 
asymptomatic15. Third, information on asthma was obtained by questionnaire, which might have 
led to misclassification although a validated questionnaire was used to minimize bias. Last, selec-
tion bias due to loss to follow-up might have occurred. Most importantly, those lost to follow-up 
were more likely to be of non-European ethnicity, and more likely to be seropositive for EBV. This 
might have led to either an over- or underestimation of the effect, if the associations of those lost 
to follow-up with respiratory health would be different from those included in the study. This is 
unlikely, but cannot be excluded27 28.
Underlying mechanisms
Some evidence on possible underlying mechanisms for the associations of herpesviridae with the 
immune and pulmonary system are provided in murine studies. One murine study demonstrated 
that mice infected in early life with murid herpesvirus4, the murine equivalent of EBV, were 
protected against housedustmite-induced airway allergy, compared to uninfected mice29. These 
infected mice had a reduced peribronchial infiltration by inflammatory cells, and lower numbers 
of eosinophils and interleukin-4. 5 and 6 in broncho-alveolar fluid. Additionally, the T-helper-2 
polarisation of housedustmite-specific T-cells, but not T-helper-1 polarisation, was suggested to 
be impaired among infected mice. Another murine study found that after infection with murid 
herpesvirus4, or murine cytomegalovirus, more secretion of T-helper-1 cytokines was present, 
which might inhibit the T-helper-2 pathway30. In our study, we found that mainly ethnicity ex-
plained the association of EBV with a higher lung function. The association of CMV in the absence 
of EBV with inhalant allergic sensitization was explained by ethnicity, and also sociodemographic 
and health-related, and lifestyle factors. A previous study within our cohort demonstrated that 
non-Dutch children were more likely to be seropositive for EBV and CMV31. These ethnic differ-
ences were partly explained by socio-economic factors and factors related to crowding for EBV, 
but not for CMV. Other studies also demonstrated an association of ethnicity with the prevalence 
of herpesviridae, although the role of other factors explaining the association such as socio-eco-
nomic or lifestyle-related factors in these studies were less prominent32 33. Another prospective 
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cohort study demonstrated that maternal age was associated with time to infection for EBV and 
CMV, regardless of other factors such as daycare and siblings34. Additionally, they demonstrated 
that CMV is often acquired earlier than EBV, which might be explained by the immune response 
after CMV infection. Our findings suggest that there might be no causal association of EBV and 
CMV with respiratory health, but that ethnicity and possible other confounding factors are the 
underlying explaining mechanisms.
Conclusion
Seropositivity for EBV and CMV at the age of 6 years were associated with a higher lung func-
tion and inhalant allergic sensitization, respectively, but not asthma at school-age. However, the 
association of seropositivity for EBV with school-age lung function was explained by child’s ethnic-
ity, while the association of seropositivity for CMV in the absence of EBV with inhalant allergic 
sensitization was additionally explained by sociodemographic and health-related, and lifestyle 
related factors. Future studies should focus on the role of age of the child at primaryinfection, 
specifically in relation to lung function and asthma, and the possible explaining role of ethnicity.
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Age (years) 31.2 (4.9) 30.0 (5.2) <0.001
History of asthma or atopy, yes (%) 1,118 (36.4) 907 (38.2) 0.166
Educational level, low/middle (%) 1,595 (48.5) 1,929 (56.3) <0.001
Body mass index at intake (kg/m2) 24.6 (4.2)
24.9 (4.5) 0.009
…
Parity, nulliparous (%) 1,948 (56.9) 2,056 (55.0) 0.096
Psychological distress during pregnancy1 0.13 (0.00, 0.88) 0.15 (0.00, 0.98) 0.018
Smoking during pregnancy, yes (%) 440 (14.2) 381 (15.7) 0.116
Pet keeping, yes (%) 938 (33.7) 720 (33.5) 0.834
Child’s characteristics
Female sex (%) 1,729 (48.8) 1,957 (50.9) 0.068
Gestational age at birth (weeks)1 40.1 (37.0, 42.0) 40.0 (36.3, 42.0) <0.001
Birth weight (grams) 3,448 (544) 3,374 (596) <0.001
Ethnicity, European (%) 2,395 (68.7) 2,323 (63.5) <0.001
Ever breastfeeding, yes (%) 2,693 (92.8) 1,987 (91.7) 0.132
Day care attendance 1st year, yes (%) 1,385 (62.9) 954 (60.7) 0.168
EBV IgG at 6 years, positive (%) 1,787 (50.4) 351 (58.6) <0.001
CMV IgG at 6 years, positive (%) 1,470 (41.5) 261 (43.2) 0.418
Values are means (SD), valid percentages (absolute numbers) or 1medians (5-95th percentiles). Values are


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Airway bacterial carriage and childhood 
respiratory health: a populati on-based 
prospecti ve cohort study.
van Meel ER, Jaddoe VWV, Looman KIM, de Jongste JC, Moll HA, Duijts L.




Airway bacterial carriage might play a role in respiratory disease. We hypothesize that nasal 
carriage with Staphylococcus aureus, or nasopharyngeal carriage with Haemophilus influenzae, 
Moraxella catarrhalis and Streptococcus pneumonia predispose individuals to adverse respiratory 
health.
Objective
To examine the association of early-life airway bacterial carriage with respiratory tract infections 
and vice-versa, and of early-life airway bacterial carriage with wheezing, lung function and asthma 
in later childhood.
Methods
We collected upper airway swabs for bacterial culturing for S. aureus, H. influenzae, M. catarrhalis 
and H. influenzae at six timepoints between the ages of 6 weeks to 6 years among 945 chil-
dren participating in a population-based prospective cohort study. Information on respiratory 
tract infections and wheezing until age 6 years, and asthma at age 10 years was obtained by 
questionnaires. Lung function at age 10 years was measured by spirometry. We tested possible 
bidirectional associations between airway bacterial carriage and respiratory tract infections by 
cross-lagged models, and associations of repeatedly measured airway bacterial carriage with 
wheezing, lung function and asthma by generalized estimating equations models and regression 
models.
Results
Cross-lagged modelling showed that early-life airway bacterial carriage was not consistently as-
sociated with upper and lower respiratory tract infections, or vice-versa. Nasopharyngeal carriage 
with any bacteria in infancy was associated with an increased risk of wheezing (OR (95% CI): 
1.66 (1.31, 2.10)). Airway bacterial carriage was not consistently associated with school-age lung 
function or asthma.
Conclusion
Nasopharyngeal carriage with any bacteria is associated with wheezing, but not respiratory tract 
infections, asthma or lung function.
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InTROduCTIOn
Respiratory tract infections in early life have been associated with the development of chronic 
obstructive respiratory disease in childhood and adulthood1 2. Previous studies showed that 
hypopharyngeal bacterial carriage of Haemophilus influenzae, Moraxella catarrhalis and Staphy-
lococcus pneumonia in infancy is associated with an increased risk of lower respiratory tract infec-
tions in the first three years of life3. Alternatively, respiratory tract infections might also influence 
airway bacterial carriage through bacterial superinfection or changed bacterial colonization after 
a viral infection4 5. Therefore, it is difficult to disentangle the direction of the association between 
airway bacterial carriage and respiratory tract infections. Additionally, previous studies have 
shown that airway bacterial carriage with these pathogens in infancy is associated with increased 
risks of wheezing and asthma in childhood6-9. Most observational studies have focused on the 
association of airway bacterial carriage in infancy with wheezing or asthma in early childhood, but 
its persistence into later childhood and the relation with lung function is not known.
We hypothesized that airway bacterial carriage in early childhood is more prominently as-
sociated with an increased risk of respiratory tract infections than vice-versa, and that bacterial 
carriage in early childhood is associated with wheezing, lower lung function and asthma in later 
childhood. Therefore, we examined in a population-based prospective cohort study among 945 
children the associations of airway bacterial carriage of H. influenzae, M. catarrhalis, S. pneumo-
nia or Streptococcus aureus from age 6 weeks to 6 years with respiratory tract infections taking 
possible bidirectional associations into account. Next, we examined whether airway bacterial 
carriage with these pathogens was associated with wheezing from age 1 to 6 years, and lung 
function and asthma at age 10 years.
METhOdS
Design
This study was embedded in a subcohort of 1,232 Dutch mother and their children of the Genera-
tion R Study, a population-based prospective cohort from early fetal life onwards in Rotterdam, 
the Netherlands10 11. The study has been approved by the Medical Ethical Committee of the 
Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands (MEC-2012-165). 
Written informed consent was obtained from parents or legal representatives of all children. After 
exclusion of twins, children without upper airway swabs, and children without any information on 
respiratory health, 945 children were included in the analysis.
Bacterial carriage
At the age of 6 weeks, 6 and 14 months, and 2, 3 and 6 years after birth, upper airway swabs of the 
nose and nasopharyngeal area were taken at the research center, as described earlier12 13. Swabs 
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were classified as either negative or positive for S. aureus, H. influenzae, M. catarrhalis or S. pneu-
moniae. Nasopharyngeal carriage of H. influenza, M. catarrhalis or S. pneumoniae was studied 
separately, and additionally nasopharyngeal carriage with any bacteria was classified as positive 
when either of these three pathogens was positive, and negative if all three were negative.
Respiratory health
We obtained information on physician-attended upper (ear infection, throat infection, croup or 
whooping cough) and lower (pneumonia, bronchitis or bronchiolitis) respiratory tract infections 
by questionnaires at the age of 2, 6 and 12 months, and 2, 3, 4 and 6 years. Information on wheez-
ing was obtained by questionnaire annually from 1 to 4 years, and at age 6 years. Lung function 
measures were obtained by spirometry during a visit at the research centre at the mean age of 9.8 
(SD 0.34) years, and converted into sex-, height-, age-, and ethnicity-adjusted z-scores according 
to the Global Lung Initiative reference data14-16. Asthma was defined as ever diagnosis of asthma, 
obtained by questionnaire at the age 10 years, with either wheezing or asthma medication use in 
the past 12 months. Questions on wheezing and asthma were based on the International Study 
on Asthma and Allergy in Childhood (ISAAC) Questionnaire, a validated questionnaire for respira-
tory epidemiological research17.
Covariates
Information on maternal history of asthma and atopy, education level, smoking during pregnancy, 
psychological distress during pregnancy, parity and pet keeping was obtained by questionnaires 
during pregnancy. Maternal history of asthma and atopy included diagnosis of asthma, house-
dustmite allergy, hay fever or eczema. Maternal psychological distress was measured by the 
Global Severity Index18. Child’s gestational age at birth was obtained from midwife and hospital 
records. Questionnaires in the first year of life provided information on breastfeeding and daycare 
attendance, and questionnaires until age 6 years on antibiotic use.
Statistical analysis
First, we compared characteristics of mothers and children included in the study to those eligible 
at baseline but not included using t-tests, Mann-Whitney U tests and chi-squared tests. Next, we 
analysed the associations of airway bacterial carriage with respiratory tract infections using cross-
lagged models. Cross-lagged models take potential bidirectional associations between the expo-
sure and the outcome into account . With this method, we were able to disentangle the directions 
of the observed associations of airway bacterial carriage with respiratory tract infections2 19. Next, 
we analysed the associations of airway bacterial carriage at 6 weeks, 6 and 14 months, and 2, 3 
and 6 years separately, with childhood wheezing, and school-age lung function and asthma. Since 
we did not expect bidirectional associations between airway bacterial carriage and wheezing until 
the age of 10 years, we used generalized estimating equation (GEE) models with a toeplitz cor-
relation matrix to examine these associations. Last, we studied the association of airway bacterial 
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carriage with lung function and asthma at school-age using linear and logistic regression models, 
respectively. All models are adjusted for confounders, with missing data imputed by multiple 
imputation. All measures of association are presented as odds ratios (OR) or Z-score differences 
and their corresponding 95% Confidence Intervals (95% CI). Statistical analyses were performed 
using Mplus version 7.4 (Muthén & Muthén), SAS version 9.4 (SAS Institute Inc., Cary, NC, USA) 
and SPSS version 25.0 for Windows software (IBM Corp).
RESulTS
Subject characteristics
Characteristics of children and their mothers, and of those not included, are presented in Table 
4.1.1, Figures 4.1.1 and 4.1.2, and Supplementary Table S4.1.1. Nasal bacterial carriage with S. 
aureus decreased from 54.0% at age 6 weeks to 13.5-15.3% at age 2-3 years, and thereafter in-
creased to 27.8% at age 6 years (Figure 4.1.1). Nasopharyngeal carriage with any of H. influenzae, 
M. catarrhalis or S. pneumoniae increased from 22.9% at age 6 weeks to 66.5% at age 2 years, 
Table 4.1.1. Characteristics of children and their mothers
n = 945
Maternal characteristics
History of asthma or atopy, yes (%) 39.6 (374)
Educational level, low/middle (%) 34.0 (321)
Smoking during pregnancy, yes (%) 12.1 (114)
Maternal psychiatric symptoms1 0.12 (0.00, 0.54)
Parity, nulliparous (%) 63.1 (596)
Pet keeping, yes (%) 43.7 (413)
Child’s characteristics
Female sex (%) 49.1 (464)
Gestational age at birth (weeks)1 40.3 (37.3, 42.1)
Ever breastfeeding, yes (%) 90.8 (858)
Day care attendance 1st year, yes (%) 68.3 (645)
Current asthma age 10 years, yes (%) 4.0 (33)
Lung function measures age 10 years
FEV1 (L) 2.05 (0.29)
FVC (L) 2.38 (0.35)
FEV1/FVC (%) 86.33 (5.58)
FEF75 (L/s) 1.15 (0.34)
Values are means (SD), valid percentages (absolute numbers) or 1medians (5-95th percentiles). Forced Expira-
tory Volume in the first second (FEV1). Forced Vital Capacity (FVC). Forced Expiratory Flow after exhaling 75% 
of FVC (FEF75). Data was missing and not imputed for asthma (n=121) and lung function measures (n=172).
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and thereafter decreased to 37.2% at age 6 years. The prevalences of these three pathogens 
separately showed a similar pattern, but with lower prevalence rates. The prevalences of upper 
and lower respiratory tract infections increased until age 2 years and decreased thereafter, while 
the prevalence of wheezing decreased from age 1 to 6 years (Figure 4.1.2). The prevalence of 
asthma was 4.0% at age 10 years (Table 4.1.1).
Early-life airway bacterial carriage and respiratory tract infections
For upper respiratory tract infections, cross-sectional correlations and cross-lagged associations 
showed that both nasal and nasopharyngeal bacterial carriage were not associated with upper 
respiratory tract infections, or vice-versa (Supplementary Figure S4.1.1). For lower respiratory 
tract infections, cross-sectional correlations showed that only M. catarrhalis carriage was associ-
ated with an increased risk of lower respiratory tract infections at 6 months, but a decreased risk 
 
Figure 4.1.1. Prevalence (%) of bacterial carriage of the upper airways in childhood. Nasopharyngeal (NP). 
Nasopharyngeal carriage of any bacteria was classified as positive when either of H. influenza, M. catarrhalis 
or S. pneumoniae was positive, and negative if all three were negative.
 Figure 4.1.2. Prevalence (%) of wheezing, upper and lower respiratory tract infections and antibiotic use in 
childhood. Upper respiratory tract infections (URTI), lower respiratory tract infections (LRTI), antibiotics (AB).
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at age 14 months and similarly vice-versa (OR (95% CI): 2.78 (1.30, 5.93) and 0.24 (0.10, 0.59), 
respectively) (Table 4.1.2 and Supplementary Figure S4.1.2). Cross-lagged associations showed 
that only H. influenza at age 6 weeks was associated with an increased risk of lower respiratory 
tract infections at age 6 months (OR (95% CI): 5.77 (2.80, 11.72)), while only lower respiratory 
tract infections at 6 months were associated with an increased risk of carriage with M. catarrhalis 
at age 14 months (OR (95% CI): 2.69 (1.21, 5.83)).
Early-life bacterial carriage and wheezing
S. aureus was not associated with overall wheezing (Figure 4.1.3A). Nasopharyngeal carriage of 
any bacteria at 6 months was associated with an increased risk of overall wheezing (1.66 (1.31, 
2.10)) (Figure 4.1.3B). Per year, nasopharyngeal carriage of any bacteria at the age of 6 months 
was associated with an increased risk of wheezing at the age of 1 year (1.81 (1.23, 2.66)), and 
at age 1 year with an increased risk of wheezing at 2 years (1.72 (1.02, 2.90)). Associations of 
nasopharyngeal carriage of H. influenzae, M. catarrhalis and S. pneumoniae individually with 
wheezing showed similar tendencies (Supplementary Figure S4.1.3). M. catarrhalis at age 6 
months was associated with an increased risk of overall wheezing (1.33 (1.07, 1.65)), while M. 
catarrhalis at age 6 weeks and 2 years was associated with a decreased risk of overall wheezing 
(0.65 (0.42, 1.00) and 0.66 (0.47, 0.91) respectively).
Early-life bacterial carriage, lung function and asthma
Overall, no consistent associations of early-life airway bacterial carriage with lung function or 
asthma in later childhood were observed (Table 4.1.3). Only H. influenza and any nasopharyngeal 
carriage at age 14 months were most prominently associated with a decreased risk of current 
asthma at age 10 years (OR (95% CI): 0.28 (0.08, 0.99) and 0.38 (0.15, 0.94), respectively). For 
all analyses, effect estimates did not materially change when excluding antibiotic use as a con-
founder (data not shown).
dISCuSSIOn
Principal findings
Within this population-based prospective cohort study, studying the effect of airway bacterial 
carriage with S. aureus, H. influenzae, M. catarrhalis and S. pneumonia, we observed no consis-
tent directions of associations between airway bacterial carriage and respiratory tract infections 
during childhood. Nasopharyngeal carriage of any bacteria at the age of 6 months was associated 
with an increased risk of wheezing in childhood, especially until age 2 years. We did not find 
any consistent associations of airway bacterial carriage with lung function and asthma in later 
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Comparison with previous studies
Studies examining longitudinal associations of bacterial carriage and respiratory tract infections 
on a population-based level are scarce. A prospective cohort study among 411 children in Den-
mark studied the associations of hypopharyngeal carriage with H. influenzae, M. catarrhalis or 
S. pneumoniae at the age of 4 weeks with respiratory health up to age 5 years3 6 8. This study 
demonstrated that hypopharyngeal carriage with any of these bacteria was associated with an 
increased risk of pneumonia or bronchiolitis in the first three years of life3. We only found few 
associations between airway bacterial carriage and lower respiratory tract infections. This is most 
probably due to insufficient power, since the prevalence of lower respiratory tract infections in 
our study was maximum 11.7%, while in this study this was 58%. However, we did observe that 
H. influenzae at age 6 weeks was associated with an increased risk of lower respiratory tract 
infections at age 6 months, and that M. catarrhalis at the ages of 6 months is associated with 
an increased risk, and at 14 months with a decreased risk of lower respiratory tract infections at 
those ages, and vice-versa. A case-control study assessing the airway microbiome also showed 
that children with lower respiratory tract infections had a low abundance of M. catarrhalis com-
pared to age-, sex- and time-matched healthy controls20. These findings, combined with ours, 
suggest that mostly M. catarrhalis and lower respiratory tract infections in early life seem to 
influence each other. Why specifically M. catarrhalis seems to have an effect remains open for 
discussion, given the different findings in other studies20 21. The Danish study also demonstrated 
that hypopharyngeal carriage is associated with an increased risk of wheezing especially in the 
first three years of life, and an increased risk of asthma at age 5 years6 8. In line with these findings, 
we observed that nasopharyngeal carriage with any bacteria at age 6 months was associated with 
an increased risk of overall wheezing until age 10 years, mostly with wheezing in the first 2 years. 
We however did not observe an association of airway bacterial carriage with asthma at school-
age. Prospective cohort studies that used microbiome analyses showed an association of a high 
abundance of Streptococcus, but not Moraxella with wheeze at age 5 or 10 years21 22. Differences 
in findings, especially with regards to the association of hypopharyngeal bacterial carriage with 
lower respiratory tract infections and asthma between our study and the Danish study, might be 
explained by the higher prevalence of lower respiratory tract infections in their cohort, and as-
sessment of asthma at an earlier age. Additionally, effects might differ between the high-risk and 
our general population, although we did not observe interaction of maternal asthma or atopy. 
Lastly, results may differ when focusing on individual pathogens, as compared to more recent 
studies that focuses on the entire microbiome. To date, findings suggest that bacterial carriage in 
infancy is associated with short-term, but not long-term respiratory health.
Underlying mechanisms
The hygiene hypothesis postulates that early-life exposure to certain micro-organisms might 
be protective for the risk of later-life atopic diseases23 24. Micro-organisms might influence the 










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































which could subsequently influence the risk of atopic diseases such as asthma25. Additionally, the 
immune system might also affect the risk of bacterial airway colonization with micro-organisms26. 
Airway bacterial carriage in early life has been associated with a low-grade systemic inflammation 
at age 6 months, including C-reactive protein and Interleukin-6, which could also affect the risk 
of wheezing or asthma27. Bacterial carriage might influence the risk of lower respiratory tract 
infections, and vice-versa21. However, we observed limited evidence for this. Bacterial carriage 
in infancy seems most prominently associated with adverse respiratory health, which might be 
explained by the high dynamics of bacterial carriage between 6 weeks and 6 months. Future 
large-scale prospective studies are needed to explore whether assessment of the microbiome 
as opposed to specific bacterial culturing is more informative in the association with respiratory 
health, and whether airway bacterial carriage and the microbiome only affect short-term or also 
long-term respiratory health.
Strengths and limitations
The main strength of our study is that it is embedded in a population-based prospective cohort 
study with repeated assessment of airway bacterial carriage and respiratory health. Limitations 
include the low prevalences of a positive culture and lower respiratory tract infections in the first 
6 months of life, leading to limited power. Second, only a small group of children had airway swabs 
taken at every visit. Therefore, we were not able to study the effect of cumulative or persistent 
positive swabs on respiratory health. Third, questionnaire data was used to obtain information on 
respiratory tract infections, wheezing and asthma. We only used information on doctor-diagnosed 
respiratory tract infections, and validated questionnaires for wheezing and asthma. However, 
variability in agreement between parents’ and clinicians’ report on respiratory health cannot be 
fully excluded, which might have led to non-differential misclassification and therefore dilution of 
the effect estimates28. Fourth, although we used standard material and commonly used methods, 
sensitivity of culturing might be affected. This will however most likely be operator dependent, 
and lead to random misclassification29. Lastly, we should consider the possibility that any found 
associations are due to chance. Although this might be the case for the associations with lung 
function and asthma, we believe this to be less likely for the associations with lower respiratory 
tract infections and wheezing, given the pattern of effects, with mostly low p-values.
In conclusion, we observed no consistent associations in either direction between airway bacte-
rial carriage and respiratory tract infections during childhood, or of airway bacterial carriage with 
lung function and asthma in later childhood. Only nasopharyngeal carriage of any bacteria at the 
age of 6 months was associated with an increased risk of wheezing in childhood, especially with 
wheezing in the first 2 years of life. This implies that airway bacterial carriage seems to have an 
effect on short-term effect on respiratory health only. Future studies should focus on the effect 
of the airway microbiome, which comprises more than individual pathogens, on short and long-
term respiratory health.











Supplementary Figure S4.1.1. Associations of S. aureus (A), H. influenzae (B), M. catarrhalis (C), S. pneu-
moniae (D) and any nasopharyngeal carriage (E) with upper respiratory tract infections, and vice-versa. Values 
are odds ratios from cross-lagged models. Models are adjusted for maternal history of asthma and atopy, 
education level, smoking during pregnancy, stress during pregnancy, parity and pet keeping, and child’s gesta-
tional age at birth, breastfeeding and daycare attendance. Bold values indicate significant associations. Upper 












Supplementary Figure S4.1.2. Associations of S. aureus (A), H. influenzae (B), M. catarrhalis (C), S. pneumoni-
ae (D) and any nasopharyngeal carriage (E) with lower respiratory tract infections, and vice-versa. Values are 
odds ratios from cross-lagged models. Models are adjusted for maternal history of asthma and atopy, educa-
tion level, smoking during pregnancy, stress during pregnancy, parity and pet keeping, and child’s gestational 
age at birth, breastfeeding and daycare attendance. Bold values indicate significant associations. For some 
associations, no effect estimate could be given due to limited power, as indicated by --. Lower respiratory tract 
infections (LRTI). Nasopharyngeal (NP).


























































































































Supplementary Figure S4.1.3. Associati ons of H. infl uenzae (A), M. catarrhalis (B) and S. pneumoniae (C) 
with wheezing from age 1 to 10 years. Values are odds rati os with 95% confi dence interval from generalized 
esti mati ng equati on models. *p-value <0.05. Models are adjusted for maternal history of asthma and atopy, 
educati on level, smoking during pregnancy, stress during pregnancy, parity and pet keeping, and child’s gesta-
ti onal age at birth, breastf eeding, daycare att endance, and anti bioti c use in the past 2 months (2 months), 6 
months (6 months) or year (1 to 6 years). Only airway bacterial carriage before or at the age of assessment of 
wheezing was included in the models, and models were additi onally adjusted for any wheezing in the preced-
ing period if the fi rst age at which wheezing was assessed was later than 1 year of age.
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History of asthma or atopy, yes (%) 39.1 (329) 37.1 (23) 0.758
Educational level, low/middle (%) 33.7 (315) 49.8 (144) <0.001
Smoking during pregnancy, yes (%) 12.0 (102) 17.7 (11) 0.181
Maternal psychiatric symptoms1 0.12 (0.00, 0.54) 0.15 (0.00, 0.88) 0.219
Parity, nulliparous (%) 63.1 (595) 52.3 (157) 0.001
Pet keeping, yes (%) 58.0 (488) 59.7 (37) 0.799
Child’s characteristics
Female sex (%) 50.9 (481) 55.7 (167) 0.150
Gestational age at birth (weeks)1 40.3 (37.3, 42.1) 39.9 (33.7, 41.9) <0.001
Ever breastfeeding, yes (%) 91.0 (838) 87.1 (54) 0.306
Day care attendance 1st year, yes (%) 70.5 (577) 66.7 (34) 0.566
Antibiotic use, yes (%)
 Age 2 months 9.6 (74) 18.4 (9) 0.048
 Age 6 months 23.1 (146) 30.0 (15) 0.272
 Age 1 year 35.5 (308) 42.6 (23) 0.294
 Age 2 years 43.3 (375) 48.1 (25) 0.500
 Age 3 years 33.4 (280) 38.5 (20) 0.451
 Age 4 years 26.3 (221) 27.5 (14) 0.861
 Age 6 years 19.9 (176) 22.2 (12) 0.680
Values are valid percentages (absolute numbers) or 1medians (5-95th percentiles). Differences between groups
were evaluated using chi-square tests for categorical variables or Mann-Whitney U tests for non-normal
distributed variables. Values are based on observed data.
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Infants with less diverse gut microbiota seem to have higher risks of atopic diseases in early life, 
but any associations at school age are unclear.
Objective
To examine the associations of diversity, relative abundance and functional pathways of stool 
microbiota with atopic diseases in school-aged children.
Methods
We performed a cross-sectional study within an existing population-based prospective cohort 
among 1,440 children aged 10 years. On stool samples, 16S rRNA gene sequencing was per-
formed, and taxonomic and functional tables were produced. Physician-diagnosed eczema, 
allergy and asthma were measured by questionnaires, allergic sensitization by skin prick tests, 
and lung function by spirometry.
Results
Alpha diversity of stool microbiota was associated with a decreased risk of eczema (OR 
(95%CI): 0.98 (0.97, 1.00)), and beta diversity was associated with physician-diagnosed inhal-
ant allergy (R2 (p-value): 0.001 (0.047)). Lachnospiraceae, Ruminococcaceae_UCG-005 and 
Christensenellaceae_R-7_group species were associated with decreased risks of eczema, inhalant 
allergic sensitization, and physician-diagnosed inhalant allergy (OR range (95%CI): 0.88 (0.79, 
0.96) – 0.94 (0.88, 0.98)), while Agathobacter species was associated with an increased risk of 
physician-diagnosed inhalant allergy (1.23 (1.08, 1.42)). Functional pathways related to heme 
and terpenoid biosynthesis were associated with decreased risks of physician-diagnosed inhalant 
allergy and asthma (OR range (95%CI): 0.89 (0.80, 0.99) - 0.86 (0.73, 1.02)). No associations of 
stool microbiota with lung function were observed.
Conclusions
The diversity, relative abundance and functional pathways of stool microbiota were most con-
sistently associated with physician-diagnosed inhalant allergy in school-aged children, and less 
consistent with other atopic diseases.
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InTROduCTIOn
Atopic diseases such as eczema, allergy and asthma are a major public health concern. At school 
age, up to 30% of children is affected by at least one of these atopic diseases globally1 2. Genetic 
susceptibility alone does not explain the high prevalence of atopic diseases as environmental 
exposures, partly through changes in the developing immune system, are likely to have major 
influence on the development of atopic diseases3 4. The hygiene hypothesis suggests that the 
urbanization and modern public health practices lead to less microbial exposure, and thereby 
a less stimulated immune system, and subsequently an increased risk of eczema, allergy and 
asthma4. The gut microbiota has a prominent role in the development and regulation of the im-
mune system5. Previous cohort and case-control studies have demonstrated that the diversity 
and relative abundance of stool microbiota, as proxy for gut microbiota, in early life are associated 
with the risk of atopic diseases6. Specifically, children with a less diverse stool microbiota before 
the age of 1 year, and with greater relative abundance of Bacteroidaceae, Clostridiaceae and 
Enterobacteriaceae, and lower relative abundance of Bifidobacteriaceae and Lactobacillaceae, 
have a higher risk of eczema, allergy or asthma until age 3 years6. Whether stool microbiota is also 
associated with atopic diseases in later childhood is less clear. Only few studies have been per-
formed with limited power to detect the effects of diversity and differential relative abundance of 
stool microbiota on the risks of eczema, allergy and asthma on a population-based level. Lastly, 
information on the association of stool microbiota with lower lung function, one of the underlying 
mechanism in asthma, is lacking.
Therefore, we aimed to examine among 1,440 children participating in a prospective population-
based cohort study the associations of diversity, relative abundance, and functional pathways of 




This cross-sectional study was embedded in the Generation R Study, a population-based prospec-
tive cohort study from early fetal life onwards in Rotterdam, the Netherlands7. The study has 
been approved by the Medical Ethical Committee of the Erasmus MC University Medical Centre 
Rotterdam, in Rotterdam, The Netherlands. Written informed consent was obtained from both 
parents or legal guardians. A total of 1,440 children with relevant data for stool microbiota and 
atopic diseases were available at a mean age of 9.8 years (SD: 0.27) for the current analysis.
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Stool microbiota
Stool samples of children participating in the Generation R Study were collected at home using 
a Commode Specimen Collection System (Covidien, Mansfield, MA) and a feces collection tube 
(Minigrip Nederlands, Lelystad, The Netherlands) without preserving agent. Stool samples were 
stored at 4°C until mailing, and thereafter sent by post to the appropriate laboratory of the Eras-
mus MC, and locally stored at -20°C 8. DNA was isolated in two batches from stool samples accord-
ing to manufacturer’s protocols (Arrow Stool DNA; Isogen Life Science; DiaSorin S.P.A.), utilizing 
bead beating and automated DNA isolation. Stool microbiota profiles were determined by Next 
Generation Sequencing (Illumina MiSeq) of the V3 and V4 variable regions of the 16S ribosomal 
RNA (rRNA) gene according to the protocol described by Fadrosh et. al.9. For current analyses, 
phylogenetic profiling and denoising was performed using DADA2 to produce amplicon- or exact 
sequence variants (ASVs)10. High-throughput sequencing produced compositional data, therefore, 
we used the term ‘relative abundance’ to refer to the counts of ASVs reads generated by 16S rRNA 
gene sequencing11. ASVs were assigned a taxonomy from the SILVA version 132 rRNA database us-
ing the RDP naïve Bayesian classifier12 13. The sequence data was then analysed for alpha diversity 
metrics (Chao richness index, Shannon diversity Index, and Inverse Simpson Index). Pair-wise beta 
diversities were calculated using Bray-Curtis dissimilarity metrics and Aitchison distance in cen-
tred log-ratio (CLR) transformed ASV relative abundances 11. As a sensitivity analyses among the 
same subjects, we compared the observations of the current data processing approach using the 
DADA2 pipeline with the results obtained by our previously in-house developed wrapper pipeline 
wrapper pipeline (microRapTor) based on QIIME (version 1.9.0), TAGCleaner (version 0.16), PEAR 
(version 0.9.6), and UPARSE (version 8.1) software package 14-17. Samples were subsampled at 
10,000 reads and combined reads of all samples were clustered into operational taxonomic 
units (OTUs) using the UPARSE command cluster_otus at a minimum cluster identity of 97% 8. 
Taxonomy was assigned to the representative read of each OTU using the SILVA rRNA database 
version 128 12 and RDP Naïve Bayesian Classifier version 2.12 13.
atopic diseases
At age 10 years, information on current physician-diagnosed eczema, inhalant allergy (for pollen 
(hay fever), house dust mite, cat or dog), food allergy (for cashew nut or peanut) and asthma 
was obtained from a parental-reported questionnaire with questions adapted from the ISAAC 
core questionnaires18 19. Current asthma was defined as physician diagnosis of ever asthma, with 
asthma medication use and/or wheezing in the past 12 months. Sensitization to the most relevant 
inhalant and food allergens on a population level was examined by skin prick tests. Inhalant al-
lergens included house dust mite, 5-grass mixture, birch, cat, and dog (ALK-Abelló B.V., Almere, 
The Netherlands), and food allergens included hazelnut, cashew nut, peanut, and peach19 20. Lung 
function was measured by spirometry at our research center according to ATS/ERS criteria, and 
values of forced expiratory volume in the first second (FEV1) and forced vital capacity (FVC) were 
converted into sex-, height-, age-, and ethnicity-adjusted Z-scores according to GLI-reference 
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values21-23. The ratio FEV1 and FVC was dichotomized into obstructive and non-obstructive lung 
function (Z-score cut-off of ≤-1.64 and >1.64, respectively)23. We assumed that children with two 
or more atopic diseases tend to have a more severe variant of their atopic diseases24 25. There-
fore, we regrouped children into those with only one atopic disease (with any eczema, asthma 
or physician-diagnosed food or inhalant allergies), or two or more atopic diseases for sensitivity 
analyses.
Covariates
Information on maternal education (primary or secondary school; higher than secondary school) 
was available from parental questionnaires obtained at enrolment. Child’s sex was obtained from 
midwives and hospital records, and ethnic origin (European; non-European) was defined based 
on the parents’ country of birth26. Child’s height and weight were measured during their visit 
to our research center to calculate their body mass index (BMI) (kg/m2). Information on the 
use of antibiotics in the past 3 months was derived from a questionnaire obtained during stool 
sample collection. We considered these covariates as most influential lifestyle and socioeconomic 
confounders based on literature and their associations with both the determinant and the out-
come in our population 27. Therefore, confounders such as diet, steroid medication use, recent 
probiotics use (past 3 days), inflammatory bowel syndrome, celiac disease, and travel activities in 
the past month were not included in the models. Confounders were missing in 7% or less in our 
population for analysis, and therefore not imputed. Furthermore, the general collection time and 
DNA isolation batch were considered as technical covariates as these are correlated with overall 
composition (beta-diversity) of stool microbiota8.
Statistical analysis
We compared characteristics of those included and not included in our study using Pearson’s 
Chi-square and independent sample t- tests. Analyzing high-throughput sequencing data is 
challenging, and rather than a golden standard, the use of multiple independent tools are rec-
ommended28. Therefore, we used both count-based and compositional approaches to examine 
the associations of stool microbiota with atopic diseases. All models were adjusted for lifestyle 
and socioeconomic confounders, and technical covariates. Unadjusted analyses are presented 
in Supplementary Tables 4.2.1, 4.2.2, and 4.2.3. We considered the adjusted model as our main 
model for interpretation of results. Functional pathways were predicted with PICRUSt2 29 30. The 
statistical analyses were performed in R version 4.0.0 31 using the packages microbiome32, zCom-
positions33, vegan34, and phyloseq35, and analysis of composition of microbiomes (ANCOM) with 
a detection cut-off of 0.60 (Supplementary Figure 4.2.1)36. Measures of association are presented 





Table 4.2.1 shows the characteristics of the subjects. Compared with children included in 
the analysis, those not included had mothers who were lower educated, were more often of 
non-European ethnicity, and had a higher BMI (Table 4.2.1). Characteristics of the major phyla, 
families and genera of stool microbiota of the children included in the analyses are presented in 
Figure 4.2.1. Supplementary Figure S4.2.2 shows that the major phyla for children with any atopic 
disease and without any atopic diseases are similar.








Maternal education, higher % (n) 53.8 (719) 49.8 (1,436)*
Child characteristics
Sex, female % (n) 50.3 (725) 50.4 (1,605)
Ethnicity, non-European % (n) 30.1 (430) 33.7 (1,039)*
Body mass index (BMI) at age 10 years, mean (SD) 17.4 (2.6) 17.7 (2.8)*
Antibiotic use in the past 3 months, yes % (n) 3.9 (56) 0.0 (0)
Stool sample
 Collection time in days, median (IQR) 2.00 (1.00-3.00) 1.50 (1.00-2.00)
 DNA isolation batch, number 2 %(n) 89.0 (1,281) 100.0 (3)
 Alpha diversity metrics, mean (SD)
  Chao index 150.6 (37.7) 150.2 (31.7)
  Shannon Index 4.0 (0.41) 4.0 (0.4)
  Inverse Simpson Index 31.9 (14.3) 30.1 (15.9)
Eczema, yes % (n) 7.0 (89) 7.0 (182)
Sensitization for food allergens, yes % (n) 6.4 (80) 7.2 (188)
Sensitization for inhalant allergens, yes % (n) 30.8 (385) 32.3 (842)
Physician-diagnosed food allergy, yes % (n) 2.3 (29) 2.1 (49)
Physician-diagnosed inhalant allergy, yes % (n) 11.8 (150) 12.4 (296)
Obstructive lung function, yes % (n) 5.1 (67) 4.5 (123)
Asthma, yes % (n) 5.0 (64) 6.0 (145)
Values are percentages (absolute values), mean (standard deviation (SD)) or median (interquartile range 
(IQR)) based on observed data. For the included subjects, data were missing for maternal education (n=103), 
ethnicity (n=13), BMI (n=5), eczema (n=147), sensitization for food (n=195) and inhalant allergens (n=189), 
physician-diagnosed food (n= 201) and inhalant allergy (n=170), lung function (n=118), and asthma (n= 172). 
*p-value for difference <0.05.
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Figure 4.2.1. Characteristi cs of stool microbiota of the study populati on (n=1,440)
Left : Number of observed taxa at each taxonomy level. Within brackets represents the number of unique 
amplicon sequence variants (ASVs) identi fi ed in each taxonomic class.
Right: donut plots of average relati ve abundance of the top major phyla, families and genera and within brack-
ets the percentage coverage of the total relati ve abundance.
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Diversity of stool microbiota and atopic diseases
In the adjusted analyses, all alpha diversity indices and Aitchison beta diversity showed that the 
diversity, and overall compositional variation of stool microbiota was not different between those 
with and without atopic diseases, except for eczema, namely inverse Simpson index was associ-
ated with a decreased risk of eczema (OR (95%CI): 0.98 (0.97, 1.00)) (Table 4.2.2). The Bray-Curtis 
beta diversity showed that the overall compositional variation of stool microbiota was different 
between children with and without physician-diagnosed inhalant allergies only (Bray-Curtis beta-
diversity R2 (adjusted p-value): 0.001 (0.047) (Table 4.2.2). We observed no associations of alpha 
and beta diversity of stool microbiota with two or more atopic diseases, compared to those with 
only one atopic disease (data not shown). Sensitivity analyses with previous in-house developed 
pipeline showed that alpha diversity indices and Bray-Curtis beta diversity were not associated 
with any atopic diseases. Aitchison beta diversity showed that overall compositional variation of 
stool microbiota was different between children with and without physician-diagnosed inhalant 
allergy (Aitchison beta-diversity R2 (adjusted p-value): 0.001 (0.014))
Differential relative abundance of stool microbiota and atopic diseases.
The associated ASVs with atopic diseases are depicted in Supplemental Figure S 4.2.3. In the 
adjusted ANCOM and logistic regression analyses, Lachnospiraceae_unknowngenus_5 was as-
sociated with a decreased risk of eczema (OR (95%CI): 0.88 (0.79, 0.96)), and with a decreased 
risk of sensitization for inhalant allergens (0.94 (0.89, 0.98)) (Table 4.2.3). Ruminococcaceae_UCG-
005_unknownspecies_2 and Christensenellaceae_R-7_group_unknownspecies_2 were associated 
with a decreased risk of physician-diagnosed inhalant allergy (0.89 (0.82, 0.96) and 0.94 (0.88, 
0.99), respectively), while Agathobacter_unknownspecies was associated with an increased risk 
of physician-diagnosed inhalant allergy (1.23 (1.08, 1.42)). No associations were observed for 
specific ASVs of stool microbiota with sensitization for food allergens, physician-diagnosed food 
allergy, lung function, and asthma in the adjusted ANCOM analyses. No specific ASVs were as-
sociated with two or more atopic diseases compared to only one atopic disease in the adjusted 
ANCOM analyses (data not shown). Sensitivity analyses with the previous in-house developed 
pipeline showed similar results for Lachnospiraceae genus with sensitization for inhalant allergens 
(0.99 (0.99, 1.00)), and Ruminococcaceae_UCG-005 species and Christensenellaceae_R-7_group 
species with physician-diagnosed inhalant allergy (0.99 (0.98, 1.00) and 1.00 (1.00, 1.00)).
Functional pathways of stool microbiota and atopic diseases
In the adjusted ANCOM and logistic regression analyses, N-acetylneuraminate catabolism was 
associated with a decreased risk of sensitization for food allergens (OR (95%CI): 0.71 (0.54, 0.92)) 
(Table 4.2.4). Ethylmalonyl-CoA, L-leucine degradation I, Adenosylcobalamin biosynthesis I (an-
aerobic) and Aerobic respiration I (cytochrome c) pathways were associated with a decreased 
risk of sensitization for inhalant allergens in the adjusted ANCOM analyses, but the associations 
attenuated to non-significant in the adjusted logistic regression analyses (OR range (95%CI: 0.80 




































































































































































































































































































































































































































































































































































































































































































































































































































Table 4.2.3. Differential relative abundance of stool microbiota and atopic diseases at age 10 years
Amplicon sequence variants (ASV) Odds ratio (95%CI)
Eczema Lachnospiraceae unknowngenus_5 0.88 (0.79, 0.96)**
Sensitization for inhalant allergens Lachnospiraceae unknowngenus_5 0.94 (0.89, 0.98)**
Physician-diagnosed inhalant allergy
Ruminococcaceae_UCG-005 unknownspecies_2 0.89 (0.82, 0.96)**
Christensenellaceae_R-7_group unknownspecies_2 0.94 (0.88, 0.99)*
Agathobacter unknownspecies 1.23 (1.08, 1.42)**
The number of subjects included for the adjusted ANCOM and adjusted logistic regression analyses for ec-
zema (n=1,217), sensitization for food allergens (n=1,156), sensitization for inhalant allergens (n=1,161), 
physician-diagnosed food allergy (n=1,169), physician-diagnosed inhalant allergy (n=1,197), lung function 
(n=1,229), and asthma (n=1,192). Models were adjusted for maternal education, child’s sex, ethnicity, body 
mass index at age 10 years, antibiotic use in the past 3 months, DNA isolation batch and general collection 
time, and other associated Amplicon sequence variants (ASVs) with the outcome of interest. No associations 
were found for stool microbial ASVs with sensitization for food allergens, physician-diagnosed food allergy, 
lung function, and asthma at age 10 years. *p-value <0.05, **p-value<0.01.
Table 4.2.4. Associations of functional pathways of stool microbiota with atopic diseases at age 10 years
Functional pathway Odds ratio (95%CI)
Sensitization for food allergens N-acetylneuraminate catabolism; sialic acid degradation 0.71 (0.54, 0.92)**
Sensitization for inhalant 
allergens
Ethylmalonyl-CoA pathway 0.80 (0.60, 1.08)
L-leucine degradation I pathway 0.91 (0.75, 1.09)
Adenosylcobalamin biosynthesis I (anaerobic) pathway 1.16 (0.98, 1.41)
Aerobic respiration I (cytochrome c) pathway 1.01 (0.94, 1.07)
Physician-diagnosed food allergy L-lysine biosynthesis II pathway 0.67 (0.52, 0.89)**
Physician-diagnosed inhalant 
allergy
Taxadiene biosynthesis 0.89 (0.78, 1.01)
Geranylgeranyldiphosphate biosynthesis I (via mevalonate) 0.90 (0.83, 0.98)*
Superpathway of heme b biosynthesis from glycine 0.92 (0.85, 0.99)*
Methylphosphonate degradation I pathways 0.94 (0.85, 1.06)
Asthma
Superpathway of heme b biosynthesis from glycine 0.89 (0.80, 0.99)*
L-glutamate degradation V (via hydroxyglutarate) 0.88 (0.79, 0.99)*
Taxadiene biosynthesis 0.86 (0.73, 1.02)
The number of subjects included for the adjusted ANCOM and adjusted logistic regression analyses for eczema 
(n=1,217), sensitization for food allergens (n=1,156), sensitization for inhalant allergens (n=1,161), physician-
diagnosed food allergy (n=1,169), physician-diagnosed inhalant allergy (n=1,197), lung function (n=1,229), 
and asthma (n=1,192). Models were adjusted for maternal education, child’s sex, ethnicity, body mass index 
at age 10 years, antibiotic use in the past 3 months, DNA isolation batch and general collection time, and other 
associated pathways with the outcome of interest. No associations were found for stool microbial functional 
pathways with eczema, and lung function at age 10 years. *p-value <0.05, **p-value<0.01.
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(0.60, 1.08) - 1.16 (0.98, 1.41)). L-lysine biosynthesis II pathway was associated with a decreased 
risk of physician-diagnosed food allergy (0.67 (0.52, 0.89)) in the adjusted ANCOM and logistic re-
gression analyses. Geranylgeranyldiphosphate biosynthesis I (via mevalonate) and superpathway 
of heme b biosynthesis from glycine were associated with a decreased risk of physician-diagnosed 
inhalant allergy (0.90 (0.83, 0.98) and 0.92 (0.85, 0.99), respectively), while the identified path-
ways of Taxadiene biosynthesis and Methylphosphonate degradation I from adjusted ANCOM 
analyses attenuated to non-significant in the adjusted logistic regression model (0.89 (0.78, 1.01) 
and 0.94 (0.85, 1.06), respectively). The superpathway of heme b biosynthesis from glycine, and 
L-glutamate degradation V (via hydroxyglutarate) were associated with a decreased risk of asthma 
(0.89 (0.80, 0.99) and 0.88 (0.79, 0.99), respectively), while the association of Taxadiene biosyn-
thesis with a decreased risk of asthma in adjusted ANCOM analyses attenuated to non-significant 
in the adjusted logistic regression (0.86 (0.73, 1.02)). No functional pathways of stool microbiota 
were associated with eczema or lung function. No specific functional pathways were associated 
with two or more atopic diseases compared to only one atopic disease (data not shown).
dISCuSSIOn
In this population-based prospective cohort study among children aged 10 years, we observed 
that the diversity, relative abundance, and functional pathways of stool microbiota were associ-
ated with physician-diagnosed inhalant allergy. Associations of diversity, relative abundance, and 
functional pathways of stool microbiota with other atopic outcomes were less consistent.
Comparison with previous studies
Compared to our previous study on diversity, compositional, and functional differences of stool 
microbiota of children and adults, the top four major phyla and the top 10 major families remained 
the same, and of the top most abundant genera 24 were also in the top 30 genera of the in the 
current study population8. In addition, we gained more unique ASV numbers on each taxonomic 
level using the DADA2 pipeline with the final dataset, including 1443 different ASVs in the current 
study compared to 661 operational taxonomic units in our previous study. We observed that 
inverse Simpson index (alpha diversity) of stool microbiota was associated with a decreased risk 
of eczema only, and not with other current atopic diseases at age 10 years. We observed that the 
overall composition of stool microbiota, based only on Bray-Curtis beta diversity, is different in 
children with and without physician-diagnosed inhalant allergy at the age of 10 years. A recent 
systematic review of previous cohort and case-control studies performed in children mostly be-
fore the age of 6 months showed associations of alpha diversity of stool microbiota with eczema, 
inhalant and food allergies, and asthma, while studies performed in older children using modern 
sequencing methods showed conflicting results6. Therefore, the relative abundance of stool 
microbiota might be more important in atopic diseases than the diversity at school age. The ASVs 
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that we identified as being associated with atopic diseases at 10 years were in line with results 
of previous studies among children younger than 5 years These demonstrated that genera from 
Lachnospiraceae, Ruminococcaceae, and Prevotellaceae families, and higher taxonomic order of 
Clostridiaceae measured at ages 0-2 years were associated with atopic diseases at ages 0-8 years6. 
However, the direction of associations between specific stool microbiota and atopic diseases was 
not consistent. For example, the family of Lachnospiraceae and the order of Clostridiaceae were 
associated with both increased and decreased risks of atopic diseases6. The differences in results 
of diversity and relative abundance of stool microbiota with atopic diseases in our and previous 
studies might be due to differences in characteristics of children included in the analysis, such 
as age and geographic location, and the prospective or cross-sectional design. It might be more 
challenging to find associations of stool microbiota with atopic diseases in older children, since 
the complexity of gut microbiota increases with age, despite its stabilization in later life8. Also, the 
heterogeneity of the bioinformatics and statistical approaches of the studies due to the composi-
tional nature of stool microbiota data, and limitation of sequencing technique could explain the 
differences in results11. Homogenization of microbiota tables is needed to adequately compare 
results of gut microbiota with atopic diseases between different studies. Future studies should 
analyse gut microbiota at lower taxonomic levels, because specific microbial species within a 
genus may influence atopic diseases differently.
No specific functional pathways of stool microbiota were consistently associated with all atopic 
diseases, which might be explained by differences in the etiology of atopic diseases, and only a 
small proportion of children that follows the atopic march in our population-based cohort 37-39. 
The most consistent observations included functional pathways related to heme and terpenoid 
biosynthesis, which were associated with decreased risks of physician-diagnosed inhalant allergy 
and asthma. Taxadiene biosynthesis, Geranylgeranyldiphosphate biosynthesis I (via mevalonate) 
and Mevalonate pathway I (eukaryotes and bacteria) are part of the pathways class of biosynthe-
sis of terpenoids, which are a class of naturally occurring organic compounds, derived from five 
carbon isoprene units, and often used in cosmetics, pharmaceuticals, or biofuels40. Murine stud-
ies showed that mevalonate biosynthesis plays a role in T-helper 2 cell differentiation, and that 
inhibiting mevalonate pathway can lower the allergic inflammation and airway hyperreactivity, 
making it a possible novel therapeutic target for atopic diseases41 42. This is in line with findings of 
a recent review suggesting that terpenoids have anti-inflammatory effects, and might be effective 
in treating respiratory inflammation and atopic dermatitis43. Although the specific superpathway 
of heme b biosynthesis from glycine has not been previously found to be associated with atopic 
diseases, hemeoxygenase-1 (HO-1) protein, which catabolizes heme to biliverdin, free iron and 
carbonoxide, is increased in murine lung tissue in allergic airway inflammation and in skin lesions 
of patients with eczema44 45. In addition, iron-deficiency has also been related to increased risk 
of atopic diseases, possibly through changes in the gut microbiome46. Interestingly, we observed 
that N-acetylneuraminate catabolism (also known as sialic acid degradation) pathway was associ-
ated with a decreased risk of sensitization of food allergens. Further, this finding might explain 
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the increased sialic acid content that a recent study found on total IgE from individuals with a 
peanut-allergy as compared to those without any allergies47. We did not observe an association 
of N-acetylneuraminate catabolism with physician-diagnosed food allergy, which might be due to 
the used definition of allergy. Allergic sensitization measured by skin prick tests reflects children 
who are sensitized but partly do not experience symptoms of food allergy. Another interesting 
observation included the association of L-glutamate degradation V (via hydroxyglutarate) with a 
decreased risk of current asthma. Via this pathway, bacteria are able to ferment amino acids into 
short chain fatty acids (SCFA) among other products. This observation supports the hypothesis 
of SCFA having anti-inflammatory properties, and its association with decreased risks of atopic 
diseases48 49.
Interpretation of results
To the best of our knowledge, our study is one of the few studies to examine the associations of 
stool microbiota with atopic diseases in school-age children from the general population. Our 
results contribute to the body of knowledge on the role of gut microbiota in the development 
of atopic diseases in later childhood. We observed no consistent associations of gut microbiota 
with eczema, allergy and asthma using DADA2 pipeline and our previously in-house developed 
pipeline, which suggests that the role of gut microbiota on atopic diseases might be limited in 
later childhood. The relation between gut microbiota and atopic diseases might be influenced by 
the severity of the condition, steroid use, and persistence of atopic diseases. Therefore, observa-
tions might be different in hospital-population or at an individual based level, when children have 
multiple and persistent atopic diseases, and greater disease severity. Furthermore, due to the 
cross-sectional design of our study, we could not examine the influence of early life gut micro-
biota on later life gut microbiota, and subsequently atopic diseases in later life. Our observations 
that diversity and relative abundance of stool microbiota were not prominently associated with 
atopic diseases at school age support the hypothesis of an ‘early window of opportunity’ in which 
the gut microbiota plays an more important role in the maturation of the immune system in early 
childhood, and to a lesser extent in later childhood50. This has also been suggested by murine 
studies that showed that changes in gut microbiota in neonatal mice, but not in adult mice are 
associated with the of development of atopic diseases51 52. Gut microbiota protects the host from 
potential pathogenic colonization, contributes to the intestinal barrier function, and helps develop 
and regulate the immune system5. Especially in early childhood, when maturation of the gut and 
immune system is still ongoing, disruption of systems contributing to the maturation of the gut 
and immune system might increase the risk of developing atopic diseases. T-regulatory cells play 
an important role in the immune responses to allergens, the regulation of type 2 T-helper cells, 
and the production of immunoglobulin type E53. Gut microbiota can induce the differentiation of 
T-regulatory cells, and reduce pro-inflammatory cytokines through different pathways, such as 
via the production of short-chain fatty acids leading to activation of G protein–coupled receptors 
signaling pathways and epigenetic changes50. Also, gut microbiota might affect atopic diseases 
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through interaction with other microbiota, such as on the lung or skin54 55. Gut bacteria and 
their metabolites can migrate to the blood, the lymphatic system, skin, and lung via an impaired 
intestinal barrier, and can produce short chain fatty-acids that can exhibit antimicrobial effects 
against for example Staphylococcus aureus, which on the skin and nose has been associated with 
increased risk of eczema and eczema severity54 55. Our study was designed cross-sectionally and 
prospective cohort studies should examine the role of early life microbiome and its longitudinal 
development on later life atopic diseases.
Strengths and limitations
The strengths of this study include its cross-sectional design within a well-characterized 
population-based prospective study, a large number of subjects, and examining stool microbiota 
with atopic diseases at school age using a combination of compositional and non-compositional 
approaches. Also, we used novel and open source microbiome analyses tools such as DADA2 and 
PICRUSt2, which enables better comparison with other (future) studies, since the used DADA2 
pipeline produced sequences reads with counts that can be compared directly across studies10 29. 
However, limitations of this study should also be considered in the interpretation of the results. 
Children not included in the analyses had less favourable socio-economic factors, were more of-
ten of non-European ethnicity, and had a higher BMI, which could have resulted in selection bias 
if the associations of gut microbiota with atopic diseases would have been different in children 
included and not included in the analysis. Non-differential misclassification of eczema, asthma 
and physician-diagnosed allergies remains possible due to collection via self-reported question-
naires and might have led to dilution of results. We used validated questionnaires to minimize 
this bias18 56. In addition, residual confounding might still be present as in any observational study. 
Besides inhaled asthma medication, no information was available on steroid use. However, on a 
population level most atopic diseases are of mild severity, and therefore the effect of steroid use 
on the associations of stool microbiota with atopic disease will most likely be constrained. Fur-
ther, although the 16S rRNA gene amplification and shotgun metagonomics approaches provide 
different information, the phylogeny and biomolecular function have been shown to be strongly 
correlated30. Shotgun metagenomic sequencing would allow greater precision in the functional 
predictions obtained from PICRUSt2 (28). Unfortunately, metagenomic profiling was not avail-
able considering the high costs of performing shotgun sequencing in our large population-based 
cohort. Also, high inter-individual variability of the gut microbiota and high-dimensionality of 
the microbiota data can hinder the power of analysis. Uniform and harmonized methodological 
approaches for better identification and comparison of results between large-scale studies are 
urgently needed57. Lastly, although we consider the applied methods as the most appropriate 
following the current standards set in the field, analytical tools in the field of microbiota are still 
developing and as such results may depend on the method applied. While microbiome profiling 
methods continue to evolve further, our study already provides some leads that await replication 
to confirm the involvement of the gut microbiota in the etiology of atopic diseases.
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Conclusion
We observed that the diversity, relative abundance and pathways derived from stool microbiota 
were consistently associated with physician-diagnosed inhalant allergy, and less consistent with 
current eczema, food allergy outcomes and asthma at school age. The role of stool microbiota 
on atopic diseases therefore seems limited in later childhood. Despite the relatively large sample 
of our study, we cannot exclude that weak associations with other atopic diseases were not 
detected given the large dimensionality and heterogeneity of the stool microbiome data, and the 
low prevalence of some of the atopic diseases. Additionally, the effect of the stool microbiota on 
atopic diseases with a different etiology might differ. Future large-scale studies should repeatedly 
examine the longitudinal associations of stool microbiota and atopic diseases from infancy to 
school-age. This might clarify any age specific influences of gut microbiota on the development of 
atopic diseases throughout childhood.
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Supplementary Figure S4.2.1. Study design
 
Supplementary Figure S4.2.2. Relati ve abundance of phyla for children with any atopic disease outcome 
compared to those without any atopic diseases.
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Supplementary Table S4.2.3. Unadjusted analysis of functional pathways of stool microbiota with atopic dis-
eases at age 10 years
Functional pathway Odds ratio (95%CI)
Sensitization for inhalant 
allergens
Ethylmalonyl-CoA pathway 0.91 (0.85, 0.96)**
L-leucine degradation I pathway 0.91 (0.86, 0.97)*
Adenosylcobalamin biosynthesis I (anaerobic) pathway 0.94 (0.90, 0.98)**
Aerobic respiration I (cytochrome c) pathway 0.95 (0.91, 0.99)*
Glycerol degradation to butanol pathway 1.07 (1.01, 1.14)*
Physician-diagnosed food allergy L-lysine biosynthesis II pathway 0.67 (0.52, 0.89)**
Physician-diagnosed inhalant 
allergy
Taxadiene biosynthesis 0.82 (0.73, 0.92)**
Geranylgeranyldiphosphate biosynthesis I (via mevalonate) 0.92 (0.86, 0.99)*
Mevalonate pathway I (eukaryotes and bacteria) 0.92 (0.85, 0.99)*
Peptidoglycan biosynthesis V (β-lactam resistance) 0.95 (0.90, 1.00)
(S)-propane-1,2-diol degradation 1.09 (1.01, 1.19)*
Asthma
Superpathway of heme b biosynthesis from glycine 0.87 (0.79, 0.96)**
L-glutamate degradation V (via hydroxyglutarate) 0.87 (0.79, 0.97)*
4-aminobutanoate degradation V 0.76 (0.61, 0.97)*
The number of subjects included for the unadjusted ANCOM and unadjusted logistic regression analyses were 
for eczema (n=1,293), sensitization for food allergens (n=1,245), sensitization for inhalant allergens (n=1,251), 
physician-diagnosed food allergy (n=1,239), physician-diagnosed inhalant allergy (n=1,270), lung function 
(n=1,322), and asthma (n=1,268). No associations were found for stool microbial functional pathways with 
eczema, sensitization for food allergens, and lung function at age 10 years. *p-value <0.05, **p-value<0.01.
Supplementary Table S4.2.2. Unadjusted differential relative abundance of stool microbiota and atopic dis-
eases at age 10 years
Amplicon sequence variants (ASVs) Odds ratio (95%CI)
Eczema Lachnospiraceae unknowngenus_5 0.86 (0.79, 0.94)**
Sensitization for inhalant allergens Lachnospiraceae unknowngenus_5 0.93 (0.89, 0.97)**
Physician-diagnosed food allergy Ruminococcus_2 bromii 1.16 (1.03, 1.30)*
Physician-diagnosed inhalant allergy
Ruminococcaceae_UCG-005 unknownspecies_2 0.87 (0.81, 0.93)**
Christensenellaceae_R-7_group unknownspecies_2 0.92 (0.87, 0.97)**
Agathobacter unknownspecies 1.26 (1.11, 1.45)**
Prevotella_9 unknownspecies_4 0.88 (0.80, 0.95)**
The number of subjects included for the unadjusted ANCOM and unadjusted logistic regression analyses were 
for eczema (n=1,293), sensitization for food allergens (n=1,245), sensitization for inhalant allergens (n=1,251), 
physician-diagnosed food allergy (n=1,239), physician-diagnosed inhalant allergy (n=1,270), lung function 
(n=1,322), and asthma (n=1,268). No associations were found for stool microbial Amplicon sequence vari-
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abSTRaCT
Asthma is a common disease in childhood, and might predispose for chronic obstructive respira-
tory morbidity in adolescence and adulthood. Various early-life risk factors might influence the 
risk of wheezing, asthma and lower lung function in childhood. Cohort studies demonstrated 
that lower respiratory tract infections in the first years of life are associated with an increased 
risk of wheezing and asthma, while the association with lung function is less clear. Additionally, 
the gut and airway microbiome might influence the risk of wheezing and asthma. The interaction 
between respiratory tract infections and the microbiome complicates studies of their associations 
with wheezing, asthma and lung function. Furthermore, the causality behind these observations 
is still unclear, and several other factors such as genetic susceptibility and the immune system 
might be of importance. This review is focused on the association of early-life respiratory tract 
infections and the microbiome with wheezing, asthma and lung function, it’s possible influencing 
factors and perspectives for future studies.
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InTROduCTIOn
Asthma is a common disease in childhood and has a worldwide prevalence of 5-10%1. In preschool 
children, the prevalence of asthma related symptoms, such as wheezing and shortness of breath, 
is even higher1. Results of birth cohort studies of the last decades suggest that part of the origins 
of childhood asthma occur in early life2-10. Lower lung function or asthma in childhood might 
predispose to chronic obstructive respiratory diseases, including COPD, in adolescence and adult 
life11 12. Therefore, identifying risk factors in early life is important to understand the develop-
ment of lower lung function and asthma and allow prevention of disease. Recent studies suggest 
that early-life respiratory tract infections could lead to airway obstruction and hyperreactivity13, 
and subsequently increased risk of persistent lower lung function and asthma. Also, exposure to 
microorganisms seems associated with either an increased risk or lower risk of atopic diseases, 
depending on the type of bacteria, the composition of the microbiome, or both.
In this review, we describe the current knowledge from cohort studies on the role of early-life 
respiratory tract infections and the microbiome in the development of asthma.
RESPIRaTORy TRaCT InfECTIOnS
Respiratory tract infections occur most frequently in early childhood, which is also the age with 
the most rapid development of the immune and respiratory system14-16. The prevalence varies per 
type of respiratory tract infection. In developed countries, the incidence of pneumonia in children 
until the age of 5 years is 0.05 episodes per child year17. Symptoms of an upper respiratory tract 
infection, such as sore throat and rhinorrhea, in children until the age of 5 years are more com-
mon, with a reported prevalence of 5.06 episodes per child year in the USA18.
The diagnosis of early-life respiratory tract infections in studies that examine the relation of 
respiratory tract infections with wheezing, asthma or lung function varies largely, and is mainly 
divided into respiratory tract infections diagnosed in the laboratory or physician-diagnosed. For 
laboratory proven respiratory tract infections, nasal samples are taken either during symptoms 
of an acute respiratory tract infection19-27, or at scheduled time points19 24 28. These are mainly 
analyzed for either human rhinovirus (HRV) or respiratory syncytial virus (RSV), the most common 
viral pathogens, and more rarely for other viruses, such as adenovirus, coronavirus or influenza 
virus. The difference in timing of sampling could potentially lead to biased results, since the 
prevalence of a virus during an acute respiratory infection is most likely not comparable to the 
prevalence of a virus during an asymptomatic period. Studies that used physician-diagnosed 
respiratory tract infections in early-life as outcomes used either questionnaires or standardized 
registries. Some prospective cohort studies used questionnaires in which parents were asked 
whether their child has had a specific infection in a specific period of time29-31. Alternatively, 
studies use ICD-codes or hospital (admission) registries to identify children with respiratory tract 
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infections32-37. Such differences in definitions could lead to differences in effect sizes, which is also 
illustrated by a cohort study that compared RSV infections in children that visited the outpatient 
clinic, the emergency department or who were hospitalized34 in relation to asthma diagnosis. 
Children with RSV infections in these 3 different clinical groups had a 1.86, 2.41 and 2.82 fold 
increased risk for asthma, respectively, compared with children without a hospital visit for RSV 
infections. This is in line with another retrospective cohort study that showed that children with 
RSV infections who were at the outpatient clinic or prolonged hospitalized had a 1.38 vs 2.5921 
increased odds for recurrent wheeze at the age of 5 years, respectively, compared with those 
without an RSV infection. The use of questionnaires or registries has the advantage of easily ac-
cessible data at relatively low cost, but could possibly lead to misclassification. Viral sampling is 
more reliable in terms of accurate diagnosis, but whether sampling during symptoms of an acute 
respiratory tract infection is comparable to sampling at scheduled times is unclear. Additionally, 
costs will be higher and logistics are more complex. Thus, in large observational population-based 
cohort studies, questionnaires or registries are cost-effective methods to assess respiratory tract 
infections, while smaller studies using viral sampling provide information on specific agents.
In preschool children, asthma is difficult to diagnose and mainly based on the occurrence of 
wheezing. Previous population-based or high risk cohorts showed that HRV, RSV, or bronchiol-
itis in the first 1-3 years of life are associated with an up to 13-fold increased risk of preschool 
wheezing20-23 28 30 38. One cohort study showed that hospitalization for RSV was associated with an 
increased risk of recurrent wheezing at the age of 18 years39. Cohort studies or case-control stud-
ies that focused on childhood asthma at age 4 to 13 years showed that HRV, RSV or bronchiolitis 
in the first year, the first two or the first three years of life were associated with an increased 
risk of asthma with odds ratios ranging from 1.39 to 13.5519 29 32-37 40. Some studies examined a 
group of, and not individual, respiratory tract infections only. A case-control study showed that 
hospitalization for any respiratory tract infection in the first year of life was associated with a 1.5-
fold increased risk of asthma at the age of 5 years35, while a high-risk cohort study demonstrated 
that wheezy and febrile lower respiratory tract infections in the first year of life were associated 
with an increased risk of asthma at the age of 5 of 10 years. However, these latter associations 
seemed only present when the child had allergic sensitization before the age of 2 years41 42. It 
has also been suggested that the number of respiratory tract infections, rather than a specific 
infection, is associated with an increased risk of asthma43. Thus, it might be that individual and 
type of respiratory infections are less important for the development of preschool wheezing or 
childhood asthma than groups and number of respiratory tract infections.
Only a few studies have examined the effect of early-life respiratory tract infections on lung 
function. Population-based cohorts, but also a high-risk cohort and a case-control study showed 
that respiratory tract infections in the first or the first three years of life were associated with 
a lower lung function, specifically Forced Expiratory Volume in 1 second (FEV1), Forced Expira-
tory Flow after exhaling 50% of the Forced Vital Capacity (FEF50) , FEV1/FVC, Midexpiratory Flow 
(FEF2575) or Peek Expiratory Flow (PEF) mostly at age 6-8 years24-26, although one prospective 
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cohort study assessed lung function multiple times between the ages of 11 to 26 years44. The 
decrease in lung function varied between –62.8 to –80 mL for absolute values, and –2.5 to –20% 
for percentage predicted values. However, two population-based cohorts found no associations 
of lower respiratory tract infections before the age of 2 years or pneumonia or whooping cough 
in the first 7 years of life with lung function at the age of 10 years31, or decline in FEV1 between 
the age of 35 and 4545, respectively. It could be argued that respiratory tract infections in later 
childhood might not have the same adverse effect as in earlier childhood, explaining why no 
association was found in the latter study. Further studies on the role of early respiratory tract 
infections with later life wheezing, asthma and lung function are warranted.
The vast majority of the studies focused on respiratory tract infections in the first 1-3 years of 
life. It is speculated that respiratory tract infections in early life most probably have the greatest 
adverse effect, since both the immune system and the respiratory system are still under develop-
ment in this stage of life15 16. Early-life respiratory tract infections could lead to a disturbance in the 
development of both systems leading to persistent adaptations, and risk of respiratory morbidity 
in later life.
It remains unclear whether lower respiratory tract infections influence the risk of lower lung 
function, asthma and wheezing, or vice versa. Some evidence on causality is provided by two 
randomized controlled trials (RCT) comparing palivizumab with placebo in preterm infants. Both 
demonstrated that compared with the placebo, palivizumab decreased the risk of later wheezing, 
either in the first year of life46 or at the age of 2 to 5 years47. However, some studies that measured 
early-life lung function suggest the opposite direction of causality. One prospective cohort study 
showed that increased bronchial responsiveness in infancy was associated with increased risk of 
severe bronchiolitis48 and another showed that children with a lower respiratory system compli-
ance, and higher resistance at the age of 2 months, were at greater risk for hospitalization for an 
RSV infection and wheeze after the infection25. However, the latter study group demonstrated 
that the association of HRV in the first year of life with wheezing at the age of 4 years remained 
significant after adjusting for lung function measurements at the age of 2 months28. Additionally, 
another cohort study demonstrated that lower respiratory tract infections in the first year of life 
were associated with an increased respiratory rate at 1 year of age, and that recurrent lower re-
spiratory tract infections were associated with a lower tidal volume and increased lung clearance 
index, irrespective of lung function measured at the age of 6 weeks49. To examine the direction 
of causality, further longitudinal studies with detailed information on respiratory tract infections 
and lung function measures early and later in life are urgently needed to provide more insight in 
the causal direction of these associations.
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ThE MICRObIOME
The microbiome could be defined as the community of micro-organisms living in or on the human 
body50. Two locations of the microbiome are of great interest in relation to wheezing, asthma 
and lung function, namely the airway and gut microbiome. Analyses of bacterial communities 
are mostly performed by 16S rRNA gene sequencing, identifying different bacteria. Challenges 
in measuring the airway microbiome lie in the relative low density of bacterial communities 
when compared to the gut microbiome. Additionally, the lower airway microbiome is difficult to 
sample and carries the risk of contamination of the upper respiratory tract microbiome51. When 
studying the microbiome, it is possible to focus on microbiome diversity or composition, or on 
specific bacteria. For microbiome diversity, the richness and evenness of species is estimated, for 
example by using the Shannon index or the Simpson’s diversity index52. Here, richness reflects the 
number of different species, while evenness reflects how even these different species are distrib-
uted. Another approach is to model bacterial community compositions, to form distinguishable 
groups53. If specific bacteria are used as the exposure, it is possible to focus on bacterial groups or 
specific bacteria. Some of these bacteria might have a beneficial effect on wheezing, asthma and 
lung function,, such as Bifidobacterium spp, whilst others might have a negative effect, such as 
Clostridium difficile. The use of different methods for the determination of the microbiome makes 
it difficult to compare studies. Also, the question remains whether the focus should be on specific 
bacteria, or rather on the total composition of the microbiome. Characterizing specific bacteria is 
used more commonly, and is less complicated in terms of both analysis and interpretation but is 
likely to be an over simplification of the health effects of the entire microbial composition.
Airway microbiome
The composition of the airway microbiome changes in the first years of life. Nasopharyngeal sam-
ples in healthy subjects around the age of 2 months are mostly dominated by Staphylococcus and 
Corynebacterium, but this frequency decreases with increasing age. In contrast, Alloicoccus and 
Moraxella colonization is low at the age of 2 months, but is increased at the age of 12 months54. 
Interestingly, when an acute respiratory illness had occurred in between the two sample periods, 
a transition to Moraxella or a stable colonization with Moraxella was most commonly present. 
Other than respiratory illness, exposure to pets, daycare attendance, siblings and antibiotic use 
in the four weeks prior to sampling were associated with nasopharyngeal colonization, show-
ing mostly higher rates of Haemophilus and Moraxella colonization. Additionally, a prospective 
cohort study collected samples of the hypopharyngeal microbiome at the age of 1 week, 1 month 
and 3 months, and showed that the microbiome at the age of 1 week represented over 60% of the 
microbiome at 3 months55. Thus, although various factors can influence the airway microbiome, 
it is also likely that the microbiome formation in later life is determined by early colonization.
Various airway microbiota have been linked to later life asthma and wheezing. A prospective 
high-risk cohort study showed that Streptococcus colonization at the age of 2 months was as-
The role of respiratory tract infections and the microbiome in the development of asthma: A narrative review. 221
sociated with an increased risk of chronic wheeze at the age of 5 years54, while another pro-
spective cohort study showed that in neonates, S. pneumoniae, M. catharallis and H. influenza 
were associated with an increased risk of wheezing at the age of 5 years56. Additionally, some 
cross-sectional studies have compared the lung microbiome obtained by bronchoalveolar lavage 
or broncho-epithelial brush of asthmatics and healthy controls. Those studies showed that the 
bronchi of both children and adults with asthma contained more Haemophilus spp57, and that 
that the bacterial concentration and diversity were higher in adults with suboptimally controlled 
asthma58, compared with children or adults without asthma. To date, it is nclear whether differ-
ences in the microbiome of the airways and lungs precede asthma, or whether the disease itself 
is the cause of these changes.
Gut microbiome
The composition of the gut microbiome changes during the first years of life, mostly as an effect 
of the changing diet in the same period59. The introduction of supplementary feeding, the intro-
duction of solids and the start of weaning60 are important time periods in which the microbial 
composition changes. These time periods should be taken into account when deciding at which 
age to sample feces for measuring the gut micriobiome, or when interpreting results of different 
studies.
Previously published human studies have linked the gut microbiome with the development of 
atopic diseases such as asthma. A prospective cohort study showed that C difficile colonization 
at the age of 1 month was associated with an increased risk of recurrent wheeze until the age of 
2 years, but also with eczema and atopic sensitization at the same age61. However, only the pres-
ence of C difficile, not the concentration in the feces was associated with these outcomes. Other 
bacteria, such as bifobacteria, B fragilis species, E coli and lactobacilli were not associated with 
recurrent wheeze. A birth cohort study characterized the bacterial composition at the age of 1 
month and 6 months within three distinct groups53. The group with a lower abundance of bacteria 
such as Bifidobacteria and Lactobacillus, but a higher abundance of fungi such as Candida had the 
highest risk of asthma, predominantly multisensitized atopy at the age of 2 years, and asthma 
at the age of 4 years. No difference was observed between the three groups in the risk of atopy 
at the age of 2 years, defined as an IgE level above 0.35 IU ml-1. A comparison of stool samples 
at the age of 4 years between non-wheeze, non-sensitized controls and wheezy-sensitized cases 
showed no difference in the microbiome composition62. Both a prospective cohort and a substudy 
of an RCT showed that the gut microbiome until the age of 1 month is also associated with asthma 
development at the age of 6 or 7 years63 64. The microbiome at the age of 12 months however was 
not associated with asthma. In summary, previous studies support the hypothesis that mostly the 
microbiome in early life is important for the development of wheezing and asthma at a later age63.
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RESPIRaTORy TRaCT InfECTIOnS and ThE aIRway MICRObIOME
It is likely that respiratory tract infections and the airway microbiome influence each other. 
Respiratory tract infections could have an effect on the microbiome both during, and after the 
infection65. Additionally, it is possible that the microbiome colonization of the airway could 
increase the risk of a subsequent respiratory tract infection66. Hypopharyngeal colonization 
with S. pneumoniae, H. influenza or M. catharralis in the first 3 years of life is associated with an 
increased risk of pneumonia and bronchitis at the age of 4 years, providing evidence for the latter. 
It has also been shown that early Streptococcus colonization is associated with an increased risk 
of a lower respiratory tract infection at an earlier age, while Moraxella colonization is associated 
with an upper respiratory tract infection at an earlier age54. These findings suggest that respira-
tory tract infections might not only influence the airway microbiome, but also vice versa. This 
further complicates the relationship of either with wheezing, asthma and lung function, and the 
understanding of this association.
InfluEnCIng faCTORS
Several factors could be of influence in the associations of respiratory tract infections or the 
microbiome with wheezing, asthma and lung function. The difference between the influencing 
factors is of importance in the matter of possible prevention or treatment strategies.
Environmental factors
Mode of delivery has been suggested as a possible intermediate factor in the relationship be-
tween the microbiome and risk of asthma67-72. Children born through a caesarian section are 
likely to have a lower gut microbiome diversity, especially in the first three months of life. Mode 
of delivery might also influence the airway microbiome, although the association of mode of de-
livery with the airway microbiome has been studied less. Antibiotic use could be related to both 
the associations of respiratory tract infections with wheezing, asthma and lung function, and to 
the associations of the microbiome with these outcomes. Respiratory tract infections could lead 
to increased antibiotic use, which thereby has as an intermediate effect on wheezing, asthma 
and lung function73 74. The use of antibiotics could also have an effect on the composition of the 
gut microbiome, and therefore act as a confounder in the associations of the microbiome with 
asthma or wheezing75-77. Confounding by indication or reverse causation can complicate studies 
on the effect of the microbiome. For example, it has been suggested that the use of antibiotics is 
a results of confounding by indication, meaning that only respiratory tract infections themselves 
have an effect on wheezing, asthma and lung function, and that a observed adverse effect of 
antibiotic use on these outcomes is solely because of the direct relation between the use of 
antibiotics and respiratory tract infections74.
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Intrinsic factors
An explaining factor for the associations of respiratory tract infections with wheezing, asthma 
and lung function is genetic susceptibility. The 17q21 locus, the strongest known susceptibility 
locus for asthma, was demonstrated to be associated with HRV wheezing in early life as well, 
but not with RSV wheezing illness78. Similarly, CDHR3 gene variation increases risk of childhood 
asthma with severe exacerbations79, with an increased susceptibility to rhinovirus C infections as 
a possible underlying mechanism80. Genetic differences in immune response to infections are also 
of interest. Some single nucleotide polymorphisms (SNPs) have been identified to be associated 
with respiratory tract infections and asthma or airway hyperreactivity, including picornavirus with 
atopic asthma and airway hyperreactivity, and RSV with atopic asthma and airway hyperreactiv-
ity81. A cohort study of children with RSV demonstrated that genes coding for the Interleukin (IL) 
pathway, specifically IL4 which might promote allergic inflammation and asthma, are associated 
with both RSV infection and wheezing, suggesting a potential role for genetic differences in im-
mune responses to infections82. The immune system could also be an explaining factor in the 
associations of the microbiome with asthma and wheezing. The gut-associated lymphoid tissue 
is an important factor in the immune system, and plays a role in the development of the gastro-
intestinal immune system83. Additionally, the birth cohort study that demonstrated that one of 
three distinct groups of bacterial composition of the gut microbiome was associated with a higher 
risk of asthma and atopy, also showed that this same group was associated with CD4+ cell dysfunc-
tion. Specifically, CD4+IL4+ cells are upregulated, as is the concentration of IL-4 released, which 
could contribute to airway inflammation53. This could possibly mean that the risk of asthma and 
wheezing due to differences in the gut microbiome might be mediated by differences in the im-
mune system. The immune system could be a true underlying causal factor in these associations, 
meaning that the immune system could influence both the risk of respiratory tract infections or 
alter the microbiome, and influence the risk of wheezing, asthma and lung function separately. 
Alternatively, the immune system might be a mediating factor in the association of respiratory 
tract infections or the microbiome with wheezing, asthma and lung function. Further studies on 
the role of the immune system are needed to disentangle these associations.
The associations between respiratory tract infections and wheezing, asthma and lung function 
might be modified by some factors such as the atopic status characterized by sensitization or 
paternal asthma or atopy. In a prospective cohort study, associations of wheezy or febrile lower 
respiratory tract infections was only found if children were sensitized by the age of 2 years, de-
fined as a positive skin prick test for either food or inhalant allergens41 42. Some differences in the 
effect estimates for bronchiolitis with asthma were also found when children with and without 
atopic parents were compared, although for both groups the effect estimates were significant 
(odds ratios 3.11 versus 1.66)40. The role of genetics, the immune system and atopy in the associa-
tions of the microbiome or respiratory tract infections with wheezing, asthma and lung function 
should be explored further.
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fuTuRE RESEaRCh
The role of respiratory tract infections and the microbiome has been of increasing interest in the 
past decade, but population-based cohort studies on its associations with wheezing, asthma and 
lung function are scarce. Population-based prospective cohort studies with frequent measures of 
respiratory tract infections and the microbiome in early life are needed to better understand the 
causal pathway between respiratory tract infections and the microbiome, and the development 
of chronic obstructive respiratory diseases in later life. Although the associations of respiratory 
tract infections with wheezing, asthma and lung function has been studied more commonly, 
the question still remains whether observed associations are causal, or whether children with 
a lower lung function at birth or at risk of asthma are more likely to develop respiratory tract 
infections before asthma occurs. Additional to frequent early-life measures of respiratory tract 
infections and the microbiome, population-based prospective cohort studies with lung function 
measurements in infancy could provide more insight. Large studies or meta-analyses might be of 
interest to take heterogeneity or small effect estimates into account. Studies should also focus 
on the relationship between the microbiome and respiratory tract infections, and their combined 
associations with chronic obstructive respiratory diseases. Additional to bacteria and viruses 
influencing each other, it is also possible that there is an interaction between bacteria and fungi 
in the airway. Studies on this subject, as well as the role of fungi alone, are scarce and should be 
addressed in future studies. Also, contamination of lower respiratory tract sampling with bacteria 
from the upper respiratory tract remains a problem. However, it has also been suggested that in 
healthy persons, the bacterial communities in the upper and lower respiratory tract resemble 
each other. RCT’s within this research area are scarce, but could provide more insight in the causal 
pathway. Identifying true causal factors, as opposed to confounding and intermediating factors, is 
the first step towards development of preventive strategies or specific treatment options.
COnCluSIOn
Results of cohort studies of the last decades show that mostly lower respiratory tract infections in 
the first years of life are associated with an increased risk of wheezing and asthma and lower lung 
function in later life. The presence of specific bacteria in the airway and gut in the first years of 
life, or the composition of the gut microbiome seem associated with an increased risk of wheez-
ing and asthma only. The airway microbiome and respiratory tract infections could influence each 
other, which complicates their relation as well as the understanding of their associations with 
later life chronic obstructive respiratory diseases (Figure 4.3.1). More detailed population-based, 
prospective cohort studies taking influencing factors into account, as well as RCT’s, are needed 
to further study the causal effect of respiratory tract infections and the microbiome in early life 
on later life wheezing, asthma and lung function. Specifically, longitudinal analysis of both the 
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gut and airway microbiome to identify critical periods, early lung function measurements to es-
tablish causality in the association of respiratory tract infections with wheezing, asthma and lung 
function, and the relation between the microbiome, respiratory tract infections and the immune 
system are needed. This could ultimately allow targeted treatment and prevention strategies 
aiming at reducing respiratory morbidity at the long term.
 
Figure 4.3.1. Pathways leading from respiratory tract infections and the microbiome in early life, to chronic 
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InTROduCTIOn
It is suggested that asthma has its origins in early life1-4. Early life exposures could lead to devel-
opmental adaptations of the immune and respiratory system, that increase the risk of lower lung 
function and asthma.
The main aim of this thesis was to identify early-life exposures leading to an increased risk of 
adverse respiratory health in childhood. The main results, strengths and limitations of these stud-
ies have been discussed in the previous chapters. In this chapter, a general discussion of the main 
findings of this thesis and their interpretation will be given. Additionally, this chapter will provide 
a discussion on general methodological issues, and will conclude with the clinical implications and 
suggestions for future research.
MaIn fIndIngS and ThEIR InTERPRETaTIOn
fetal and infant exposures
Maternal psychological distress during pregnancy has previously been associated with an increased 
risk of wheezing and asthma in early childhood5-7. These findings might reflect intra-uterine 
mechanisms as well as unmeasured confounding factors. Additionally, it is unclear whether these 
effects persist in later childhood. Therefore, we assessed the association of both maternal and 
paternal psychological distress during pregnancy with school-age lung function and asthma. We 
demonstrated that maternal psychological distress during pregnancy was consistently associated 
with a 1.5 to 2-fold increased risk of school-age asthma in the offspring, while paternal psycho-
logical distress during pregnancy was not (Table 5.1). Additionally, maternal overall psychological 
distress and maternal depressive symptoms were associated with a lower FEV1 and FVC in the 
children. The observed associations were not mediated by parental psychological distress after 
pregnancy, or childhood lower respiratory tract infections. These findings suggest that maternal 
psychological distress during pregnancy might have direct intra-uterine effects on fetal lung de-
velopment and later-life respiratory morbidity. Possible underlying biological mechanisms could 
be an impaired development of the fetal HPA axis or increased corticotrophin releasing hormone 
secretion due to maternal psychological distress, leading to developmental adaptations of the 
lungs8 9.
Previous studies have shown an association of breastfeeding with respiratory tract infections, 
wheezing and asthma10-12. In this thesis, we examined the association of breastfeeding with lung 
function and asthma at school age. We demonstrated that a shorter duration and non-exclusive 
breastfeeding were associated with a lower FEV1 and FVC (Table 5.1). Breastfeeding was not 
associated with asthma at school age. This might indicate that breastfeeding is only associated 
with short-term respiratory health, such as preschool wheezing and early-life respiratory tract 
infections. This could be explained by a diminishing protective effect of breastfeeding over time, 
234 Chapter 5
or a different effect for atopic and non-atopic asthma, since asthma at a later age is more likely to 
be atopic. Additionally, these findings suggests that the use of detailed breastfeeding measures, 
as opposed to examining ever breastfeeding only, is of importance. Although previous studies 
suggested that the association between breastfeeding and childhood asthma might be mediated 
by lower respiratory tract infections, our study showed that the observed associations were not. 
Differences in these findings might potentially be due to misclassification of asthma at an earlier 
age .
Thus, these findings suggest that both maternal psychological distress during pregnancy and 
duration and exclusivity of breastfeeding are of importance in the development of childhood 
respiratory health. These associations are not mediated by lower respiratory tract infections, 
suggesting that these exposures have a direct effect on respiratory health rather than an indirect 
effect mediated by increased susceptibility to respiratory infections. Future studies might specifi-
cally focus on the role of preventive strategies to improve mental health during pregnancy, and 
the association with offspring health.
Fetal and childhood infections
Respiratory tract infections could lead to airway sensitization, and subsequently airway hyperre-
activity and adverse respiratory health13-15. We studied the associations of respiratory tract infec-
tions with school-age asthma and lung function in two studies using data of one population-based 
prospective cohort, the Generation R study, and of 38 cohorts of an international collaboration. 
In the Generation R Study, we found that lower respiratory tract infections in early childhood 
were associated with an increased risk of lower lung function and asthma (Table 5.2). By using 
Table 5.1. Overview of the results presented in this thesis on fetal and infant exposures and school-age lung 
function and asthma.
Lung function
fEv1 fvC fEv1/fvC fEf75 Asthma
Maternal stress
Overall = = = = ↑
Anxiety = ↓ = = ↑
Depression ↓ ↓ = = ↑
Breastfeeding
Never = = = = =
Shorter ↓ ↓ = = =
Non-exclusive = ↓ = = =
Lung function was measured by spirometry, and asthma by questionnaire at age 10 years. FEV1: Forced Expira-
tory Volume in the first second. FVC: Forced Vital Capacity. FEF75: Forced Expiratory Flow after exhaling 75% 
of the FVC. . A ↑ represents a positive association, a ↓ a negative association, and a = that no association 
was observed.
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cross-lagged models, we demonstrated that lower respiratory tract infections were associated 
with wheezing, but not vice-versa. By performing a meta-analysis, we were able to use individual 
participant data from the general European population. This method allowed harmonization 
of the data, usage of the same set of confounders and therefore more powerful analyses. We 
demonstrated that early-life upper respiratory tract infections were associated with an increased 
risk of school-age asthma, and early-life lower respiratory tract infections with increased risks of 
school-age lower FEV1, FEV1/FVC and FEF75, and asthma (Table 5.2). Results were not modified 
by wheezing in early-life suggesting that these associations are present irrespective of possible 
early-life susceptibility to asthma. It is likely that both upper and lower respiratory tract infec-
tions have an effect on the immune system through adapted T-helper-2 and regulatory T-cell 
responses, which could subsequently lead to an increased risk of asthma16. Additionally, lower 
respiratory tract infections might have a more direct effect on the lungs through disruption of 
the normal lung development and growth, specifically in the small airways. This could in its turn 
lead to a lower lung function, predominantly airway obstruction and airflow limitation. Within 
the Generation R Study, we were also able to study possible bidirectional associations of upper 
and lower respiratory tract infections with wheezing, asthma and lung function. We observed 
that lower respiratory tract infection until the age of 3 years were most strongly and consistently 
associated with and increased risk of lower lung function and asthma at school age (Table 5.2). 
These associations were not found for lower respiratory tract infections after the age of 3 years, 
or upper respiratory tract infections at any age. Additionally, due to cross-lagged modelling, we 
observed that these associations were not bidirectional, i.e. wheezing was not associated with 
an increased risk of lower respiratory tract infections at a later age. This concurs with the finding 
from the meta-analysis that lower respiratory tract infections might influence the risk of lower 
lung function and asthma, irrespective of possible early-life susceptibility to asthma.
Specific infections might, next to respiratory tract infections, in specific periods influence 
the immune system, and subsequently lead to an increased risk of respiratory disease. First, 
we studied the association of maternal Chlamydia trachomatis infection during pregnancy, 
the most common sexually transmitted disease, with childhood respiratory health. Chlamydia 
trachomatis during pregnancy has been associated with an increased risk of prematurity and 
short-term respiratory health such as neonatal pneumonia17 18. However, the association with 
long-term respiratory health is unknown. We observed that maternal Chlamydia trachomatis 
infection during pregnancy was associated with an 1.5-fold increased risk of childhood wheezing, 
lower lung function, and a 2-fold increased risk of asthma at school age (Table 5.2). Chlamydia 
trachomatis infection during pregnancy was not associated with an increased risk of childhood 
lower respiratory tract infections. The association of maternal Chlamydia trachomatis during 
pregnancy with wheezing was partly explained by birth characteristics, such as gestational age 
at birth, while the association with lung function and asthma was not. This could indicate that 
the mediating effect of birth characteristics is only present on short-term respiratory health. 
Other mechanisms explaining the association of Chlamydia trachomatis during pregnancy with 
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wheezing, asthma and lung function could be an intra-uterine effect on the immune system of 
the fetus, leading to increased production of interleukins19. Additionally, Chlamydia trachomatis 
during pregnancy might have a direct effect on the lung, as shown by an increase in alveolar 
diameter in mice infected during the neonatal period20. Lastly, maternal Chlamydia trachomatis 
infection during pregnancy might cause chorio-amnionitis, which is associated with both preterm 
birth and an increased risk of asthma and lower lung function21 22. Further studies are needed to 
assess whether screening and treatment for Chlamydia trachomatis during pregnancy influences 
short- and long-term respiratory health.
Second, we assessed the association of Epstein-Barr virus and Cytomegalovirus infection with 
school-age lung function and asthma. Infections with Epstein-Barr virus and Cytomegalovirus 
are common in childhood. Both have a different immune response, and therefore infection with 
specific combinations of viruses might lead to disbalanced T-helper-cell mediated responses23. 
Subsequently, this could affect the risk of respiratory diseases. This is supported by a study 
that demonstrated that Cytomegalovirus in the absence of Epstein-Barr virus only is associated 
with an increased risk of atopy, but not asthma24. We assessed the association of Epstein-Barr 
virus, Cytomegalovirus and specific combinations of these viruses with lung function, asthma 
Table 5.2. Overview of the results of studies presented in this thesis on fetal and childhood infections and 
childhood respiratory health.
Lung function Symptoms and disease
fEv1 fvC fEv1/fvC fEf75 lRTI Wheezing Asthma
Respiratory infections
Generation R Study
URTI = = = = N.A. ↑ =
LRTI ↓ ↓ ↓ ↓ N.A. ↑ ↑
Meta-analysis
URTI = = = = N.A. n.s. ↑
LRTI ↓ = ↓ ↓ N.A. n.s. ↑
Maternal Chlamydia = = ↓ ↓ = ↑ ↑
herpesviridae
EBV = = = = n.s. n.s. =
CMV = = = = n.s. n.s. =
EBV and CMV combined = = = = n.s. n.s. =
Lung function was measured by spirometry at age 10 years. Lower respiratory tract infections and wheezing 
were measured by repeated questionnaires from age 2 months to 6 years, and age 1 to 10 years, respectively. 
Asthma was measured by questionnaire at age 10 years. FEV1: Forced Expiratory Volume in the first second. 
FVC: Forced Vital Capacity. FEF75: Forced Expiratory Flow after exhaling 75% of the FVC. URTI: upper respira-
tory tract infections. LRTI: lower respiratory tract infections. EBV: Epstein-Barr virus. CMV: Cytomegalovirus 
N.A.: not applicable. n.s.: not studied in this thesis. . A ↑ represents a positive association, a ↓ a negative 
association, and a = that no association was observed.
General discussion and summary 237
and inhalant allergic sensitization at school age. In the unadjusted analyses only, seropositivity 
for Epstein-Barr virus was associated with a higher FEV1 and FEF75, while seropositivity for both 
Epstein-Barr virus and Cytomegalovirus only was associated with a higher FEV1, FVC and FEF75 . 
Only Cytomegalovirus in the absence of Epstein-Barr virus was associated with an increased risk 
of inhalant allergic sensitization. However, after adjustment for confounders, all these associa-
tions attenuated into non-significant (Table 5.2). This was mostly explained by ethnicity of the 
child for associations of Epstein-Barr virus and Cytomegalovirus with lung function measures, and 
by all confounders for the association of Cytomegalovirus only with inhalant allergic sensitization. 
The results indicate no associations of Epstein-Barr virus and Cytomegalovirus with lung function, 
asthma and inhalant allergic sensitization. Rather, confounding factors such as socio-demographic 
and health-related factors, lifestyle-related factors and ethnicity are the explanation. Further 
studies should focus on the role of the age at acquired EBV and CMV infection, and specifically 
co-infections, on their association with lung function, asthma and inhalant allergic sensitization.
By studying these exposures, we were able to demonstrate the importance of early-life 
infections in the development of respiratory health. Future studies should focus on underlying 
mechanisms, and targets for possible preventive strategies.
Childhood bacterial carriage and the microbiome
Airway bacterial carriage during infancy with Haemophilus influenzae, Moraxella catarrhalis and 
Streptococcus pneumonia has been associated with an increased risk of lower respiratory tract 
infections, wheezing and asthma, specifically until 5 years of age25 26. However, airway bacterial 
carriage might have bidirectional associations with both upper and lower respiratory tract infec-
tions in the relation with childhood asthma. In this thesis, we demonstrated that airway bacterial 
carriage and upper respiratory tract infections do not influence each other (Table 5.3). Also, air-
way bacterial carriage and lower respiratory tract infections do not have consistent bidirectional 
associations, although M. catarrhalis and H. influenzae show some bidirectional associations with 
lower respiratory tract infections in the first year of life. Nasopharyngeal carriage with any bacte-
ria was associated with an increased risk of wheezing, especially in the first year of life, while no 
consistent association of any airway bacterial carriage with school-age lung function and asthma 
was found. These findings, combined with previous studies, suggest that airway bacterial carriage 
might have an effect on short-term respiratory health only, and not on long-term respiratory 
health. This could suggest that bacterial carriage, as opposed to the entire microbiome does not 
appropriately reflect the complexity of the association of bacteria with respiratory health.
Recently, advanced laboratory analyses have enabled us to study the composition of the entire 
microbiome, as opposed to single pathogens. The gut microbiome in infancy has been associated 
with childhood respiratory health, but the role of the gut microbiome at a later age in relation to 
respiratory health is not known27. We therefore assessed the association of the gut microbiome 
with lung function and asthma cross-sectionally in children aged 10 years. Both alpha and beta-
diversity were not associated with lung function and asthma (Table 5.3). Only one specific OTU 
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was borderline significant associated with a lower FEV1/FVC, while none OTUs were associated 
with asthma. The diversity and abudance of stool microbiota were associated with the risk of 
sensitization for inhalant allergens and psyhician-diagnosed inhalant allergy, and stool microbiota 
lipid metabolism pathways with physician-diagnosed inhalant allergy. These findings suggest that 
the effect of the gut microbiome on asthma might be limited in later childhood, although it might 
have an effect on allergic conditions.
Our findings indicate that mostly airway bacterial carriage and the microbiome in infancy are of 
importance in the development of respiratory health. Future studies using repeatedly measures 
of the airway and gut microbiome and the presence of lower respiratory tract infections and 
wheezing in early-life, are needed in order to better understand the role of the early-life influ-
ences and possible bidirectional associations.
METhOdOlOgICal COnSIdERaTIOnS
Most of the studies presented in this thesis were embedded in the Generation R Study, a prospec-
tive population-based cohort study from fetal life onwards. Additionally, an individual participant 
meta-analysis was performed, using data from 38 birth cohorts from Europe. Specific method-
ological considerations of the separate studies have been discussed in their respective chapters 
in this thesis. Some general methodological considerations, including selection bias, information 
bias, confounding and external validity will be discussed in the following section.
Table 5.3. Overview of the results of studies presented in this thesis on childhood bacterial carriage and the 
microbiome and childhood respiratory health.
Lung function Symptoms and disease
fEv1 fvC fEv1/fvC fEf75 uRTI lRTI Wheezing Asthma
Airway bacterial carriage
Nasal s. aureus = = = = = = = =
Any NP carriage = = = = = = ↑ =
Gut microbiome
Alpha diversity n.s. n.s. = n.s. n.s. n.s. n.s. =
Beta diversity n.s. n.s. = n.s. n.s. n.s. n.s. =
Specific OTUs n.s. n.s. = n.s. n.s. n.s. n.s. =
Lung function was measured by spirometry at age 10 years. Lower respiratory tract infections and wheezing 
were measured by repeated questionnaires from age 2 months to 6 years, and age 1 to 10 years, respectively. 
Asthma was measured by questionnaire at age 10 years. FEV1: Forced Expiratory Volume in the first second. 
FVC: Forced Vital Capacity. FEF75: Forced Expiratory Flow after exhaling 75% of the FVC. LRTI: lower respira-
tory tract infections. NP: nasopharyngeal. OTUs: operational taxonomic units. n.s.: not studied in this thesis. 
A ↑ represents a positive association, a ↓ a negative association, and a = that no association was observed.
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Selection bias
Selection bias occurs when the likelihood of being selected for a study, or being retained in the 
study during follow-up leads to a result that is different from the result when the entire target 
population is selected. The percentage of pregnant women eligible for enrolment in the Genera-
tion R Study that are actually included in the study is not estimable. However, the response rate 
based on the number of children at birth is 61%28. Household income and highest education of 
the parents suggest a selection towards the more affluent population, since both income and 
education are higher than in the whole study area. Loss to follow-up might be related to either 
exposure or outcome, and could therefore potentially lead to biased results. This bias could cause 
either over- or underestimation of the effect. Of the original participating cohort, 82% were 
able to be invited, and of those 93% participated in the study at school-age28. Those not lost 
to follow-up were older, more frequently Dutch and higher educated. This selections toward a 
relatively healthy population could have led to biased effect estimates. This might have led to 
either an over- or underestimation of the effect, if the associations of those lost to follow-up with 
respiratory health would be different from those included in the study. This is unlikely, but cannot 
be excluded.
Information bias
Information bias, or misclassification, is defined as incorrect classification of the information 
about participants. This misclassification is non-differential if it is random, i.e. not related to 
exposure or outcome, and differential if it is non-random, i.e. related to exposure or outcome. 
While differential misclassification could lead to either over- or underestimations of the effect, 
non-differential misclassification usually leads to an underestimation of the effect. Various of 
the exposures in this thesis, including parental psychological distress, maternal Chlamydia tra-
chomatis during pregnancy, breastfeeding, and child’s airway bacterial carriage, respiratory tract 
infections and herpesviridae have been collected before outcome assessments. Additionally, both 
parents and researchers involved in the initial data collections were not aware of the research 
questions, which makes differential misclassification less likely. Maternal Chlamydia trachomatis 
infection during pregnancy, childhood airway bacterial carriage, microbiome composition and 
herpesviridae have been measured by objective tests and therefore misclassification is less likely 
to occur. Breastfeeding and respiratory tract infections were self-reported by the parents, which 
could lead to differential misclassification. Mothers might have overreported breastfeeding prac-
tices, since breastfeeding is deemed as the most healthy choice. This would most likely have led 
to an underestimation of the effect of breastfeeding on lung function or asthma. For respiratory 
tract infections, only physician-attended infections were taken into account, in order to minimize 
bias.
Although lung function measured by spirometry does depend on maximal performance of 
the participants, researchers were unaware of lung function or asthma status of the participant 
making differential misclassification less likely. Wheezing and asthma were measured by validated 
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questionnaires, but since these were self-reported by the parents differential misclassification 
might have occurred. This could have led to both over- and underestimation of the effect. Thus, 
although misclassification might have occurred, we suspect this effect to be minimal.
Confounding
A confounder can be characterized as a variable that influences both exposure and outcome, 
and is no intermediary in the causal chain. If confounders are not taken into account in the 
analysis, this may lead to biased effect estimates. The studies presented in this thesis were all 
adjusted for many potential confounders, which have been selected from literature and tested in 
our population. However, we cannot fully exclude the possibility of residual confounding, due to 
unmeasured variables or variables that are not known as a possible confounder.
External validity
External validity reflects the generalizability of the results of a study to other populations. The 
Generation R Study is based on the general population in Rotterdam, the Netherlands, with a dis-
tribution of different ethnic groups comparable to the city. When compared to the characteristics 
at enrolment, mothers who still participated when their children were adolescents were older, 
more frequently Dutch and higher educated28. This pattern of loss to follow-up is comparable 
to other population-based prospective cohort studies. However, this selection towards a more 
affluent population should be kept in mind when results are applied to other populations.
The meta-analysis was performed with data from 38 different cohort studies from across Eu-
rope. Although some Eastern European countries were included, these were underrepresented. 
Additionally, as within the Generation R Study, it could be assumed that those still participating 
in these studies during follow-up were likely higher educated and more frequently Caucasian. 
However, the results from this study are most likely a fair representation of the general European 
population.
Methodological issues in meta-analyses
In an individual participant data (IPD) meta-analysis, the original data from participants is col-
lected and analysed, as opposed to a meta-analysis in which the results from published studies 
are combined. The main advantages of an IPD meta-analysis is that it allows for better harmonisa-
tion of the data and that it is not subject to publication and reporting bias, therefore minimizing 
the risk of biased results. By using the raw data, we were able to better harmonize data and per-
form sensitivity analyses to account for possible differences in results due to different methods 
of data ascertainment. We found similar results for cohorts using ISAAC –based questionnaires 
for asthma, which are validated for epidemiological research, when compared to the results of 
the full meta-analysis. However, there were substantial differences between cohorts in terms 
of prevalence of respiratory tract infections, which might not only reflect true differences in 
prevalence between countries, but also differences in data ascertainment. This would most likely 
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reflect non-differential misclassification, leading to an underestimation of the effect. Additionally, 
in an IPD meta-analysis, both a one-stage and two-stage approach can be used for the analyses. 
In a one-stage approach, all data is synthesized while taking account of clustering of data within 
the same cohort, while in a two-stage approach, data is analysed per cohort and effect estimates 
are then combined while taking account of the relative size of the cohort. In general, a one-stage 
model yields more reliable results in the case of heterogeneity or smaller numbers, while two-
stage models are less computationally difficult and can easily visualize heterogeneity by means of 
forests plots29 30. In our meta-analysis, we used both methods in order to test the robustness of 
the results. Both methods yielded similar results.
CauSalITy
The findings from this thesis are based on observational studies, which makes it difficult to estab-
lish causality. Randomized clinical trials could not be conducted for ethical or practical reasons. 
However, the Bradford Hill criteria can be useful in establishing evidence for a possible causal 
relationship. These include strength, consistency, specificity and temporality of the associations, 
a dose-response relationship, a plausible mechanism, coherence with for example animal stud-
ies and experimental evidence. For the associations of parental psychological distress, early-life 
respiratory tract infections and Chlamydia trachomatis during pregnancy with respiratory health, 
we found consistent associations for similar exposures and outcomes. For all associations except 
microbiota and respiratory health, the exposure was measured before the outcome, indicating 
causality. For all observations plausible mechanisms, partly supported by animal studies, are 
available. Thus, causal inference could largely be drawn from our observational studies since 
certain criteria have been met.
ClInICal IMPlICaTIOnS and fuTuRE PERSPECTIvES
The results presented in this thesis are based on observational data, which limits the possibility 
to draw conclusions about underlying mechanisms. Still, some clinical implications and future 
perspectives can be discussed.
We demonstrated the importance of fetal and infant exposures in the development of respira-
tory health. The association of maternal psychological distress with offspring asthma demonstrates 
the importance of attention for mental health during pregnancy. Further studies could focus on 
the effect of preventive strategies to improve mental health before and during pregnancy, and the 
effect on offspring health. For example, a randomized clinical trial of pregnant woman giving one 
group regular care and one group mind-body therapy using attractive group educational sessions 
by well-trained nurses during pregnancy could be of benefit. Additionally, studies focusing on 
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the underlying mechanisms, such as cortisol levels during pregnancy or epigenetics could be of 
interest.
In this thesis, fetal and childhood infections were identified, which might contribute to the 
development of respiratory health. Hypothetically, prevention of infections could lead to im-
provement of respiratory health. One example of this is a trial, in which preterm born children 
are randomized to receive either a monoclonal antibody (palivizumab) which protects against re-
spiratory syncytial virus, or placebo. Palivizumab seemed protective against wheezing in the first 
year of life, although the effects at preschool age seem more limited with only a decreased risk 
of current asthma, but not ever asthma or lung function31 32. This is however limited to preterm 
infants, and future studies could focus on the effect in other risk groups, or the full population. 
Additionally, respiratory tract infections might be used in risk stratification or predictive tools in 
the identification of those at risk for adverse respiratory health. Future studies might also focus on 
the mechanisms underlying the association of Chlamydia trachomatis infection during pregnancy 
with asthma-related morbidity, and the possible effect of early identification of those infected. 
Since Chlamydia trachomatis is easily and effectively treated, even during pregnancy, screening 
programs might lead to improved offspring health33.
In this thesis, we found a minimal association of airway bacterial carriage in infancy, and the 
gut microbiome at school-age, with asthma-related morbidity only. However, bacterial carriage 
identified by culturing may underestimate the importance of the full range of the bacterial 
composition and the interaction between bacteria, and these are better reflected by the airway 
microbiome. There are suggestions that the airway microbiome in infancy is associated with short 
term respiratory health, including wheezing and lower respiratory tract infections34-36. The asso-
ciation with long-term respiratory health, including school-age lung function and asthma, as well 
as the possible bidirectional relationship between the airway microbiome and respiratory tract 
infections is less clear, and would be an interesting target for future studies. Lastly, we did not 
find a consistent relationship between the gut microbiome and respiratory health at school-age. 
The gut microbiome in infancy does seem to impact respiratory health, but similar to the airway 
microbiome, data on long-term effects of the gut microbiome on respiratory health is lacking27 37. 
Shifts in microbiome composition have a local but also a strong systemic effect such as altering 
maturation of the immune system into a more inflammatory state by altered T-helper 2 (Th2) 
activity 38 39. Also, low-grade, chronic inflammation is suggested to lead to tissue and organ altera-
tions potentially increasing the risk of chronic lung diseases 40-45. An integrative approach using 
the microbiome and its relation with different biomarkers for chronic systemic inflammation and 
its effects on chronic lung disease outcomes at a population-based level would be of interest for 
future studies, as well as preventive strategies to influence the gut microbiome composition in 
early life.
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COnCluSIOn
Most likely, an important part of the origins of asthma lie in early life. In this thesis, we identi fi ed 
early-life exposures, specifi cally infecti ons and bacteria, leading to an increased risk of adverse 
respiratory health in childhood (Figure 5.1). Further studies are needed to explore possible un-
derlying mechanisms for these associati ons. Future studies could focus specifi cally on preventi on 
and risk predicti on of early-life infecti ons, the role of the airway and gut microbiome in infancy 
and the possible bidirecti onal relati onship between infecti ons and the microbiome in the devel-
opment of respiratory health. Additi onally, future preventi ve strategies could be developed to 
improve childhood respiratory health.
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Figure 5.1. Overview of exposures infl uencing childhood asthma development studied in this thesis. Grey font 
denotes that the exposure is not associated with lower lung functi on and asthma.
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In dit proefschrift onderzochten we de hypothese dat factoren vroeg in het leven, en meer spe-
cifiek luchtweg- en specifieke infecties en bacteriën, kunnen zorgen voor veranderingen in de 
ontwikkeling van het respiratoire en immuunsysteem, wat vervolgens kan leiden tot een hoger 
risico op een lagere longfunctie en astma op de kinderleeftijd. De identificatie van deze blootstel-
lingen en infectieziekten vroeg in het leven die kunnen bijdragen aan de ontwikkeling van een 
slechtere gezondheid van de longen kunnen helpen bij het begrijpen van de ontwikkeling van een 
lagere longfunctie en astma. Hiermee kan de eerste stap genomen worden voor het ontwikkelen 
van preventie strategieën.
In hoofdstuk 1 wordt de achtergrond en de rationale van de studies die beschreven worden 
in dit proefschrift gegeven. Tevens worden de onderzoeksdoelen van de studies beschreven en 
wordt de indeling van het proefschrift toegelicht.
hoofdstuk 2 beschrijft de associatie van blootstellingen in het foetale leven en op de zuige-
lingenleeftijd met longfunctie en astma op de schoolleeftijd, en of deze associaties gemedieerd 
worden door lage luchtweginfecties. In Hoofdstuk 2.1 beschrijven we dat psychische klachten 
van moeder tijdens de zwangerschap geassocieerd zijn met een hoger risico op astma en deels 
ook lagere longfunctie bij hun kinderen op de schoolleeftijd. Psychische klachten van de partner 
tijdens de zwangerschap zijn niet geassocieerd met lagere longfunctie of astma. Dit impliceert dat 
psychische klachten van moeder tijdens de zwangerschap een direct effect zouden kunnen hebben 
op de longontwikkeling van het kind, en niet zozeer dat dit verklaard zou kunnen worden door bij-
voorbeeld leefstijlfactoren die moeder en partner delen. Hoofdstuk 2.2 beschrijft dat een kortere 
duur van borstvoeding en niet-exclusieve borstvoeding deels geassocieerd zijn met een lagere 
longfunctie op de schoolleeftijd. Borstvoeding was niet geassocieerd met astma. Dit geeft aan 
dat borstvoeding waarschijnlijk alleen een effect heeft op gezondheid van de longen in de eerste 
levensjaren, en dat het van belang is om gedetailleerdere maten van borstvoeding te gebruiken 
in onderzoek naar de relatie van borstvoeding met longfunctie of astma. Zowel de associatie van 
psychische klachten van moeder tijdens de zwangerschap als borstvoeding met longfunctie en 
astma worden niet verklaard door lage luchtweginfecties bij het kind. Hoogstwaarschijnlijk heb-
ben deze blootstellingen in het vroege leven een direct effect op longfunctie en astma, in plaats 
van dat deze zorgen voor een verhoogde gevoeligheid voor lage luchtweginfecties.
Samenvattend tonen we een associatie aan van psychische klachten van de moeder tijdens de 
zwangerschap met een lagere longfunctie en astma, en van duur en exclusiviteit van borstvoeding 
met een lagere longfunctie bij het kind.
In hoofdstuk 3 beschrijven we de associaties van infecties tijdens de zwangerschap en op de 
kinderleeftijd met gezondheid van de longen op kinderleeftijd. Zowel Hoofstuk 3.1 als 3.2 richten 
zich op het effect van luchtweginfecties met longfunctie en astma. In Hoofdstuk 3.1 laten we 
zien dat lage luchtweginfecties in de eerste drie levensjaren geassocieerd zijn met een lagere 
longfunctie en een verhoogd risico op astma op schoolleeftijd. Tevens tonen we aan dat deze 
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associaties onafhankelijk zijn van een piepende ademhaling op kinderleeftijd en dat een piepende 
ademhaling niet geassocieerd is met een hoger risico op lage luchtweginfecties op latere leeftijd. 
Hoofdstuk 3.2 richt zich tevens op de associatie van luchtweginfecties met longfunctie en astma, 
waarbij er gebruik gemaakt wordt van data uit de algemene Europese populatie. We laten zien 
dat bovenste luchtweginfecties geassocieerd zijn met een hoger risico op astma, terwijl lage 
luchtweginfecties geassocieerd zijn met zowel een lagere longfunctie als een hoger risico op 
astma. Deze associaties blijven bestaan wanneer we stratificeren voor een piepende ademha-
ling ten tijde van de luchtweginfectie. Deze bevindingen impliceren dat luchtweginfecties het 
risico op een lagere longfunctie en astma ten minste deels onafhankelijk van enige predispositie 
voor astma beïnvloeden. In hoofdstuk 3.3 bekijken we de associatie van maternale Chlamydia 
trachomatis tijdens de zwangerschap met gezondheid van de longen op kinderleeftijd. Maternale 
Chlamydia trachomatis tijdens de zwangerschap is geassocieerd met een lagere longfunctie en 
een verhoogd risico op astma op schoolleeftijd, en met een piepende ademhaling op kinder-
leeftijd. Maternale Chlamydia trachomatis tijdens de zwangerschap is echter niet geassocieerd 
met lage luchtweginfecties op kinderleeftijd. Hoofdstuk 3.4 beschrijft dat Epstein-Barr virus en 
Cytomegalovirus voor de leeftijd van 6 jaar niet geassocieerd zijn met een lagere longfunctie, 
astma en allergische sensitisatie wanneer andere verklarende factoren zoals etniciteit en leefstijl 
in acht genomen worden.
Samenvattend tonen we aan dat infecties tijdens de zwangerschap en op kinderleeftijd, zoals 
luchtweginfecties en maternale Chlamydia trachomatis tijdens de zwangerschap, geassocieerd 
zijn met een verhoogd risico op een lagere longfunctie en astma op kinderleeftijd. Epstein-Barr 
virus en Cytomegalovirus zijn niet geassocieerd met gezondheid van de longen indien er rekening 
gehouden wordt met leefstijl, sociaal-economische factoren en ethniciteit.
hoofstuk 4 beschrijft de associatie van bacterieel dragerschap en het microbioom met gezond-
heid van de longen. In Hoofdstuk 4.1 tonen we aan dat bacterieel dragerschap van de luchtwegen 
geassocieerd is met een piepende ademhaling in de eerste levensjaren. Bacterieel dragerschap 
van de luchtwegen is niet geassocieerd met longfunctie en astma op schoolleeftijd. Tevens laten 
we zien dat bacterieel dragerschap van de luchtweg en lage luchtweginfecties elkaar niet lijken 
te beïnvloeden. Hoofdstuk 4.2 richt zich op de cross-sectionele associatie van het microbioom 
van de darm met longfunctie en astma op schoolleeftijd, en laat zien dat het darmmicrobioom 
niet geassocieerd is met longfunctie of astma, maar wel met inhalatie allergie en sensitisatie voor 
inhalatieallergenen. Hoofdstuk 4.3 geeft een overzicht van de rol van luchtweginfecties en het 
microbioom in de ontwikkeling van een lagere longfunctie, astma en een piepende ademhaling.
Samenvattend tonen we aan dat bacterieel dragerschap in het vroege leven geassocieerd is 
met een piepende ademhaling, terwijl zowel bacterieel dragerschap van de luchtwegen in het 
vroege leven als het microbioom van de darm op schoolleeftijd niet geassocieerd zijn met long-
functie of astma.
Samenvatting 253
Tot slot wordt in hoofdstuk 5 een algemeen overzicht en interpretatie van de studies die 
beschreven worden in dit proefschrift gegeven. Tevens worden methodologische overwegingen, 
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